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 ABSTRACT 
Distal Determinants of Cardiovascular Disease Risk Factors 
Amna Umer 
Introduction: Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in 
the world. West Virginia (WV) has one of the highest prevalence of CVD in the United States. 
The first two studies examined the association between perinatal risk factors (birth weight (BTW) 
and breastfeeding) and subsequent childhood and maternal CVD risk factors 11 years post-
partum. The purpose of the third study was to conduct a systematic review and meta-analysis to 
examine the evidence regarding the relationship between childhood obesity and adult CVD risk 
factors. 
Method: We used longitudinally linked data from three cross-sectional datasets in WV for the 
first (N=19,583) and second study (N=10,457). The outcome variables included blood pressure 
for children and lipid levels for both mothers and children. The exposures were BTW of the 
infant (study 1) and reported history of breastfeeding obtained retrospectively when the child was 
in fifth grade (study 2). Mean differences, correlations, and simple regression analyses were 
performed to examine the unadjusted associations. Multiple regression analysis was performed 
adjusting for current body mass index (BMI) and additional covariates. For the third study, the 
search strategy included (1) electronic searches in multiple databases (PubMed (MEDLINE), 
Web of Science, and Scopus) on June 5, 2015, and (2) citation tracking (N=4,840 citations). 
Studies were included if they met the following criteria (1) longitudinal study-design, (2) 
childhood exposure and adult outcomes collected on the same individual over time, (3) childhood 
obesity, as defined by the authors, (4) English language articles, (5) studies published by June, 
2015, (6) the primary outcome measures included: systolic blood pressure (SBP), diastolic blood 
pressure (DBP), total cholesterol (TC), high-density lipoprotein cholesterol (HDL), low-density 
lipoprotein cholesterol (LDL), non-high-density lipoprotein cholesterol (non-HDL), triglycerides 
(TG), and (7) outcome not self-reported.  
Results: BTW was significantly associated with HDL (b= 0.14mg/dL; 95% CI: 0.11, 0.18), LDL 
(b = -0.1mg/dL; 95% CI: -0.19, -0.016), non-HDL (b = -0.18mg/dL; 95% CI: -0.28, -0.09), and 
log-TGs (b=-0.007 (-0.008, -0.005) per 1000 g increase in BTW in the adjusted analyses. There 
was a positive association between BTW and maternal TC levels, which became non-significant 
in the adjusted analysis [b= 0.4 mg/dL (95% CI: -0.01, 0.90) per1000 g increase in BTW]. None 
of the other maternal lipids were significant in the unadjusted or the adjusted analysis. For the 
second study, there was a significant association between reported history of breastfeeding and 
child’s TGs (beta=-0.04; 95% CI: -0.06, -0.01) when adjusted for the child’s current BMI and 
additional covariates. Maternal lipids were not significantly related to their breastfeeding history. 
For the third study, a total of 23 studies were included in the systematic review and 21 in the 
meta-analysis. The findings suggest that childhood obesity is significantly and positively 
associated with adult SBP (Zr = 0.11; 95% CI: 0.07, 0.14), DBP (Zr = 0.11; 95% CI: 0.07, 0.14), 
and TG (Zr =0.08; 95% CI: 0.03, 0.13), and inversely associated with adult HDL (Zr =-0.06; 95% 
CI: -0.10, -0.02). For those studies that adjusted for adult BMI, associations were reversed.  
Conclusion: Low BTW was associated with poor lipid levels (LDL, HDL, non-HDL, and TG) 
and breastfeeding was protective for TGs in fifth grade children independent of their current 
BMI. As CVD risk factors persist from childhood into adulthood, the small effect sizes observed 
in the first two studies can have potential unfavorable consequence on lipid levels in later 
adulthood. The results of the systematic review with meta-analysis suggest that childhood obesity 
is significantly and positively associated with adult SBP, DBP, and TG and negatively associated 
with adult HDL. Well-designed, longitudinal studies with improved reporting as well as data 
analysis that include both unadjusted and adjusted associations for adult adiposity are needed 
before any definitive conclusions can be made. 
 iii 
DEDICATION 
I dedicate my doctoral dissertation to my parents and my husband. Thank you for your love, 
support, and encouragement throughout my life.  
 
 
ACKNOWLEDGEMENTS 
I would like to express sincere gratitude to my dissertation committee chair Dr. Christa Lilly for 
her constant guidance, support, and friendship without which this work would not have been 
possible. I would like to thank all my committee members Dr. Lesley Cottrell, Dr. Peter 
Giacobbi, Dr. Kim Innes, and Dr. George Kelley for their invaluable advice and support. I would 
specially like to thank Dr. George Kelley for teaching me the complex science of conducting 
systematic reviews and meta-analysis; Dr. Collin John, Candice Hamilton, and Cris Britton for 
not only providing me with the data for my dissertation but for their incredible support and 
encouragement for the past four years; the faculty and staff at the School of Public Health, the 
WATCH/Birth Score Project team, and the CARDIAC Project team at West Virginia University; 
Dr. Roger Edwards from Northeastern University for mentoring me on my first research project; 
my family and friends who provided unconditional love and support throughout this journey. 
Lastly, I wish to thank my husband who has been my biggest cheerleader and supporter 
throughout this process.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 iv
Table of Contents 
CHAPTER 1: Project overview ........................................................................................ 1 
Introduction ............................................................................................................................... 1 
Cardiovascular Disease (CVD) ............................................................................................... 1 
CVD Risk Factors.................................................................................................................... 1 
Early Life Exposure and Origins of Childhood and Maternal CVD Risk Factors .................. 5 
Distal Determinants of CVD Risk Factors .............................................................................. 6 
Summary .................................................................................................................................... 6 
Specific Aim 1 ......................................................................................................................... 7 
Specific Aim 2 ......................................................................................................................... 8 
Specific Aim 3 ......................................................................................................................... 8 
CHAPTER 2: Birth weight and childhood and maternal cardiovascular disease risk 
factors ............................................................................................................................... 10 
Abstract .................................................................................................................................... 10 
Introduction ............................................................................................................................. 11 
Child Birth Weight and Child CVD Risk Factors ................................................................. 12 
Child Birth Weight and Maternal CVD Risk Factors ............................................................ 13 
Low Birth Weight, Preterm Births, and Small for Gestational Age ...................................... 14 
Statement of the Problem ...................................................................................................... 15 
Methods and Materials ........................................................................................................... 16 
Data Sources .......................................................................................................................... 16 
Variables ................................................................................................................................ 17 
Statistical Analysis ................................................................................................................ 20 
Results....................................................................................................................................... 22 
Discussion ................................................................................................................................. 24 
Blood Pressure in Children .................................................................................................... 24 
Lipids in Children .................................................................................................................. 25 
Adjusting for Current BMI .................................................................................................... 26 
Lipids in Mothers .................................................................................................................. 27 
Limitations of the Study ........................................................................................................ 28 
Strengths of the Study ........................................................................................................... 28 
Conclusion ................................................................................................................................ 29 
Chapter 3: Breastfeeding and childhood and maternal cardiovascular risk factors 30 
Abstract .................................................................................................................................... 30 
Introduction ............................................................................................................................. 31 
Breastfeeding and Childhood CVD Risk Factors .................................................................. 32 
Breastfeeding and Maternal CVD Risk Factors .................................................................... 33 
Biology of Breastfeeding and CVD....................................................................................... 34 
Statement of the Problem ...................................................................................................... 35 
Methods and Materials ........................................................................................................... 36 
Data Sources. ......................................................................................................................... 36 
Variables. ............................................................................................................................... 37 
Statistical Analysis. ............................................................................................................... 39 
Results....................................................................................................................................... 41 
Discussion ................................................................................................................................. 43 
Blood Pressure in Children .................................................................................................... 43 
Lipid in Children ................................................................................................................... 44 
Lipid in Mothers .................................................................................................................... 46 
Limitations of the Study ........................................................................................................ 47 
 v
Strengths of the Study ........................................................................................................... 47 
Conclusion ................................................................................................................................ 48 
Chapter 4: Childhood obesity and adult cardiovascular disease risk factors: a 
systematic review with meta-analysis. ........................................................................... 49 
Abstract .................................................................................................................................... 49 
Introduction ............................................................................................................................. 50 
Overview ............................................................................................................................... 50 
Obesity and CVD Risk Factors ............................................................................................. 50 
Critical Evaluation of Existing Knowledge ........................................................................... 51 
Significance of the Topic ....................................................................................................... 52 
Research Design and Methods ............................................................................................... 53 
Purpose .................................................................................................................................. 53 
Study Eligibility .................................................................................................................... 53 
Data Sources .......................................................................................................................... 54 
Study Selection ...................................................................................................................... 55 
Data Abstraction. ................................................................................................................... 55 
Risk of Bias Assessment ....................................................................................................... 55 
Statistical Analysis ................................................................................................................ 56 
Results....................................................................................................................................... 60 
Study Characteristics ............................................................................................................. 60 
Participant Characteristics ..................................................................................................... 61 
Risk of Bias Assessment ....................................................................................................... 62 
Primary Outcomes ................................................................................................................. 62 
Sensitivity Analysis ............................................................................................................... 67 
Discussion ................................................................................................................................. 68 
Findings ................................................................................................................................. 68 
Critical Evaluation of Results compared to Previous Systematic Reviews and Meta-analysis 
on the Topic ........................................................................................................................... 70 
Implications for Research ...................................................................................................... 72 
Implications for Practice ........................................................................................................ 73 
Strengths of the Study ........................................................................................................... 73 
Limitations of the Study ........................................................................................................ 74 
Conclusion ................................................................................................................................ 75 
Chapter 5: Discussion ..................................................................................................... 76 
Summary of Key Findings ...................................................................................................... 76 
Overview ............................................................................................................................... 76 
Birth Weight and CVD Risk Factors ..................................................................................... 77 
Breastfeeding and CVD Risk Factors .................................................................................... 79 
Childhood Obesity and Adult CVD Risk Factors ................................................................. 80 
Limitations of the Dissertation .............................................................................................. 82 
Strengths of the Dissertation ................................................................................................. 82 
Potential Public Health Implications and Future Recommendations .................................... 83 
Conclusion ................................................................................................................................ 85 
References ........................................................................................................................ 85 
Chapter 1 .................................................................................................................................. 86 
Chapter 2 .................................................................................................................................. 93 
Chapter 3 ................................................................................................................................ 100 
Chapter 4 ................................................................................................................................ 107 
Chapter 5 ................................................................................................................................ 114 
 vi
Tables ............................................................................................................................. 120 
Chapter 2 ................................................................................................................................ 120 
Supplemental Tables Chapter 2 ........................................................................................... 133 
Chapter 3 ................................................................................................................................ 138 
Supplemental Table Chapter 3 ............................................................................................ 148 
Chapter 4 ................................................................................................................................ 155 
Figures ............................................................................................................................ 163 
Chapter 4 ................................................................................................................................ 163 
Additional Files ............................................................................................................. 177 
Chapter 4 ................................................................................................................................ 177 
 1
CHAPTER 1: Project overview 
Introduction 
 
Cardiovascular Disease (CVD) 
Cardiovascular Disease is the leading cause of death in the world and also in the United 
States (U.S.). According to the Global Burden of Disease Study, more than 17.3 million people 
died from CVD in 2013, representing 31% of all global deaths1,2 and nearly 50% of deaths from 
chronic diseases worldwide.3 The number of CVD mortalities is projected to rise to more than 
23.6 million by 2030.4,5 Based on U.S. mortality data, CVD accounted for 34.3% deaths in 2006,6 
32.8% deaths in 2008,7 31.9% deaths in 2010,8 and 30.8% of all deaths in 2013.4 Although CVD 
mortality rate is declining, it is still the leading cause of death in the U.S. and accounts for nearly 
1 out of 3 deaths.4 According to the 2016 Heart Disease and Stroke Statistics update, more than 
one third of U.S. adults have one or more than one types of CVD.4 For 2011-12, the estimated 
cost of CVD (direct and indirect) was $316.6 billion, which is projected to increase to $918 
billion by 2030.4  There are geographic disparities in the CVD prevalence in the U.S. The 
Appalachian region in the southeastern U.S. has among the highest rates of CVD compared to 
rest of the nation.9-11 West Virginia (WV), a state entirely within the Appalachian region, has one 
of the highest CVD mortality rates in the U.S.4 In 2013, the age adjusted CVD mortality rate in 
WV was 270.6 per 100,000, ranking 47th in the nation (U.S.: 225.2 per 100,000 population).4 
With such a high prevalence of CVD, it becomes important to assess the risk factors of CVD in 
order to implement preventative measures. Some of the known risk factors for CVD include high 
blood pressure (hypertension), abnormal lipid profile, obesity, diabetes mellitus, and family 
history of heart disease, which are linked to known risky health behaviors such as smoking, 
physical inactivity, poor diet, and excessive alcohol intake.12-15 Previously these risk factors were 
thought to be prevalent in adulthood only, but are now detected during early childhood and 
adolescence as well.16,17 These risk factors have the propensity to track from childhood into 
adulthood and thus are considered predictors of adult CVD risk factors.18 As current adolescents 
enter adulthood, the prevalence of CVD is expected also to rise,19 as projected that more than 
43% of men and 45% of women in the U.S. will have some form of CVD and 41.4% will have 
hypertension by 2030.4,20  
 
CVD Risk Factors  
For this study we focus on three CVD risk factors: (1) blood pressure measured by 
systolic blood pressure (SBP) and diastolic blood pressure (DBP), (2) lipids including total 
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cholesterol (TC), low-density lipoprotein cholesterol (LDL), high-density lipoprotein cholesterol 
(HDL), non-high-density lipoprotein cholesterol (non-HDL), and triglycerides (TG), and (3) 
obesity.  
High Blood Pressure. High blood pressure can be due to high SBP ≥140 mmHg or high 
DBP ≥90 mmHg or both. Hypertension is defined as SBP and DBP ≥140/90 mmHg for adults’ 
≥20 years, and ≥95th percentile for age and sex for children and adolescents.21 High SBP, high 
DBP, and hypertension are all independent risk factors for CVD.22-24 Hypertension is responsible 
for approximately two-thirds of stroke and one-half of ischemic heart diseases.25,26 According to 
National Health and Nutrition Examination Survey (NHANES) 2009-2012 data, nearly one third 
(32.6%) of U.S. adults’ ≥20 years have hypertension.27 Among children and adolescents ages 8 -
17, 11.0% have pre-hypertension (SBP or DBP ≥90 but less than 95 percentile) or hypertension 
(SBP or DBP ≥95th percentile), which remained unchanged since 1999-2000.4,27 A systematic 
review with meta-analysis concluded that high blood pressure tracks strongly from childhood into 
adulthood with the average tracking correlation coefficients of 0.38 and 0.28 for SBP and DBP 
respectively.28 Not only is hypertension in adulthood one of the leading causes of heart diseases 
in the U.S.29,30, but children with hypertension may also have evidence of cardiovascular end-
organ damage such as increased left ventricular mass and thickness of carotid artery intima media 
(potential markers of hypertensive vascular damage).31-33 According to the United States Center 
for Disease Control and Prevention (CDC)’s 2013 Behavioral Risk Factor Surveillance System 
(BRFSS), the state-specific prevalence of adult hypertension in the U.S. ranges from 24%-41%. 
WV has the highest prevalence of adult hypertension in the nation (rank 50).34 Additionally, 
results from the WV CARDIAC project 2014-2015 found nearly 23% fifth grade children in WV 
to have hypertension (SBP and/or DBP ≥95% percentile).35  
Abnormal serum lipid and lipoprotein concentrations. Abnormal serum lipid and 
lipoprotein cholesterol levels (high TC, LDL, TG, non-HDL, and low HDL) are another 
established risk factor for CVD.14,15,36 Adults with high TC have nearly twice the risk of heart 
disease compared to those with normal cholesterol levels.37 High cholesterol in early life has also 
been associated with preclinical atherosclerosis that contributes to adult atherosclerosis.38-41 The 
criteria for high risk for each component of lipid profile in children and adolescents vary by age 
and gender but are based on having an individual lipid component ≥95th percentile.42 For 10-19 
year old children the individual components ≥95th percentile corresponds to approximately: TC 
≥200mg/dL, LDL ≥130 mg/dL, TG ≥130 mg/dL HDL <40 mg/dL, and non-HDL ≥145 mg/dL.42-
44 For adults the criteria for high risk for each component of lipid profile is: TC ≥240 mg/dL, 
LDL ≥160 mg/dL, TG ≥200 mg/dL, and HDL <40 mg/dL.45,46 According to the 2016 Heart 
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Disease and Stroke Statistics update,4 mainly based on NHANES 2009-2012 data showed that the 
prevalence of high TC was 13% in U.S. adults ≥20 years and 8.5% in adolescents ages 12-19. 
High LDL was prevalent in 27% of U.S. adults’ ≥20 years and nearly 7% in adolescents ages 12-
19. The proportion of low HDL varied significantly by gender. Nearly 25% of men and less than 
10% of women ≥20 years had low HDL47 and 19.5% of boys and 11% of girls (ages 12-19) had 
low HDL.4 For TG nearly a quarter (25.1%) of adults’ ≥20 years had high TG and the proportion 
in children and adolescents 12-19 years old, 10% males and 6.5% females had high TG.4 Based 
on CDC’s BRFSS 2013, WV ranks 48th in the nation with the prevalence of high TC among 
adults.34 Additionally, results from the WV CARDIAC project 2014-2015 showed that nearly 5% 
of children in fifth grade have high LDL (≥130 mg/dL) and 17% have low HDL (<40 md/dL).35 
Although nationally the prevalence of high total cholesterol and low HDL is declining in children 
ages 8-17;27 it is still an important CVD risk factor. Furthermore, as observed with high blood 
pressure, abnormal serum lipid and lipoprotein also track from childhood into adulthood as 
well.48-51  
Overweight and obesity. Overweight and obesity is another major risk factor for CVD.52 
Body Mass Index (BMI) is a person's weight in kilograms divided by the square of height in 
meters used to establish the weight status of an individual. However, at a population level it is 
one of the most commonly used measures to assess body fatness. BMI correlates well with the 
individual’s adiposity status, and is also a convenient and an inexpensive method.53,54 Overweight 
is defined as 25.0 ≤ BMI ≤ 29.9 kg/m2, and obese is defined as BMI ≥30.0 kg/m2 in adults.55 In 
children overweight is defined as BMI ranging from 85th to <95th percentile, and obesity is 
defined as ≥95th percentile using sex-specific BMI-for-age 2000 CDC growth charts.56 
Overweight and obesity during childhood and adolescence is a major public health problem. 
According to the most recent national study (NHANES 2011-2012), nearly 32% children and 
adolescents between the ages of 2 to 19 were either overweight or obese, of which 17% were 
obese. The study stratified the results by different age groups and found that nearly 8% of 2-5-
year-olds were obese compared to 18% of 6-11-year-olds and 21% of 12-19-year-olds.57 Data 
from the WV Healthy Lifestyles Act Evaluations 2008-2009 shows that 18.5% of children in 
kindergarten were obese, compared with 22.1% of second graders and 29.6% of fifth graders.58 
According to the 2007 National Survey of Children’s Health (NSCH) nearly 36% of WV 
adolescents ages 10-17 years were overweight or obese compared to the national average of 
32%.59 Results from the WV CARDIAC project 2014-2015 showed that nearly 47% of children 
in fifth grade were either overweight or obese (BMI ≥85th percentile).35  
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Overweight adolescents have a 40%-80% chance of becoming overweight or obese 
adults60,61 and adult adiposity is a well-known risk factor for developing adult CVD.62-64 Some of 
the immediate heath implications of pediatric obesity include development of other CVD risk 
factors during childhood and adolescence.65-70 Adult CVD risk factors found during childhood 
(such as high blood pressure, poor lipid profile, impaired glucose tolerance, and metabolic 
syndrome71-73) are amplified in the presence of pediatric obesity and referred by Ford and 
colleagues as ‘obesity-associated CVD risk factors’.71 A population-based study estimated that 
70% of obese children and adolescents between the ages of 5 to 17 have at least one risk factor 
for CVD.65 Data from the longitudinal Bogalusa Heart Study shows that overweight children 
were 4.5 and 2.4 times as likely to have elevated SBP and DBP, compared to normal weight 
children respectively.74 Moreover, overweight children were 2.4 times as likely to have high TC, 
3 times likely to have high LDL, 3.4 times as likely to have low HDL, and 7 times as likely to 
have high TG compared to normal weight children.74 A recent systematic review with meta-
analysis concluded that obese children, when compared to normal weight children, have raised 
SBP by 7.49 mmHg, DBP by 4.45 mmHg, and TC by 0.15 mmol/L.70  
Moreover, data from NHANES 2011-12 showed that two-third of adults are either 
overweight or obese (68.5%) in the U.S. The prevalence of extreme obesity (6.3%; BMI ≥40.0 
kg/m2) was higher in women (8.3%; 95% CI: 6.9, 9.8) compared to men (4.4%; 95% CI: 2.8, 
6.8).57 According to the 2014 BRFSS data, the state specific obesity rates ranged from 21.3% 
percent in Colorado to 35.9% in Arkansas. In the past decade the obesity rates in WV has 
increased from 27.6% in 2004 to 35.7% in 2014, ranking the second highest rate of adult obesity 
in the nation.75  
Adult obesity is also associated with numerous comorbid conditions such as 
hypertension, dyslipidemia, diabetes, insulin resistance, and metabolic syndrome and all these 
conditions increases the risk for CVD.76 Obese individuals have an increased risk of developing 
hypertension. Some studies have suggested that 60–75% of hypertension can be attributed to 
adult overweight or obesity.62,77,78 Furthermore, obesity is a predictor of higher TG, LDL, and 
lower HDL.62 Results from a meta-analysis of 21 cohort studies concluded that overweight was 
an independent risk factor for heart diseases, but the association was partially mediated by the 
effects of overweight on blood pressure and cholesterol levels, which accounted for nearly 45% 
of the increased risk of heart disease.79 Data from NHANES III showed a strong association of 
adult body mass index (BMI) with hypertension and abnormal lipid profile. The report showed 
that the prevalence of high blood pressure was 15% for underweight/normal weight men and 
women, and 38% for obese women and 42% for obese men.80   
 5
Link between childhood obesity and adult CVD risk factors. In summary, research 
suggests that childhood obesity is an independent risk factor for developing childhood CVD risk 
factors,65-68 and obese children also have higher risk of becoming overweight/obese adults,60,61,81 
which is an independent risk factor for developing adult CVD risk factors.62,64,76-78 However, 
studies that have examined the direct relationship between childhood obesity and adult CVD have 
yielded inconsistent results.63,71,82-84 Recent systematic reviews suggest that the relationship 
between childhood obesity and adult high blood pressure or poor lipid profile is weak, possibly 
because the results are confounded by adult obesity.84,85 Thus, it remains unclear whether 
childhood obesity is an independent risk factor for adult CVD risk factors or whether childhood 
obesity persists as adult obesity and indirectly increases the risk of adult CVD.86,87 
 
Early Life Exposure and Origins of Childhood and Maternal CVD Risk Factors  
There is growing evidence that early-life risk factors may influence the development of 
fatty streaks and vascular endothelial dysfunction in children to atherosclerotic plaques in early 
adulthood and subsequent CVD in later life.88-91 For example, research shows an association 
between birth weight and obesity,92 hypertension,93 and dyslipidemia.94 Conversely, early-life 
protective factors (such as breastfeeding) have been shown to reduce the risk of overweight and 
obesity,95 hypertension96,97 and improve cholesterol concentrations in later life.98  
These relationships may start to occur prior to birth. The Barker hypothesis (also called 
the ‘in utero fetal programming hypothesis’ or the ‘developmental origins of adult disease 
hypothesis’) proposed that intrauterine malnutrition leads to low birth weight (LBW) infants, 
which predisposes infants to develop CVD in later life.99-102 Although this hypothesis has been a 
topic of great controversy, evidence seems to be accumulating on various associations between 
perinatal risk factors and the development of CVD risk factors in subsequent years.103 Although, 
Barker and colleagues focused primarily on LBW and adult CVD, recent literature has focused on 
other perinatal risk factors such as high birth weight (HBW), maternal pre-pregnancy adiposity, 
excessive gestational weight gain (GWG), and gestational diabetes as early determinants for the 
origins of childhood and adulthood CVD.92,94,104-108 Some studies have shown that it is not only in 
the periods of gestation but also in the critical period of lactation (e.g., breastfeeding) that the 
type of nutrition can have long lasting effects on the offspring’s development of CVD risk factors 
in later life.109,110  
Surprisingly, perinatal risk factors not only impact the health of the offspring, but also are 
associated with maternal CVD morbidity and mortality in later years.111-115 Data shows that 
mothers who deliver LBW infants have significantly higher risk of maternal CVD morbidity and 
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mortality116-120 and CVD related risk factors such as hypertension121 and metabolic syndrome.122 
Furthermore, recent literature indicates that mothers who breastfeed their newborns have a 
significant positive impact on their own cardiovascular health115 including lower prevalence of 
CVD risk factors (e.g., high blood pressure and poor lipid profile).123 
 
Distal Determinants of CVD Risk Factors 
There is an ongoing debate on using the term ‘distal’ and ‘proximal’ causes of 
disease/outcome in the field of public health research. Social and behavioral sciences, a branch of 
public health research that focuses on social determinants of health use the term ‘distal’ for social 
and economic risk factors and ‘proximal’ for individual and biological factors.124,125 Others 
suggest that proximal are more direct or ‘downstream’ factors and distal are indirect or 
‘upstream’ health determinant for the outcome of interest.124 For the purpose of this current 
dissertation, distal determinant of CVD risk factors are predictor variables, which are temporally 
distal (far in relation to time) from when the health outcomes are being assessed. We focused on 
two distal perinatal factors (birth weight of the infant and breastfeeding) and later childhood and 
maternal CVD risk factors for study 1 and study 2 (aims 1 and 2 respectively). For the third study 
we focused on childhood obesity as the distal determinant of adult CVD risk factors.  
 
Summary 
 
CVD morbidity and mortality accounts for nearly one-third of all diseases and death 
nationally and worldwide. Although the mortality from CVD is declining in the U.S. since the 
past decade, CVD morbidity is expected to increase from nearly 33% to more than 43% by 
2030.4,20 Several well-established adult CVD risk factors (i.e. high blood pressure, high 
cholesterol, and obesity) are now prevalent during childhood as well. Childhood obesity in itself 
is an independent risk factor for other childhood CVD risk factors including high blood pressure 
and abnormal lipid profile.  
Additionally, the development of CVD risk factors may start as early as in utero and 
infancy, and these early life exposures can impact the cardiovascular health in later years. CVD 
risk factors such as childhood obesity, high blood pressure, and dyslipidemia share common early 
life exposures such as birth weight and breastfeeding. However, there is limited data focusing on 
these associations during childhood independent of child’s obesity status. Surprisingly, these 
perinatal risk factors (birth weight and breastfeeding) have been linked to maternal CVD risk 
factors in subsequent years.120,122,126-128 However, this topic is a recent and an active area of 
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research with limited number of studies have explored these associations for maternal 
cardiovascular health in subsequent years. Most relevant to our study, no studies examined these 
associations longitudinally across the lifespan in the state of WV; where there is a vital need to 
assess these risk factors and implement early preventative measures to reduce the high burden of 
CVD in this state. Data shows that WV has some of the highest rates of obesity, hypertension, 
high cholesterol levels, LBW infants, and one of the lowest breastfeeding rates in the nation. 
Thus, we intended to fill this gap in the literature with the first two studies/aims.  
For the third aim we moved our focus from perinatal exposures (birth weigh and 
breastfeeding) and its associations with childhood and maternal CVD risk factors to childhood 
exposure (over weight and obesity) and its association with adult CVD risk factors. Despite the 
high prevalence of both childhood obesity and CVD, studies examining the relationship between 
childhood adiposity and adult CVD have yielded conflicting results.63,71,82-84 However, adult 
adiposity is an established risk factor for developing adult CVD62,76-78 and there is much evidence 
to suggest that overweight children and adolescents have a higher risk of becoming overweight or 
obese adults.60,61,81 Thus, it remains unclear whether childhood obesity is an independent risk 
factor for adult CVD risk factors or whether the association is mediated through adult obesity.84-87 
Given that childhood obesity as an independent risk factor for CVD in adults is not well 
established, for the third aim/study we examined the association between childhood obesity and 
adult CVD risk factors.  
The overall objective of this project was to determine the associations between two distal 
perinatal factors (birth weight and breastfeeding) and childhood and maternal cardiovascular 
health, and determine the relationship between childhood obesity as the distal determinant of 
adult CVD risk factors. The central hypothesis of this project is that early life exposures are 
independently associated with childhood CVD risk factors and childhood obesity is an 
independent risk factor for adult CVD risk factors. Specifically, the proposed project looks to 
investigate the following specific aims. 
 
Specific Aim 1 
Investigate the association between infant’s birth weight on childhood CVD risk factors 
(SBP, DBP, TC, LDL, HDL, non-HDL, and TG) at 11 years of age (controlling for child’s 
current body mass index (BMI), and the subsequent risk of developing maternal CVD risk factors 
(TC, LDL, HDL, non-HDL, and TG) 11 years post partum. 
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Objective 1.1. Determine the association between infant’s birth-weight on childhood 
CVD risk factors (SBP, DBP, TC, LDL, HDL, non-HDL, and TG) at 11 years of age independent 
of childhood adiposity.  
Working Hypotheses 1.1. Low or/and high birth weight infants will have significantly 
higher SBP, DBP, TC, LDL, HDL, and TG, and lower HDL at 11 years of age independent of 
childhood adiposity.  
Objective 1.2. Determine the association between infant’s birth-weight on maternal CVD 
risk factors (TC, LDL, HDL, non-HDL, and TG) 11 years post-partum.  
Working Hypothesis 1.2. Mothers who gave birth to low or/and high birth weight 
infants will have significantly higher TC, LDL, non-HDL, and TG, and lower HDL, 11 years 
post-partum.  
 
Specific Aim 2 
Investigate the association between infant breastfeeding and childhood CVD risk factors 
(SBP, DBP, TC, LDL, HDL, non-HDL, and TG) at 11 years of age (controlling for child’s 
current BMI, and the subsequent risk of developing maternal CVD risk factors (TC, LDL, HDL, 
non-HDL, and TG) 11 years post partum. 
Objective 2.1. Determine the association between infant breastfeeding and childhood 
CVD risk factors (SBP, DBP, TC, LDL, HDL, non-HDL, and TG) at 11 years of age independent 
of childhood adiposity.  
Working Hypotheses 2.1. Infants who were breastfed have significantly lower SBP, 
DBP, TC, LDL, non-HDL, and TG and higher HDL at 11 years of age independent of childhood 
adiposity.  
Objective 2.2. Determine the association between infant breastfeeding and maternal 
CVD risk factors (TC, LDL, HDL, non-HDL, and TG) 11 years post-partum.  
Working Hypothesis 2.2. Mothers who breastfed their infants will have significantly 
lower TC, LDL, non-HDL, and TG and higher HDL after 11 years post-partum.  
 
Specific Aim 3 
Conduct a comprehensive systematic review (SR) and meta-analysis (MA) to critically 
evaluate the available evidence regarding the relationship between childhood obesity and adult 
CVD risk factors (SBP, DBP, TC, LDL, HDL, non-HDL, and TG). 
Objective 3.1. Determine the overall effect of childhood and adolescence obesity and its 
association with adult blood pressure and lipid profile. 
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Objective 3.2. Identify sources of between-study heterogeneity in relation to changes in 
adult blood pressure and lipid profile as a result of childhood and adolescence obesity. Where 
significant between study variation exists in research methodology, study design, study 
population, sample size, analysis and context, we will determine covariates responsible for such 
heterogeneity for the primary outcome variables (SBP, DBP, TC, LDL, HDL, non-HDL, and TG) 
of interest.  
 
The three specific aims/studies correspond to chapters two, three, and four. Chapter 5 
presents a summary of key findings of individual studies, strengths, limitations, and significance 
of the studies, potential public health implications as well as potential direction and 
recommendations for future research. There are wide-ranging factors that contribute to the high 
burden of CVD across the life course. Thus examining the associations of these distal 
determinants of CVD will aid in the understanding of these factors and their potential role. This 
can potentially lead to planning and implementation of ideal preventive strategies for promoting 
cardiovascular health during various life stages. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 10
CHAPTER 2: Birth weight and childhood and maternal cardiovascular disease risk factors 
 
Abstract 
 
Introduction: The reported associations between birth weight and childhood 
cardiovascular disease (CVD) risk factors have been inconsistent. The relationship between 
infants’ birth weight and later maternal CVD is also a more recent and active area of research. We 
aimed to examine the association between birth weight and subsequent childhood and maternal 
CVD risk factors 11 years post-partum. 
Methods: The study used longitudinally linked data from three cross-sectional datasets 
[West Virginia Birth Certificates, the Working in Appalachia to Track High Birth Score, Critical 
Congenital Heart Disease and Hearing Loss (WATCH)/Birth Score project, and the Coronary 
Artery Risk Detection in Appalachian Communities (CARDIAC) project] in West Virginia and 
restricted to full term infants only. The outcome variables included blood pressure measures 
(systolic blood pressure (SBP), diastolic blood pressure (DBP)) for children and lipid levels for 
both mothers and children (total cholesterol (TC), low-density lipoprotein cholesterol (LDL), 
high-density lipoprotein cholesterol (HDL), non-high-density lipoprotein cholesterol (non-HDL), 
and triglycerides (TG). The exposure was birth weight of the infant assessed as continuous and 
categorical variable using conventional cut-offs. Low birth weight (LBW) and high birth weight 
(HBW) was defined as birth weight of <2,500 grams and >4000 grams respectively. The role of 
child’s current body mass index (BMI) was assessed as a potential mediator. 
Results: The final study sample after excluding infants born pre-term (i.e., <37 weeks of 
gestation: N=2,097, 9.67%) was 19,583. In this sample, nearly 3% of the infants were LBW and 
11% were HBW. Unadjusted analyses showed a positive association between birth weight and the 
SBP, DBP, HDL, and a negative association between birth weight and TGs. When adjusted for 
the child’s BMI, the association became negative but non-significant for SBP, and remained 
positive but became non-significant for DBP. The association between birth weigh and HDL [b= 
0.14 mg/dL (95% CI: 0.11, 0.18) per 1000 g increase in birth weight] and between birth weight 
and log-TG [b=-0.007 (-0.008, -0.005) per 1000 g increase in birth weight] remained significant 
after adjustments were made for the child’s BMI. LDL and non-HDL became significant and 
negatively associated with birth weight in the adjusted analysis [LDL (b = -0.1 mg/dL (-0.19, -
0.16) per 1000 g increase in birth weight; non-HDL (b = - 0.18 mg/dL (-0.28, -0.09) per 1000 g 
increase in birth weight]. There was a positive association between birth weight and maternal TC 
levels, which became non-significant in the adjusted analysis [b= 0.4 mg/dL (95% CI: -0.01, 
0.90) per 1000 g increase in birth weight]. None of the other maternal lipids levels (LDL, HDL, 
non-HDL, and TG) were significant in the unadjusted or the adjusted analysis.  
Conclusion: In this young Appalachian population, birth weight was associated with 
lipid levels in children. LBW was associated with higher LDL, non-HDL, and TGs and lower 
HDL levels in fifth grade children independent of the current weight status. As CVD risk factors 
persist from childhood into adulthood, these small effect sizes can have potential unfavorable 
consequence on lipid levels in later adulthood. HBW seemed to show a trend towards poor 
maternal lipid levels 11 years post-partum. Well-designed longitudinal studies are needed to 
understand the complex pathways examining these associations at different life stages.  
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Introduction 
 
 Cardiovascular Disease (CVD) is the leading cause of death globally, nationally, and also 
in the state of West Virginia (WV).1-3 WV, a state entirely within the Appalachian region, has one 
of the highest CVD mortality rates in the U.S.3 In 2013, the age adjusted CVD mortality rate in 
the United States was 225.2 per 100,000 population whereas in WV the age adjusted CVD 
mortality rate was 270.6 per 100,000, ranking 47th in the nation.3 High blood pressure and poor 
cholesterol are well-established risk factors for CVD.4-8 These risk factors are not only found in 
adulthood but are prevalent during childhood as well and have been linked with numerous 
perinatal exposures such as birth weight.9-17  
The fetal origins hypothesis proposed by Barker and colleagues states that early life 
exposures such as under nutrition in utero could potentially increase susceptibility to poor health 
outcomes in later life.18 Briefly, the hypothesis suggests that this poor nutrition in utero can 
potentially trigger a response where the fetus may slow down its own growth to adapt to the 
unfavorable conditions (restricted nutrients and poor fetal oxygenation). This potentially leads to 
inadequate fetal growth (intrauterine growth restriction (IUGR)),19 as a short-term strategy for 
survival. This strategy leads to having low birth weight (LBW) but in the long term can have 
adverse health consequences.20  
LBW is defined as birth weight of <2,500 grams (5.5 lbs) and high birth weight (HBW) 
is defined as a birth weight of >4000 grams (8.8 lbs).21-23 LBW (<2,500 grams) at birth can result 
from either IUGR in a full-term infant (≥37 weeks of gestation), or from premature/preterm birth 
(<37 weeks of gestation).19 According to National Vital Statistics System the national average 
incidence of LBW is 8.0% of all live births, based on 2013 birth certificates data. The state-
specific incidences vary from 5.8% in Alaska to 11.5% in Mississippi. WV ranks 45 in the nation, 
with an incidence of 9.4%.24 Based on 2011 Pregnancy Surveillance System (PNSS) and Pediatric 
Nutrition Surveillance System (PedNSS) the national prevalence of LBW and HBW is 8.9% and 
6.4% respectively in low-income children enrolled in federally funded programs.23  
A child’s LBW is an indicator of suboptimal fetal growth and an important predictor for 
several long-term health outcomes including morbidity and mortality from CVD.25-27 However, 
others have argued that birth weight is a strong predictor of infant mortality in the first year of life 
and not a predictor for the development of chronic diseases during childhood or adulthood.28,29 
Finally, recent literature also shows that mothers who deliver LBW or HBW infants have a higher 
risk of having CVD morbidity and mortality.30,31,58 
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The detailed literature review presented below first outlines associations between birth 
weight and child CVD risk factors including blood pressure (systolic blood pressure (SBP), 
diastolic blood pressure (DBP)), and lipid profile ((total cholesterol (TC), low-density lipoprotein 
cholesterol (LDL), high-density lipoprotein cholesterol (HDL), non-high-density lipoprotein 
cholesterol (non-HDL), and triglycerides (TG)), and then expands on associations between birth 
weight and maternal CVD risk factors.  
 
Child Birth Weight and Child CVD Risk Factors 
LBW has shown to be an independent risk factor for childhood CVD risk factors such as 
obesity,32 high blood pressure,33,34 and poor lipid profile.35 For example, Gademan and colleagues 
found that birth weight was significant and inversely associated with SBP and DBP independent 
of the child’s current body mass index (BMI) at 6 years of age.33 However, Zhang and colleagues 
observed the inverse association only with SBP but a positive (linear) association with DBP. The 
study demonstrated that among children 6-15 years, SBP levels decreased 0.9 mmHg (b = -0.9; p 
= 0.002) and DBP increased 0.9 mmHg (b = 0.9; p = 0.006) for each 1,000 g increase in birth 
weight.36 Other studies also found a positive (linear) relationship between birth weight and high 
blood pressure.9,37,38 Filler and colleagues observed that birth weight was significantly and 
positively correlation with DBP z score (r = 0.037, p = 0.044), BMI z score (r = 0.123, p <0.0001) 
but not with SBP (r = -0.006, p = 0.729).37 Sousa and colleagues found that HBW adolescents (14 
years old) had a significantly higher prevalence ratio for high SBP of 3.3 (95% CI: 1.7, 6.4) 
compared with normal birth weight adolescents.38 As suggested by these conflicting relationships 
between blood pressure and birth weight, another study that examined the association at 7 years 
and 16 years (2 different cohorts) found a non-linear relationship and concluded that both LBW 
and HBW were associated with high SBP.39 A recent systematic review concluded that children 
and adults who were born preterm or very LBW (<1500 g) have moderately higher SBP later in 
life,26 and a recent meta-analysis also demonstrated an inverse linear association between birth 
weight and later risk of high SBP.40 However, other studies have found a weak association or no 
association between birth weight and subsequent risk of developing high blood pressure.41-43 This 
also includes a recent systematic review that found no significant association between LBW and 
childhood obesity or childhood hypertension.44 This relationship may be further obscured by the 
child’s current weight status. For example, Berge and colleagues found an association between 
LBW and SBP only among overweight children between the ages of 5-9 years.45  
These conflicting relationships are also found when examining the association between 
birth weight and cholesterol levels in childhood. For example, when examining the association 
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between birth weight and serum lipid profile, Donker and colleagues found an inverse association 
between birth weight and elevated TG concentrations in later childhood (ages 9-11 years).35 
Another longitudinal study found that among children (ages 4-11 years) LBW was associated 
with lower mean HDL, higher LDL, and TG levels irrespective of age or gender.34 However, 
Azadbakht and colleagues demonstrated that both LBW and HBW were significantly associated 
with low levels of HDL.9 Similarly, a recent study found no significant association between birth 
weight (when analyzed as a continuous variable) and lipid profiles, but when birth weight was 
categorized as low, normal, and high, the results showed that HBW subjects had higher TC levels 
(b = 0.971; p <0.001) and higher non-HDL levels (b = 0.960; p = 0.001) compared to children 
who had normal birth weight.36 A study using WV Coronary Artery Risk Detection In 
Appalachian Communities (CARDIAC) data on 11 years old children found that infants who 
were born preterm had higher levels of TGs compared to term infants. The study also categorized 
gestational age categories, as small for gestational age (SGA), appropriate for gestational age 
(AGA), and large for gestational age (LGA) based on Fenton’s weight graphs,46 and found that 
SGA infants were less likely to be obese in fifth grade, but those who were obese had higher TG 
levels compared to AGA or LGA obese children.47 Other studies have found no significant 
association between HBW and serum lipid profile in children (6 years of age) or between LBW 
and serum cholesterol levels at 8 years of age,10,48 in adolescents,38 or in early adulthood.49 
Consistent with these conflicting results, a recently published systematic review and meta-
analysis concluded that the current birth weight standards are poor predictors for later 
development of adverse health outcomes.44  
 
Child Birth Weight and Maternal CVD Risk Factors 
Mothers who deliver LBW infants (BTW<2500 g vs. >3500 g) have 7-11 times the risk 
of maternal CVD mortality in later years.30,50-53 Preterm delivery and delivery of a SGA infant has 
also been associated with an increase risk of maternal CVD.54-56 Catov and colleagues found that 
women who gave birth to preterm babies (independent of hypertension during pregnancy) had 
higher blood pressure several years after pregnancy compared to women who gave birth to term 
babies.57 Results from a large retrospective cohort study (N=129,290) found that mothers who 
delivered babies in the lowest birth weight quintile for gestational age had higher risks of 
maternal CVD morbidity 15–19 years later compared to mothers who delivered babies in the 
highest four quintiles grouped together.53 One study found that mothers of infants with HBW 
were more likely to be obese and have higher rates of metabolic syndrome 8 years after 
delivery.58 The study found no significant relationship between the infant birth weight and 
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maternal TC, LDL and HDL but found significant positive association for TGs only (Odds Ratio 
= 2.17; 95% CI: 1.01, 4.70).58 Thus, suggesting that HBW was associated with higher TGs. 
Another study demonstrated a positive association between delivering a LBW infant and maternal 
hypertension in later life.59 Yet another study that examined the relationship between offspring 
birth weight and parental carotid artery intima media thickness found that the relationship was 
significant and inversely associated.60 The researchers state two plausible explanations: 1) 
Maternal environmental factors (e.g., poor diet) can potentially increase maternal risk of 
atherosclerosis and impact the infant’s birth weight or 2) a potential common genetic factor could 
be related to both LBW and higher risk of atherosclerosis in subsequent years.60  
 
Low Birth Weight, Preterm Births, and Small for Gestational Age  
Birth weight of the infant is the weight of the infant at the time of delivery. Preterm birth 
is defined as birth at less than 37 weeks of gestational age, which can be due to several factors 
such as infection and/or fetal growth restriction. SGA is defined as an infant who is less than the 
10th percentile of birth weight for gestational age. SGA is most often used as a marker of intra 
uterine growth restriction (IUGR). A LBW may be due to preterm birth or due to IUGR.19 
Although there seems to be an overlap between these terms, Behrman and colleagues suggest that 
“They are not interchangeable, however, as each has distinct etiologies and risk factors. Among 
low birth weight infants, approximately two-thirds are born preterm, whereas less than 20 
percent of SGA age infants are born preterm.”61 LBW and HBW babies are found in both preterm 
and full term babies. However, preterm infants are at a greater risk of infant mortality as well as 
adverse health outcomes compared to term birth infants.61-64 Many researchers believe that birth 
weight categories (LBW, normal birth weight, HBW) and birth weight for gestational age 
categories (SGA, AGA, and LGA), both combines preterm and term births and are thus unreliable 
predictor of population risk. They further suggest that these two populations should be examined 
independently; for example, Wilcox notes, “Once the percent of preterm births is known, the 
analysis of birth weight can be simplified by restricting the sample to term births. Among term 
births, the influence of gestational age is minor and can be ignored.” 28 Lastly, some of the critics 
of Barker hypothesis have argued that Barker and colleagues failed to account for infants born 
prematurely.65 They argue that not only the determinants of preterm birth and fetal growth 
differ;66 IUGR, rather than prematurity is associated with later chronic diseases.67  
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Statement of the Problem 
As presented in the literature review on the current topic above, most studies found an 
inverse association between birth weight and CVD risk factors without excluding preterm infants 
or only focusing on preterm infants as demonstrated by earlier systematic reviews.26,68 Our study 
population included nearly 10% preterm birth infants. Furthermore, the LBW in the overall 
population was 7%, which accounts for 3% among full-term infants, and nearly 50% in preterm 
infants (49.36%). Thus, in agreement with the literature that suggests that preterm and term 
babies are two distinct populations, we aimed to examine the association of birth weight and 
CVD risk factors in full-term birth infants only. The association of birth weight in full-term births 
with CVD risk factors is less clear and our study is intended to fill this gap.  
Moreover, we can also observe from the literature that the associations between birth 
weight and childhood CVD risk factors show inconsistent results. While some studies have found 
a significant association33-35 others have found a weak association or no association between birth 
weight and poor lipid profile or blood pressure in subsequent years.41-43,69,70 Child’s birth weight 
has also shown to be associated either linearly (negatively or positively) or non-linearly (U-
shaped) with childhood obesity, 32,38,71-74 which is an independent risk factor for childhood CVD 
risk factors. Thus many argue that child’s current weight may be a potential mediator between 
these associations, while others argue that socio-demographic factors and maternal history of 
CVD may increase the risk of LBW, as well as increase the risk of CVD risk factors in the 
offspring.75,76 Thus this study aims to examine this association adjusting for important confounder 
variables as well as examine the role of childhood BMI as a potential mediator. There is also a 
paucity of information on the influence of infant’s birth weight and the subsequent risk of 
maternal hypertension and only one study in India looked at the association for maternal lipid 
profile postpartum.58 Most importantly, we did not find any study examining these associations 
(for both children and mothers) longitudinally in the state of WV; where there is a critical need to 
identify risk factors that can potentially reduce the high burden of CVD through early prevention 
and intervention. For the purpose of this study we focused on two CVD risk factors: (1) blood 
pressure (SBP and DBP) and, (2) and lipids and lipoprotein levels (TC, LDL, HDL, non-HDL, 
and TG). The main objective of the study was to determine the association between infant’s birth 
weight and childhood CVD risk factors (SBP, DBP, TC, LDL, HDL, non HDL, and TG) at 11 
years of age controlling for child’s current BMI, and the subsequent risk of developing maternal 
CVD risk factors (TC, LDL, HDL, non-HDL, and TG) 11 years post partum. 
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Methods and Materials 
 
Data Sources 
The study used data from three projects, including WV Birth Certificates, the Working in 
Appalachia to Track High Birth Score, Critical Congenital Heart Disease and Hearing Loss 
(WATCH)/Birth Score project, and the Coronary Artery Risk Detection in Appalachian 
Communities (CARDIAC) project. The WV Birth-Score Project began in 1985 and is an infant 
risk-screening tool.47,77 Health care professionals collect data on every newborn within 24-48 
hours or prior to discharge, in order to identify infants who are at a high risk of morbidity or 
mortality in the first year of life, for referral to primary care management.47,77,78 In this study, 
children participating in the Birth-Score project (all of whom are merged with the Birth 
Certificate data) born between in 1994 to 2000 were merged with data collected by the 
CARDIAC Project in years 2004-2010. The CARDIAC project collects data on fifth grade public 
school children in 55 counties in WV with informed consent by parents/guardians and assent by 
the child.79 Area coordinators employed by the project, along with health science student 
volunteers, local school nurses, and volunteer phlebotomists conduct blood pressure, 
anthropometric measurements, and blood lipid testing. The blood sample is obtained from fifth 
grade children in the CARDIAC project and analyzed by local area hospitals or by LabCorp Inc. 
(Burlington, NC). Parents of participating children were sent a voucher for screening of their 
fasting blood lipid profile and reports were submitted to the CARDIAC project. Further details of 
the data collection procedure are described elsewhere.80-83 The West Virginia University 
Institutional Review Board (Protocol number 1504666639) approved merged analysis based on 
the child’s identification number. We include only those observations where data was available 
from all three projects. 
Matching Process. The WV Vital Statistics department (in Charleston, WV) sends the 
Birth Certificate data to the Birth Score project each month. This is done to ensure the number of 
Birth Score project forms completed by each hospital for every child born in the state. The Birth 
Score project data manager performed the matching process by linking maternal social security 
numbers using SAS software. The remaining unmatched babies are printed out and hand matched 
against the Vital Statistics Birth certificate data. The first and last name of the infant, birth 
hospital, mother’s first, last, and maiden names, and date of birth are used to obtain the highest 
probable match.  
This combined Birth Certificate/Birth Score data file was then used for linkage to the 
CARDIAC data. The CARDIAC office provided the CARDIAC data file, which consists of the 
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CARDIAC identification number, the first and last name of the child, date of birth and the 
mother’s name for years 2004-2010 (N=46,198). The Birth Score applications programmer 
performed the matching process for all years. Overall, nearly 50% data match was achieved 
(N=22,136) between the CARDIAC and the Birth Score data. One of the main reasons for the 
unmatched data is the fact that not all children in the fifth grade in WV were necessarily born in 
WV and thus their information is not available in the Birth Score database.  
 
Variables 
Dependent variables. The main outcome variables for the study were available from the 
CARDIAC data, and include blood pressure (SBP and DBP) and lipid profile (TC, LDL, HDL, 
non-HDL, and TG) for the child and only lipid profile (TC, LDL, HDL, non-HDL, and TG) for 
the mother. Blood pressure was taken after the child had rested for five minutes. The first 
Korotkoff sound was used to record SBP and the fifth Korotkoff sound (K5, the last sound heard) 
was used to record DBP, measured in mm Hg. Lipids were both fasting and non-fasting, and 
measured in mg/dL; LabCorp estimated LDL using the Friedwald equation. All the outcomes 
were used as continuous variables. Some implausible values due to data coding error (e.g. SBP of 
5mm Hg) were set to missing. This included 8 observations for SBP, 28 observations for DBP, 10 
observations for TC, 27 observations for LDL, 7 observations for TG, 5 observations for maternal 
TC, and 1 observation for maternal LDL.  
Independent variable. The main exposure was defined as birth weight of the child in 
grams at the time of delivery. The continuous variable was obtained from the Birth Certificate 
data. The birth weight is also captured by the Birth Score Project with the following categories: 
<1501 grams, 1501-2000 grams, 2001-2500 grams, 2501-3000 grams, and >3000 grams. For the 
purpose of this project, we will use birth weight data for full-term infant only; i.e., for infants 
born ≥37 weeks of gestation. This variable was used as both a continuous and a categorical 
variable depending on the type of analysis. Child’s birth weight has been shown to be both 
linearly (positively72,73 and inversely 33, 38,74) and non-linearly (i.e., U-shape 9,84) associated with 
childhood CVD risk factor measures. Because of this plausible U-shaped relationship, birth 
weight was categorized using conventional cut-offs categories as LBW (<2,500 grams), normal 
birth weight (2500-4000 grams), and HBW (>4000 grams).  
Mediator. Trained area coordinators, nurses, and health science students measure the 
children’s height and weight using SECA Road Rod stadiometer (78”/200 cm) and the SECA 840 
Personal Digital Scale respectively (Seca Corp, Hanover, MD, USA). Body Mass Index (BMI) is 
a measure of weight adjusted for height and is calculated by CDC EpiInfo using the following 
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equation: BMI (kg/m2) = weight (kg)/height (m2). The study used BMI percentiles as a proxy for 
the child’s current adiposity measure.85 The BMI for children ages 2 to 20 are plotted on a gender 
specific growth chart (the 2000 CDC growth chart).86 BMI percentiles are thus a measure of 
relative weight adjusted for the child’s height, age and sex that corresponds to the 2000 CDC 
growth charts.86 
Covariates. We controlled for socio-demographic variables and other confounder 
variables that have shown to be associated with both the exposure (birth weight) and the 
outcomes of interest (CVD risk factors) or only with the outcomes of interest based on current 
literature.  
Socio-demographic variables. The socio-demographic variables included the child’s age, 
sex, race, maternal age, maternal race, education (at birth and later when child in fifth grade), and 
health insurance status at time of delivery. The age of the child in fifth grade was calculated from 
the CARDIAC screening date and parent-reported child birthdate in the CARDIAC project. The 
sex of the child was recorded at birth and at fifth grade by all three projects. This study used the 
sex (male or female), recorded by the CARDIAC project in fifth grade. The race/ethnicity of the 
child was parent-reported in fifth grade. For this study we dichotomized the race as “white” and 
“other” based on the population distribution of WV (i.e., 94% white).87 The Birth Certificate as 
well the Birth Score Project captured data on maternal race, which was dichotomized as “white” 
and “other” as well.  
Current literature shows inconsistent results of the association between maternal age and 
childhood CVD risk factors88,89 and between maternal age and maternal CVD risk factors.90,91 The 
association between maternal age at birth and childhood birth weight has been shown in 
numerous studies; 92,93 thus maternal age (continuous) at the time of infant’s birth was included as 
a confounder and recorded by the WV Birth Certificate data. For the maternal outcomes, the 
maternal age at birth was added to the child’s age in fifth grade to generate maternal age when the 
child was in fifth grade. Current literature also shows that maternal socio-economic status such as 
maternal education and maternal health insurance are not only associated with giving birth to 
LBW babies,94-96 but are also associated with CVD risk factors in childhood,97 and with maternal 
CVD health as well.98 The maternal education at time of birth was recorded as a continuous 
variable and included the number of years of education received ranging from 1 to 17. Maternal 
education was also recorded when the child was in fifth grade and was dichotomized as less than 
or equal to 12 grade and more than 12 grades of education. Maternal health insurance at the time 
of delivery was categorized as a binary variable (Medicaid and non-Medicaid).  
 19
Family history of risk factors. The CARDIAC project collects information on family 
history of heart disease, coronary heart disease, heart attack, open-heart surgery, angioplasty, and 
death from heart disease; thus, we made a new variable called family history of CVD based on 
having family history of any one of these six variables. Family history of hypertension or high 
cholesterol is associated with having high blood pressure and abnormal lipid level in later 
life;99,100 the CARDIAC project collects information on family history of cholesterol (yes or no). 
Family history of diabetes (yes or no) was also available from the CARDIAC project.  
Other infant and maternal characteristics. Additional covariates include number of 
previous pregnancies (0 or ≥1), smoking during pregnancy (yes or no), smoking in the house 
when the child was in fifth grade (yes or no), weight gain during pregnancy (measured in 
pounds), gestational age (range 37 - 44 weeks) and infant feeding intention (breastfeed or both 
breastfeed and bottle). The literature shows that children from mothers with increasing parity 
(i.e., with one or more than one number of previous pregnancies; multiparous) have lower blood 
pressure, TC and LDL compared to children of mothers with no prior pregnancies (nulliparous). 
101,102 There is also an association between nulliparity vs. multiparity and low birth weight.103 
Furthermore, there is also an association between parity and maternal CVD risk.104,105  
Smoking is a well-established risk factor for CVD. Maternal smoking during pregnancy 
has also been shown to be associated with childhood CVD risk factors106 107 as well as delivering 
LBW babies.108,109 Maternal smoking during pregnancy (yes or no) was obtained via self-report 
by the Birth Score project at birth. The CARDIAC project inquired if anyone smoked in the 
house when the child was in fifth grade as well. Current literature shows inconsistent association 
between gestational weight gain and higher risk of childhood CVD risk factors.110,111 Data on 
maternal gestational weight gain was available at birth and was assessed for its role as a 
covariate. Although this study only examined full-term birth infants (born ≥37 weeks of 
gestation), children born full term can also have low birth weight; therefore the potential role 
gestational age (ranging from 37-44 weeks) as a confounder was assessed as well. The Birth 
Score Project collects information on mother’s intention to breastfeed. Breastfeeding has shown 
to be protective for childhood CVD risk factors.112,113 Recent research also suggests that 
breastfeeding is significantly associated with positive CVD health outcomes for the mother as 
well.114-116 In our previous study we have demonstrated that intention to breastfeed is correlated (r 
= 0.66) with actual breastfeeding practices in WV children.117 Therefore, we used intent to 
breastfeed as a surrogate for actual breastfeeding practices.  
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Statistical Analysis  
All statistical analyses were conducted in SAS version 9.3 (SAS Institute, Cary NC). TG 
was log transformed in all analyses. The one-way analysis of variance (ANOVA) was used to 
determine whether there were significant differences between the means of all the outcomes of 
interest and three birth weight groups (LBW, normal birth weight, and HBW). Post hoc tests (i.e., 
Tukeys) were performed when there was significant omnibus F-tests to explore which means 
were significantly different from each other. Bivariate relationships between the birth weight 
(continuous) and the CVD risk factors (continuous variables) were assessed using Pearson 
correlation. Seven separate multiple-regression analyses were performed for the 7 continuous 
dependent variables (SBP, DBP, TC, LDL, HDL, non-HDL, and TG). All CVD outcomes were 
first regressed on birth weight (main independent variable) as a continuous variable as also as 
categorical variable using conventional cut-offs [LBW (<2,500 grams), normal birth weight 
(2500-4000 grams), and HBW (>4000 grams)] to determine for both the linear as well as the non-
linear relationship of birth weight and CVD risk factors (model 1). Two dummy variables were 
made for LBW and HBW categories and normal birth weight was utilized as the referent 
category. In separate models BMI percentile of the child in fifth grade was included in order to 
assess its role as a mediator (model 2). For all outcomes, additional covariates were added to 
model 2 (model 3). The decision to include the additional covariates was based on a priori 
hypotheses, existing literature, and associations that were found significant with the outcome 
variable at the bivariate level using Pearson (for continuous variables) or Spearman (for 
categorical variables) correlations. The covariates were dropped one at a time from the regression 
model if they were not significant (with highest p-value greater than p >0.05). However, if the 
main independent variable (birth weight) was not significant it was retained in the model 
regardless of its significance.  
Ordinary Least Squares (OLS) regression was utilized, which is the most common type of 
multiple regression model where: y = a + bx1 + bx2+ bx3+ bx4…bx15, where y is the criterion 
DV, ‘a’ is the constant, ‘b’ is the slope weight values, and x1 through x15 are the values for the 
predictors (IVs). The slope ‘b’ gives us the change in the predicted value of Y, on average, for 
each unit increase in X. Regression assumptions were assessed for all variables. The regression F 
statistic was used to determine the overall significance of the regression model and a 
corresponding p-value of ≤0.05 was used for statistical significant. The association of each 
independent variable to the outcome variable was also assessed for significance (alpha ≤0.05) by 
examining the parameter estimates and their corresponding t-test values in addition to the 95% 
confidence intervals (CI) of the t-statistic.  
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We report both standardized and unstandardized regression coefficients in order to assist 
in interpretation of the findings. The squared multiple correlations, R², and adjusted R² were 
interpreted as the effect sizes of the regression model (magnitude of the association). The study 
also performed the regression analysis with and without the main predictor variable (i.e., birth 
weight) in order to calculate the unique amount of variance shared between birth weight and 
CVD risk factors by calculating the change in R² for outcomes assessed in model 3 only. 
Furthermore, the interactions between age and sex were also assessed and dropped from the 
model if they were not significant. (Note: the only significant interaction (age*sex) was present 
for LDL). 
For the maternal CVD risk factors (TC, LDL, HDL, non-HDL, and TG), the same 
analyses were performed. The one-way analysis of variance (ANOVA) was used to determine 
whether there were significant differences between the means of all the outcomes of interest and 
three birth weight groups (LBW, normal birth weight, and HBW). Bivariate relationships 
between the birth weight (continuous) and the CVD risk factors (continuous variables) were 
assessed using Pearson correlation. Five separate multiple-regression analyses were performed 
for the 5 continuous dependent variables (TC, LDL, HDL, non HDL, and TG). If the bivariate 
relationships were significant, then multiple regression analysis was planned to regress the 
outcome variable on birth weight variable adjusting for additional covariates.  
Sensitivity analyses. To explore whether there were gender differences we included the 
interaction term between gender and birth weight in the regression analysis. If the interaction 
term was significant we performed separate regression models by gender for that outcome. In 
order to use birth weight as a continuous variable and assess for the U-shape relationship, we 
used splines modeling technique that takes into consideration the relationship between the birth 
weight and the outcome within and between levels of the predictor variable (i.e. birth 
weight).118,119 A linear spline is a continuous function formed by connecting linear segments. 
They are piecewise polynomial segments in one variable of some degree D with function values, 
which is continuous and the function has D-1 derivatives that agree at the points where they join. 
The joining points are called knots that mark one transition to the next and allowing the curve the 
freedom to change direction and follow the data more accurately to model the relationship 
between the independent and the dependent variable.118,119 We used 2 knots at the two 
conventional cut-off points for birth weight distribution (<2,500 grams and >4000 grams) and 
additional knots were also explored. This allows the slope of the regression to change at these two 
knots, thus allowing flexibility of the continuous birth weight to fit the non-linear segments (three 
segments). Lastly, we performed a post hoc sensitivity analysis by adjusting for pre-screening 
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fasting levels in the regression analysis. Nearly 5% of the study population was not fasting before 
screening. Recent data shows that cholesterol levels test for fasting and non-fasting children are 
minor and do not have clinical relevance.140 
Results 
 
A total of 22,136 participants were available for analysis with the merged data. After 
excluding the infants born preterm (i.e. <37 weeks of gestation: 2,097 (9.67%)), the final number 
of participants for this study was 19,583. From the CARDIAC project data, the mean age of the 
children in fifth grade was 10.95 (±0.48), 56% were female, 95% infants were white. The mean 
BMI percentile of fifth graders was 73.05 (±27.84). Nearly 3% of the infants were LBW and 11% 
were HBW in full-term birth infants. The CVD risk factor data was available for approximately 
85% of children. However, the maternal lipid data was available for only 6% of the mothers 
(N=1,121). The population characteristics of children and mothers are available in Table 1.  
The means of all the outcomes of interest by the three birth weight groups (LBW, normal 
birth weight, and HBW) are given in Table 2. Only SBP and DBP showed significant overall 
results. Further exploration using post-hoc comparisons showed that the mean SBP and DBP for 
infants with HBW were significantly higher than infants born with normal birth weight. For the 
mothers, none of the mean lipid levels were significantly different for the three groups. Consistent 
with the ANOVA results, the correlations between birth weight (continuous) and SBP (N=19,397, 
r = 0.03, p = 0.0002), and between birth weight and DBP  (N=19,344, r = 0.03, p <0.0001), were 
significant and positive (Table 3). For the lipid levels, the correlations between birth weight and 
HDL (N=16,066, r = 0.02, p = 0.0035) were significant and positive, and between birth weight 
and TG (N=15,951, r = -0.03, p = 0.0005) were significant and negative. For the mothers there 
was significant and positive correlation of birth weight with maternal TC (N=1,116, r = 0.06, p = 
0.0386) only (Table 3).  
The results of the multiple linear regression analysis using birth weight as a continuous 
variable showed the same pattern as observed in the correlations above for childhood CVD risk 
factors (Table 4a model 1). When using birth weight categories, only HBW was significantly 
higher than normal birth weight for child’s SBP and DBP only and showed a trend towards 
significance for TC, LDL, and non-HDL cholesterol levels (p = 0.07) in children (Table 4a model 
1). When the child’s current BMI was added to the model the association between birth weight 
and SBP and DBP became non-significant. Moreover, the association between birth weight and 
SBP, TC, and LDL reversed but were not significant (Table 4a model 2). HDL was positively, 
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and non-HDL and TG were negatively associated with the birth weight. Children born LBW had 
significantly lower HDL, and those born with HBW had significantly higher HDL levels, where 
as the reverse was true for non-HDL and TG in fifth grade (Table 4a model 2). Moreover, when 
additional covariates were adjusted for in the regression model, the association between 
continuous birth weight and LDL was significant with a 1.1 mg/dL decrease in LDL per 1000 g 
increase in birth weight (b= -1.1 md/dL; (95% CI: -1.9, -0.2) per 1000 g increase in birth weight, 
p = 0.02). The association between birth weight and non-HDL [(b= -0.2 mg/dL (95% CI: -0.3, -
0.1) per 1000 g increase in birth weight, p = 0.0002)], and between birth weight and TG [(b= -
0.005 (95% CI: -0.007, -0.004) per 1000 g increase in birth weight, p = 0.0001] remained 
significant and negative (Table 4a model 3). For HDL the association remained significant and 
positively associated with birth weight in the fully adjusted model [(b = 0.1 mg/dL (95% CI: 0.06, 
0.13) per 1000 g increase in birth weight, p = 0.0001)] (Table 4a model 3). The list of additional 
covariates and their relationship with the outcomes are detailed in Table 5. The unique variance 
shared between birth weight and the significant outcomes were determined by calculating the 
change in R-square, which ranged from 0.02% to 0.2% (Table 5).  
For the maternal lipid levels the unadjusted regression results showed that with every 
1000 g increase in the child’s birth weight the maternal TC increased by 0.5 mg/dL (95%CI: 0.02, 
0.90) (Table 4b model 1). However, the association became non-significant when adjustments 
were made for additional covariates [(b = 0.4 mg/dL (95% CI: -0.01, 0.87) per 1000 g increase in 
birth weight] (Table 4b model 2).  
No gender differences were observed in the additional sensitivity analysis that examined 
the interaction of birth weight by gender on blood pressure and lipid levels of children. The 
results of the sensitivity analyses that used spline regression models for children are presented in 
supplemental Tables S1. For the models that included the child’s current BMI and additional 
covariates (Table S1-model 3) showed that with every one-unit increase in the birth weight the 
child’s TC, LDL, and non-HDL levels decreased significantly in the <2500-gram segment only. 
DBP demonstrated a U-shaped relationship in both the crude and adjusted spline models. 
However, none of the segments were statistically significant. The results of the sensitivity 
analyses that used spline regression model for the mother data are presented in supplemental 
Table S2. The results were not significant for any of the spline birth weight segments and 
maternal lipids. The post hoc sensitivity analysis adjusting for children pre-screening fasting 
status showed no differences in the results of the multiple regression analysis that did not adjust 
for the pre-screening fasting status of the child. 
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Discussion 
 
Overall, the results showed a linear positive association between birth weight and 
maternal TC levels and between birth weight and childhood SBP, DBP, and HDL and a negative 
association of birth weight with child’s TG at the bivariate level (based on the results of the 
Pearson correlation and linear regression (unadjusted) results). When adjusted for the child’s 
current BMI percentile in fifth grade, the association between birth weight and SBP and DBP 
became non-significant. However, the association between birth weight and HDL and TG not 
only remained significant but also strengthened. Additionally, non-HDL was negatively but not 
significantly associated with birth weight in the crude analysis, and became significantly and 
negatively associated with birth weight after adjusting for the child’s current BMI. Surprisingly, 
when additional covariates were added to the models, the association between birth weight and 
LDL also became significant, demonstrating a negative association as well.  
 
Blood Pressure in Children 
Our results are consistent with studies that found a positive association between birth 
weight and childhood SBP for the crude analysis that reversed in direction for the adjusted 
association.45,120 Although the direction of our study is consistent with previous studies, unlike 
most studies the adjusted association was not significant.34,36,40,68,121 However a recent study that 
examined this association in WV fifth grade found no significant differences in SBP in fifth grade 
by gestational group (SGA, AGA, LGA) or comparing preterm to term birth infants.47 As our 
study focused on term birth infants only, it is difficult to compare the findings to the earlier work 
done on WV fifth grade children. The results of our study suggest that the association between 
birth weight and childhood is potentially mediated by the child’s current BMI. The direction of 
the association between birth weight and SBP is consistent with the Barker’s hypothesis for the 
adjusted analysis only. However, the non-significant findings suggest that the association is not 
independent of the child’s current BMI.  
Our results are similarly consistent with studies that found a significant positive 
association between birth weight and childhood DBP for the unadjusted analysis37,120 that became 
non-significant (but remained positive) after adjusting for the child’s current BMI.42 Azadbakht 
and collegues also found significant mean differences in DBP levels according to birth weight 
categories and also a positive crude association as observed in our study. However unlike the 
results of our study their findings remained signifiant after adjusting for child’s current BMI,9 as 
demostrated by other studies as well.33, 36 Our study demonstated a significant positive linear 
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association between birth weight and DBP (b = 0.06 mmHg; 95% CI: 0.03 - 0.08; p <0.0001 for 
1,000 g increase in birth weight) that attenuated and became non-significant when adjusted for 
the child’s current BMI (b = 0.01 mmHg; 95% CI: -0.01, 0.04; p = 0.4916 for 1,000 g increase in 
birth weight). The results from the spline regression models (sensitivity analysis) for DBP 
demonstrated a U-shaped relationship in both the crude and adjusted spline regression models. 
However, none of the segments were statistically significant. The direction of the association 
between birth weight and DBP is not consistent with the Barker’s hypothesis for both the crude 
and the adjusted analyses. However, it is important to note that DBP is a less reliable measure 
compared to SBP in children.122,123 Furthermore, numerous studies have shown SBP to be a 
stronger predictor of CVD compared to DBP.124 
 
Lipids in Children 
Our results are consistent with studies that have found a significant association between 
birth weight and childhood HDL (positive),9,34 and between birth weight and TGs (negative).35 
Adjustments for the child’s current BMI strengthened the relationship between birth weight and 
HDL and between birth weight and TG levels in children. LDL and non-HDL were not 
significant in the crude analysis but became significant and negatively associated with birth 
weight after accounting for the child’s BMI and additional covariates. Our results for non-HDL 
and LDL are consistent with the findings of other studies as well.34,36 For TC; our results are not 
consistent with the systematic review that found a weak inverse relationship between birth weight 
and childhood TC levels.125 Another study that used WV CARDIAC data for 11 years old 
children found that infants who were born preterm had higher levels of TGs compared to term 
infants. The study also found that SGA infants were less likely to be obese in fifth grade, but 
those who were obese had higher TG levels compared to AGA or LGA obese children.47 The 
study did not find an association with other lipid levels. However, the population in our study was 
limited to term infants only, which differed from the study by Mullett and colleagues that 
included preterm infants as well.47  
Our results demonstrated that LBW was associated with lower mean HDL and higher 
LDL, non-HDL, and TG levels independent of the child’s current BMI and additional covariates. 
When birth weight was categorized, LBW vs. normal birth weight subjects had higher LDL and 
non-HDL levels, and HBW subjects had higher HDL and lower TG compared to normal birth 
weight children. These results suggest that association between birth weight and lipid levels is 
linear and not U-shaped as demonstrated by some studies.35,84,126 Based on these results, we 
hypothesize that the association between birth weight and lipids is independent of the child’s 
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current BMI levels. However, the change in R2 showed that birth weight accounted for less than 
1% of unique variance in lipid levels of fifth grade WV children, suggesting a small effect size. 
Interpreting significant covariates included in the study may be of some interest as well 
(Table 5). The results suggest that girls had significantly higher LDL, higher TG and lower HDL 
compared to boys as observed in other studies as well.127,128 The interaction between sex and age 
was significant for LDL only, which suggested that there was an increase in LDL levels with an 
increase in age and the increase was much larger for girls than for boys. Although the age range 
in our study was only 5 years (9 to 14), we observed that there was a significant increase in the 
level of TGs129 and a decrease in HDL130 and non-HDL with age during childhood as observed in 
other studies as well.131 Race (white vs. others) was a significant factor for HDL (lower) and TG 
(higher) only, which is also consistent in the literature.129,132 Family history of CVD or cholesterol 
was positively associated with the child LDL, non-HDL, and TG levels and negatively associated 
with HDL as expected based on current literature.99,100,133 Previous literature has shown 
inconsistent association between maternal education and child’s TG levels, 134,135 our study 
demonstrates that the increase in mothers’ education at birth was associated with lower child’s 
TG levels (b= -0.01 mg/dL decrease in TG per 1 year increase in maternal education, 95% CI: -
0.02, -0.01). Maternal age at time of birth was not significantly related to childhood lipid levels as 
observed in other studies as well, 89 except for HDL levels, which increased as the maternal age at 
birth increased. Maternal smoking during pregnancy was associated with lower HDL during 
childhood as observed in another study examining lipid level in 8-year-old children.106 However, 
previous literature has shown this association with other lipid levels as well106,107 not observed in 
this study. Mother who intended to ‘breastfeed only’ had children with significantly lower non-
HDL compared to mothers who ‘intended to breastfeed and bottle-feed’ their infants. Lastly, and 
most importantly the BMI percentile was significantly associated with all lipid levels. The 
standardized regression coefficients for the outcomes ranged from 0.14 to 0.35 (negative for 
HDL) for every one unit standardized increase in the BMI percentile of children (Table 5).  
 
Adjusting for Current BMI 
Our study results showed that the positive association between birth weight and SBP, TC, 
and LDL became negative (reversed) when current BMI was added in the model. However the 
change in direction from positive to negative after adjusting for current BMI is an area of great 
controversy. Some believe that adjusting for current BMI may produce spurious inverse 
association.136,137 Tu and colleagues performed a simulation study where the true positive 
association between birth weight and adult blood pressure attenuated and even reversed when the 
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correlation between birth weight and the current weight was increased.137 However, Gillman and 
colleagues demonstrate that adjusting for current body size is not only appropriate but can also 
help us understand the inverse birth weight and CVD risk factors association.138 The systematic 
review by Lauren and colleagues concluded that there was no consistent relationship between 
birth weight and later lipid levels and most studies that adjusted for the current size were the ones 
that supported the Barkers hypothesis only.84 Other researchers have also recommended not 
adjusting for current body size.39,69 Menezes and colleagues found the positive association 
between birth weight and blood pressure that reversed direction after adjusting for current BMI. 
However the authors state that regardless of their findings they do not support the inverse 
association because birth weight adjusted for current weight is a proxy measure of post-natal 
growth and not a measure of birth weight.120 In our study the direction of association between 
birth weight and SBP, TC, and LDL changed from positive to negative when adjusted for current 
BMI. However, based on our unadjusted results (model 1) we can clearly see that LBW was 
significantly associated with higher TG and lower HDL levels and adjustment for current BMI 
only strengthened the associations. Overall, our results suggest that BMI is a key predictor of 
CVD risk factors (Table 5) and a potential mediator for the relationship between birth weight and 
CVD risk factors and therefore should be accounted for in the regression models. (Note in our 
study: Pearson correlations between BMI and birth weight (r = 0.10), SBP (r = 0.34), DBP (r = 
0.26), TC (r = 0.10), LDL (r = 0.15), HDL (r = -0.33), non-HDL (r = 0.23), and log-TG (r = 
0.35), p <0.0001).  
 
Lipids in Mothers 
The results of our study found no significant mean difference in any of the lipid levels of 
mothers by birth weight categories of the child. However, the correlation between birth weight 
and maternal TC was significant and positive. The nature of the association was further revealed 
when the birth weight was categorized in the regression analysis, which demonstrated that 
mothers who gave birth to HBW babies had higher TC compared to mothers who gave birth to 
normal birth weight babies. However, the association became non-significant when additional 
covariates were added in the model. None of the other lipid levels were significant associated 
with the birth weight of infant. Although, not significant the direction of association suggests that 
mothers who give birth to HBW babies have a trend towards increased risk of poor lipid levels 11 
years post-partum as demonstrated by a positive association between birth weight and TC, LDL, 
non-HDL, TG and a negative association with HDL. A study by Yajnik and colleagues found no 
significant relationship between the infant birth weight and maternal TC, LDL, and HDL but 
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found significant positive association for TG levels in India.58 Our results are consistent with 
Yajnik et al., findings for the direction of association between birth weight and lipid levels but not 
significant for TG as found in this earlier work.58 This may be due to differences in the birth 
weight distribution of the two populations. Furthermore, we did not have information on maternal 
lipid levels or maternal BMI, which has been associated with infants birth weight.139 We also did 
not have information on the birth weight of the mothers when they were born. Whether mother’s 
abnormal lipid levels are associated with giving birth to low or high birth weight babies, or 
whether the birth weight of the infant is a potential risk factor for maternal lipid level in later 
years, or whether the mother’s own birth weight impacts their lipid profile is difficult to establish 
at this point. The research on this topic is still in its infancy and needs further exploration.  
 
Limitations of the Study 
Some of the limitations of the study include lack of information on possible important 
confounder variables such as parental adiposity status, maternal pre-pregnancy weight, maternal 
lipid status before and during pregnancy, maternal birth weight, rapid weight gain during the first 
year of life, pubertal status of the child, family history of hypertension, physical activity, and 
dietary behaviors. Furthermore, the CARDIAC project only collects parental lipid data and thus 
the maternal CVD risk factors were limited to lipid profile only, which was available for a small 
sample of the population. Only a small percent of mothers of participating CARDIAC students 
took advantage of the free vouchers for lipid testing, thus limiting the generalizability of the 
sample. Due to the unique characteristics of the Appalachian state of WV, results may not be 
generalizable beyond the participants included in this study.  
 
Strengths of the Study 
Despite these limitations, this study demonstrates a significant linear association between 
birth weight and child’s lipid levels in fifth grade using a large longitudinal dataset with 
information available for important covariates. The direction of association of all outcomes 
(except DBP) was consistent with the Barker’s hypothesis. To our knowledge this is the first 
study that has examined these associations in the state of WV for both mothers and the children 
born full-term at birth. These results provide an important contribution for expanding the research 
examining the association between birth weight of the infant and maternal CVD health.  
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Conclusion 
 
Our earlier work has shown that HBW is associated with higher childhood BMI in fifth 
grade WV children.117 This study provides information on the relationship between birth weight 
and other CVD risk factors as well, demonstrating that LBW is associated with higher risk of 
abnormal lipid levels (higher LDL, non-HDL, and TGs and lower HDL levels) in fifth grade 
children independent of current weight status in this young Appalachian population. As there is 
tracking of CVD risk factors from childhood into adulthood, there is a potential that these small 
effect sizes can have detrimental effect on CVD in later adulthood in WV. For the mothers CVD 
risk factors, HBW of the infant seemed to demonstrate a trend towards poor maternal lipid levels 
11 years post-partum. Well-designed longitudinal studies are needed to understand the complex 
biological pathways for both the mother and the child and examine these associations at different 
stages of life. Furthermore, future research should also focus on working with diverse populations 
to establish different birth weight cut-offs that can increase the sensitivity of identifying infants 
with higher risk of future CVD as suggested by the recent systematic review as well.44  
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Chapter 3: Breastfeeding and childhood and maternal cardiovascular risk factors  
 
Abstract 
 
Introduction: The Appalachian state of West Virginia (WV) has a higher prevalence of 
cardiovascular disease (CVD) and lower breastfeeding rates compared to the national averages. 
There is paucity of research examining the relationship of breastfeeding to subsequent childhood 
and maternal CVD risk factors, an issue of particular relevance in this rural state.  
Methods: The study used longitudinally linked data from three cross-sectional datasets in 
WV datasets [West Virginia Birth Certificates, the Working in Appalachia to Track High Birth 
Score, Critical Congenital Heart Disease and Hearing Loss (WATCH)/Birth Score project, and 
the Coronary Artery Risk Detection in Appalachian Communities (CARDIAC) project]. The 
information on the main exposure “history of breastfeeding” was obtained retrospectively via 
parental recall when the child was in fifth grade. The outcome variables included blood pressure 
measures (systolic blood pressure (SBP), diastolic blood pressure (DBP)) for children and lipid 
profile for both the mother and child (total cholesterol (TC), low-density lipoprotein cholesterol 
(LDL), high-density lipoprotein cholesterol (HDL), non-high-density lipoprotein cholesterol 
(non-HDL), and triglycerides (TG)). Mean differences, correlations, and simple regression 
analyses were performed to examine the crude associations. Multiple regression analysis was 
performed adjusting for current body mass index (BMI) and additional covariates.  
Results: The final study sample after excluding infants born pre-term (i.e. <37 weeks of 
gestation: N=1,190, 10.2%) was 10,457. Nearly, 43% of the mothers self-reported breastfeeding 
their index child. The results showed a significant negative correlation between reported history 
of breastfeeding and childhood SBP (r =-0.06), DBP (r = -0.04), and TGs (r = -0.07), and a 
positive correlation between breastfeeding history and child’s HDL levels (r = 0.04). When 
adjusted for the child’s current BMI and socio-demographic variables in the regression analysis, 
the association was statistically significant for TGs only (beta = -0.04 mg/dL; 95% CI: -0.06, -
0.01; p = 0.01). Maternal mean lipid levels were not significantly different between the two 
groups nor were significantly correlated to their reported history of breastfeeding.  
Conclusion: The observed protective effect of breastfeeding on the child’s TGs level in 
fifth grade was small but significant. This supports the promotion of breastfeeding as a possible 
preventive measure for future CVD risk factors in the rural Appalachian state of WV. 
Nonetheless future research should focus on designing large prospective studies to assess and 
understand the association of breastfeeding with both maternal and child CVD risks factors at 
various life stages. 
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Introduction 
 
Cardiovascular disease (CVD) mortality accounts for nearly 50% of mortality, or 17.5 
million out of 38 million chronic disease mortality worldwide.1,2 CVD is also the leading cause of 
mortality and morbidity in the United States (U.S.)3 with nearly one third of adults having at least 
one type of CVD.4,5 CVD mortality rates are nearly 20% higher in the rural Appalachian 
population compared to the rest of the nation.6 West Virginia (WV), a state entirely within the 
Appalachian region, has one of the highest rates of CVD mortality (ranks 45) in the nation and 
also one of the highest prevalence of CVD risk factors ranking number 50th in high blood 
pressure and 48th in high total cholesterol level.7 Data on early life determinants of CVD risk 
suggests that breastfeeding is protective for cardiovascular health of an individual and also has a 
protective effect on mothers who choose to breastfeed their infant.8-11 
American Academy of Pediatrics (AAP) suggests six months of exclusive breastfeeding 
and continuation of breastfeeding until the infant is one year old while gradually introducing solid 
foods after six months.12 However, results from the 2011 National Immunization Survey (NIS) 
show that only 18.8% of mothers in the U.S. and 12.2% of the mothers in WV exclusively 
breastfeed for the first six months. The percentage of mothers who breastfeed but not exclusively 
for the first six months postpartum is also much lower in WV (29%) compared to the national 
average of 49%.13 Pediatric Nutrition Surveillance System (PedNSS), is another survey that 
monitors nutritional status of low-income children enrolled in federally funded maternal and child 
health program (mainly WIC). The results from 2011 PedNSS shows the only 13.5% of women 
in WV enrolled in these programs breastfeed for six months where as only 0.3% exclusively 
breastfed their infant. The results from 2011 NIS and PedNSS survey for the state of WV as well 
as national rates are shown in Table 1.13,14  
Bartick and colleagues performed a pediatric cost analysis and concluded that the cost of 
morbidity and mortality associated with suboptimal breastfeeding in the U.S. was approximately 
$14 billion annually in 2011.15,16 The researchers also performed a cost analysis of maternal 
morbidity and mortality associated with suboptimal breastfeeding. The study calculated the cost 
to be approximately $17 billion from premature deaths and $733.7 million (direct) and $126.1 
million (indirect) morbidity costs.17  
The detailed literature review presented below outlines the associations between 
breastfeeding and child CVD risk factors including blood pressure (systolic blood pressure (SBP), 
diastolic blood pressure (DBP)), and lipid profile [(total cholesterol (TC), low-density lipoprotein 
cholesterol (LDL), high-density lipoprotein cholesterol (HDL), non-high-density lipoprotein 
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cholesterol (non-HDL), and triglycerides (TG)], and then expands on associations between 
mothers who breastfeed their infant and maternal CVD risk factors.  
 
Breastfeeding and Childhood CVD Risk Factors 
Breastfeeding has shown to be protective against childhood obesity.18 Data shows that the 
risk of childhood obesity decreases (ranging from 15% to 35%) significantly in children who 
were breastfed compared to children who were not breastfed.19-21 In addition to childhood 
adiposity, breastfeeding has been shown to have protective effects on other CVD risk factors 
during childhood such as blood pressure, cholesterol, and diabetes.22  
A study that examined the association between breastfeeding duration and child’s blood 
pressure at 8 years of age found significant higher mean values of SBP (but not for DBP) for 
children who were breastfed for <40 days (99 mmHg) compared to children who were breastfed 
for ≥40 days (93 mmHg) 23 suggesting a dose-response relationship between breastfeeding 
duration and later childhood blood pressure.24 In another study, SBP was 1.19 mmHg (95% CI: 
0.40, 1.96) lower among 5-year-old children who were breastfed for at least 6 months compared 
to those who were not, even after adjusting the child’s current weight status.25 In another larger 
prospective cohort study, SBP was 1.2 mmHg lower (95% CI: 0.5, 1.9) and DBP was 0.9 mmHg 
lower (95% CI: 0.3, 1.4) among breastfed children, compared with children who were never 
breastfed after adjusting for covariates.26 Consistent with these results, a systematic review with 
meta-analysis found the pooled mean difference in SBP was −1.10 mmHg (95% CI: -1.79, -0.42) 
among infants who were breastfed during infancy but DBP was not significantly related to the 
type of infant feeding.27 Another systematic review on the topic showed that breastfeeding was 
associated with a 1.4 mmHg reduction in SBP and 0.5 mmHg reductions in DBP in later life.28  
However, other studies have shown no association between blood pressure and breastfed 
and non-breastfed children,29,30 or between breastfeeding duration and blood pressure in 
adolescence and young adults.31-34 For example, results from a randomized controlled trial for a 
breastfeeding promotion intervention found no differences in adiposity or blood pressure at age 
6.5 years in the experimental group compared to the control group.35,36 In an observational study, 
neither exclusive nor partial breastfeeding (compared to never breastfeeding) were significantly 
associated with blood pressure in 13-year-old adolescents.30 Furthermore, a recent systematic 
review also found no association between breastfeeding and blood pressure in children ages 10-
19.37   
Breastfeeding has also been studied in relation to childhood and adolescence cholesterol 
levels.22 A study found that cholesterol concentration was significantly lower in boys (but not in 
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girls) who were breastfed for a median duration of <2 months compared to those who were 
formula fed.38 Another study that examined the association between breastfeeding and BMI and 
serum lipids concentrations at 6 years, found that boys who were breastfed for <6 months had 
significantly higher BMI than those breastfed for >8 months and longer duration was also related 
to higher HDL levels in girls but not in boys.39 These results may also be beneficial later in life: 
one study demonstrated a significant association between breastfeeding and higher levels of TC 
and LDL cholesterol in older women compared to men.40 Two systematic reviews on the topic 
also found breastfeeding to be associated with decreased risk of blood cholesterol levels later in 
child’s life22 or in adolescence and adult life.41 
Although generally the literature notes a positive protective factor of breastfeeding 
against abnormal lipid profiles, other studies showed no association between breastfeeding and 
serum lipid concentrations in children42 or in adults.34 But even these results may be misleading 
due to the time in which the lipid measurements were taken. For example, two studies found no 
difference in mean TC and LDL levels between breast feeders and bottle feeders in adolescence 
(ages 13-16 years), but demonstrated that breastfeeding was associated with higher TC and LDL 
during infancy (<1 years) and lower mean TC and LDL levels in adults >17 years even after 
adjustment for BMI.41,43 Moreover, some studies have found the negative association with one 
lipoprotein but not with the other types of lipoproteins or only in one of the sexes. For example, 
in a population based cohort study in Brazil, the LDL cholesterol was higher among never (mean 
41.0 mg/dl; 95% CI: 39.4, 42.7) than among ever breast fed adolescent boys (38.6 mg/dl; 95% 
CI: 38.6, 40.3), while the associations with all other lipoprotein concentrations were not 
significant.44 Another study of 17-year-old adolescents found significantly higher TG levels in 
boys only and the association was not significant for girls and for other lipoprotein 
concentrations.45 Additionally, a recent systematic review with meta-analysis found no 
association between breastfeeding and TC levels for all age groups including ages 10-19.37   
 
Breastfeeding and Maternal CVD Risk Factors 
Recent research suggests that breastfeeding is significantly associated with positive 
cardiovascular health not only for the child but also for the mother.46-48 A recent study examining 
the association between lactation and CVD mortality found that parous women <65 years who 
had never breastfed had a higher CVD mortality than women who had breastfed 24 months or 
more (Hazard ratio (HR): 2.77, 95% CI: 1.28, 5.99).49 Another study noted that women who 
breastfed for a lifetime total of >2 years had a 23% lower risk of heart disease compared to 
women who had never breastfed.11 The researchers also found a dose-response relationship 
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between duration of lactation and lower prevalence of hypertension and hyperlipidemia in 
postmenopausal women (median age 63 years) even after adjusting for the maternal BMI.11 Thus, 
the beneficial effect of breastfeeding for mothers may extend to CVD risk factors such as 
metabolic syndrome, obesity, hypertension, and high cholesterol. For example, a cross-sectional 
study demonstrated that women who breastfed had significantly lower odds of metabolic 
syndrome in later life (OR = 0.79, 95% CI: 0.63; 0.99).48 Another study also found that women 
who breastfed for <12 weeks had significantly greater weight gain over a 15 year follow up 
period compared to women who breastfed for >12 weeks.50 Other researchers note that 
breastfeeding lowered maternal blood pressure as early as one month to five months 
postpartum10,51 and continued to have beneficial effects later in life (45-64 years of age).52 On 
average, women who breastfed for <3 months have higher visceral fat content,53 along with 
higher TC and TG levels compared to women who breastfed their children for at least three 
months.54 However, McClure et al., noted that the association between breastfeeding and HDL 
became non-significant after controlling for socio-demographic variables.54  
Conversely, a randomized controlled trial showed that longer breastfeeding duration did 
not lower maternal adiposity or blood pressure 11.5 years postpartum55 and a prospective cohort 
study did not find an association between breastfeeding duration and any of the serum lipid 
markers (TC, TG, HDL, and LDL) at 3 years postpartum.56  
 
Biology of Breastfeeding and CVD 
Children. The composition and constituents of human milk are specifically intended for 
human babies and any other form of feeding preparations is markedly different from human 
milk.57,58 One of the main differences in human milk and formula milk is the fat content, which 
differs throughout the day and within a single milk expression, as well as across each stage of the 
infant’s growth.59 Formula milk is not responsive to the nutritional needs of the infant as the 
infant ages.60 Human milk also contains digestive enzymes that help in the digestion of milk and 
absorption of fat.61 This enzyme is absent in formula milk, which makes the digestive process 
difficult. Some researchers hypothesize that the differences in health outcomes observed in 
children are due to the differences in the infant’s digestion of human milk or formula milk.62 
Other researchers note that the fat content in human milk may provide satiety signal, which 
protects against overfeeding, in addition to the assumption that breastfed infants better learn to 
regulate the amount of milk consumed.63-65 Studies have shown that breastfeeding increases the 
infant’s ability to self-regulate energy intake, which prevents them from overconsumption.67,68 In 
addition to digestive enzymes, human milk also contains growth factors or hormones that could 
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also have an effect on the lipid metabolism and growth and development of the infant.66 Lastly, Li 
and colleagues examined the satiety responsiveness of 6 year old children found that infants who 
were bottle fed had low satiety responsiveness compared to breastfed infants, probably due to 
parental control in infancy to empty their bottles.69 
Mother. Several experts in the field have summarized the biological explanation for the 
association between lactation and maternal lipid levels. During pregnancy, lipid levels increase 
and after delivery these levels decrease rapidly in lactating women. This is potentially due to 
alteration in lipid metabolism, as lactation process requires mobilization and redistribution of 
lipids from body fat storage for milk production.48,70 Lactation not only increases the mother's 
metabolic expenditure (nearly 500 kcal/day),71 the process also improves the metabolic system by 
making it more efficient.11,48,72 This metabolic efficiency can potentially reverse the gestational 
increases in fat and lipid accumulation and have a long-term positive impact on women’s 
cardiovascular health.70 The decrease in lipid levels have been observed as early as 6 to 13 weeks 
after delivery and up to three years postpartum; others have noted these differences even post-
menopause.11,73-75  
 
Statement of the Problem 
In summary, the literature examining the association between breastfeeding and later 
childhood CVD risk presents some inconsistent results. While most studies have found a 
significant protective effect of breastfeeding on child CVD risk factors23 others have not.30,35,41,43 
Data shows that childhood adiposity is associated with blood pressure and cholesterol.76-78 While 
some studies have controlled for childhood obesity and found that the association between 
breastfeeding and blood pressure and lipid levels attenuates,42 others have found that even after 
controlling for BMI, the association remains significant.23 These conflicting results suggest that 
childhood obesity could potentially be a partial or a full mediator between the observed effects. 
Furthermore, some studies have found this association to be gender specific,38,39,45 age specific 
(adults only),40 or specific to one or two components of CVD risk factors.44,45  
The association between maternal breastfeeding and maternal CVD risk factors also show 
inconsistent results. Some studies suggest that mothers who breastfeed have lower CVD risk 
factor in later life,11,50,52 while others did not find a significant association.55,56 Most importantly, 
to the best of our knowledge, we did not find any study examining these associations 
longitudinally in the state of WV; where focusing on improving the low breastfeeding rates in the 
state could potentially have an impact on the future CVD burden. The purpose of this study was 
to investigate the influence of infant breastfeeding and childhood CVD risk factors (SBP, DBP, 
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TC, LDL, HDL, non-HDL, and TG) at 11 years of age (controlling for child’s current BMI), and 
the subsequent risk of developing maternal CVD risk factors (TC, LDL, HDL, non-HDL, and 
TG) 11 years post partum. 
 
Methods and Materials 
 
Data Sources. 
The study used data from three projects, including WV Birth Certificates, the Working in 
Appalachia to Track High Birth Score, Critical Congenital Heart Disease and Hearing Loss 
(WATCH)/Birth Score project, and the Coronary Artery Risk Detection in Appalachian 
Communities (CARDIAC) project. The WATCH/WV Birth Score project is an infant risk-
screening instrument that was initiated in 1985.79,80 Trained health care professionals collect data 
on every newborn within 24-48 hours or prior to discharge, in order to identify infants who are at 
a high risk of poor health outcomes or mortality in the first year of life, for referral to primary 
care management.79-81 In this study, children participating in the Birth-Score project (all of whom 
are merged with the Birth Certificate data) born between in 1997 to 2004 were merged with data 
collected by the CARDIAC Project in years 2008-2014. The CARDIAC project collects data on 
fifth grade public school children in 55 counties in WV with informed consent by 
parents/guardians and assent by the child.82 Area coordinators employed by the project, along 
with health science student volunteers, local school nurses, and volunteer phlebotomists conduct 
blood pressure, anthropometric measurements, and blood lipid testing. Blood sample is obtained 
from fifth grade children in the CARDIAC project and analyzed by local area hospitals or by 
LabCorp Inc. (Burlington, NC). Parents of participating children were sent a voucher for 
screening of their fasting blood lipid profile and reports were submitted to the CARDIAC project. 
Further details of the data collection procedure are described elsewhere.83-86 The WV University 
Institutional Review Board (Protocol number 1504666639) approved the merged analysis based 
on the child’s identification number. We include only those observations where data was 
available from all three projects. 
Matching Process. The WV Vital Statistics department (in Charleston, WV) sends the 
Birth Certificate data to the Birth Score project each month. This is done to ensure the number of 
Birth Score project forms completed by each hospital for every child born in the state. The Birth 
Score project data manager performed the matching process by linking maternal social security 
numbers using SAS software. The remaining unmatched babies are printed out and hand matched 
against the Vital Statistics Birth Certificate data. The first and last name of the infant, birth 
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hospital, mother’s first, last, and maiden names, and date of birth are used to obtain the highest 
probable match.  
This combined Birth Certificate/Birth Score data file was then used for linkage to the 
CARDIAC data. The CARDIAC office provided the CARDIAC data file, which consists of the 
CARDIAC identification number, the first and last name of the child, date of birth and the 
mother’s name for years 2008-2014 (N=20,531). The Birth Score applications programmer 
performed the matching process for all years. Overall, nearly 60% data match was achieved 
(N=11,980, 58.4%) between the CARDIAC and the Birth Score data. One of the main reasons for 
the unmatched data is the fact that not all children in the fifth grade in WV were necessarily born 
in WV and thus their information are not available in the Birth Score database.  
 
Variables. 
Dependent variables. The main outcome variables for the proposed study are available 
from the CARDIAC data, and include blood pressure and lipid profile (SBP, DBP, TC, LDL, 
HDL, non-HDL, and TG) for the child and lipid profile for the mother (TC, LDL, HDL, non-
HDL, and TG). If maternal lipid profile was available for stepmother, adoptive-mother or legal 
guardian, the observations were excluded for the maternal analyses only. Blood pressure was 
taken after the child had rested for five minutes. The first Korotkoff sound was used to record 
SBP and the fifth Korotkoff sound was used to record DBP, measured in mm Hg. Lipids were 
both fasting and non-fasting, and measured in mg/dL; LabCorp estimated LDL using the 
Friedwald equation. All the outcomes were used as continuous variables. Some implausible 
values due to data coding error (e.g. SBP of 0 mm Hg) were set to missing. This included 2 
observations for SBP and 1 observation for DBP.  
Independent variable. The main exposure variable was the reported history of 
breastfeeding. Information related to breastfeeding was obtained using the CARDIAC 
questionnaire retrospectively via parental/caregiver recall when the child was in fifth grade. The 
question stated, “Was your child breastfed?” and the answer options included ‘yes’, ‘no’ and 
‘don’t know’. The ‘don't know’ option was recoded to missing.  
Mediator. Trained area coordinators, nurses, and health science students measure the 
children’s height and weight using SECA Road Rod stadiometer (78”/200 cm) and the SECA 840 
Personal Digital Scale respectively (Seca Corp, Hanover, MD, USA). Body Mass Index (BMI) is 
a measure of weight adjusted for height and is calculated by CDC EpiInfo using the following 
equation: BMI (kg/m2) = weight (kg)/height (m2). The study used BMI percentiles as a proxy for 
the child’s current adiposity measure.87 The BMI for children ages 2 to 20 are plotted on a gender 
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specific growth chart (the 2000 CDC growth chart).88 Established cut-off points were used to 
identify underweight (less than 5th percentile); healthy weight (5th to 84.9th percentile); 
overweight (85th to 94.9th percentile); obese (95th to 98.9th percentile); and morbidly obese 
(greater than 99th percentile) weight categories.89 BMI percentiles are thus a measure of relative 
weight adjusted for the child’s height, age and sex that corresponds to the 2000 CDC growth 
charts.88 
Covariates. We controlled for socio-demographic variables and other confounder 
variables that have shown to be associated with both the exposure (breastfeeding) and the 
outcomes of interest (CVD risk factors) or only with the outcomes of interest based on current 
literature.  
Socio-demographic variables. The socio-demographic variables included the child’s age, 
sex, race, maternal age, education and health insurance status at time of delivery. The age of the 
child at fifth grade was calculated from the CARDIAC screening date and parent-reported child 
birthdate in the CARDIAC project. The sex of the child was recorded at birth and at fifth grade 
by all three projects. This study used the sex (male or female), recorded by the CARDIAC project 
in fifth grade. The race/ethnicity of the child was parent-reported in fifth grade. For our study we 
dichotomized the race as ‘‘white’’ and ‘‘other’’ based on the population distribution of WV (i.e., 
94% white).90 Current literature shows inconsistent results of the association between maternal 
age and childhood CVD risk factors;91,92 thus maternal age at the time of infant’s birth was 
included as a confounder and recorded by the WV Birth Certificate data. Maternal education has 
also been shown to be associated with CVD risk factors in childhood 93 and also a predictor of 
maternal breastfeeding practices.94,95 Maternal education at time of birth was recorded as the 
number of years of education received ranging from 1 to 17 and was included as a continuous 
variable for the analysis. Current literature also shows that maternal socio-economic play an 
important role in the mother’s decision and duration to breastfeed her child.94,96,97 Maternal health 
insurance at the time of delivery was assessed as a confounder variable (as a measure of socio-
economic factor) and categorized as a binary variable (Medicaid and non-Medicaid). 
Family history of risk factors. The CARDIAC project collects information on family 
history of heart disease, coronary heart disease, heart attack, open-heart surgery, angioplasty, and 
death from heart disease; thus, we made a new variable called family history of CVD based on 
having family history of any one of these six variables. Family history of hypertension or high 
cholesterol is associated with having high blood pressure and abnormal lipid level in later life;98,99 
the CARDIAC project collects information on family history of cholesterol (yes or no).  
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Other infant and maternal characteristics. Additional covariates include number of 
previous pregnancies (0 or ≥1), smoking during pregnancy (yes or no), weight gain during 
pregnancy (measured in pounds) and birth weight of the child (measured in grams). The literature 
shows that children from mothers with increasing parity (i.e., with one or more than one number 
of previous pregnancies; multiparous) have lower blood pressure, TC and LDL compared to 
children of mothers with no prior pregnancies (nulliparous).100,101 Maternal smoking during 
pregnancy has also been shown to be associated with childhood CVD risk factors,96,102 and 
maternal smoking is also associated with breastfeeding initiation and duration.103 Current 
literature shows inconsistent association between gestational weight gain and higher risk of 
childhood CVD risk factors.104,105 We had information on maternal gestational weight gain and 
assessed for its role as a covariate in our study. Birth weight of the child is also associated with 
childhood CVD risk factor.102 The information on birth weight was available as a continuous 
variable in grams from the WV Birth Certificate data.  
 
Statistical Analysis.  
All statistical analyses were conducted in SAS version 9.3 (SAS Institute, Cary NC). TG 
was log transformed in all analyses. Independent samples t-tests were used to compare the means 
of dependent variables for the two breastfeeding groups (reported history of breastfeeding and no 
reported history of breastfeeding) and the magnitude of this association was calculated using 
Cohen’s d effect size  (Cohen’s d =  
    
	 

 where SD pooled= 
 .. ..

). Bivariate 
relationships between reported history of breastfeeding (binary: yes vs. no) and the CVD risk 
factors (continuous variables) were assessed using Spearman correlation.  
Seven separate multiple-regression analyses were performed for the 7 continuous DVs 
(SBP, DBP, TC, LDL, HDL, non-HDL, and TG). All CVD outcomes were first regressed on 
reported history of breastfeeding (model 1) (main independent variable) and then in separate 
models BMI percentile was included to assess for its role as a mediator (model 2). For the 
outcomes where the association was significant between reported history of breastfeeding and 
CVD outcomes (independent of obesity), additional covariates were added in the model (model 
3). The decision to include the additional covariates was based on a priori hypotheses, existing 
literature, and associations that were found significant with the outcome variable at the bivariate 
level using Pearson (for continuous variables) or Spearman (for categorical variables) 
correlations.  
Ordinary Least Squares (OLS) regression was utilized, which is the most common type of 
multiple regression model where: y = a + bx1 + bx2+ bx3+ bx4…bx15, where ‘y’ is the criterion 
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DV, ‘a’ is the constant, ‘b’ is the slope weight values, and x1 through x15 are the values for the 
predictors (IVs). The slope ‘b’ gives us the change in the predicted value of Y, on average, for 
each unit increase in X. Regression assumptions were assessed for all variables. The regression F 
statistic was used to determine the overall significance of the regression model and a 
corresponding p-value of ≤0.05 was used for statistical significant. The association of each 
independent variable to the outcome variable was also assessed for significance (alpha ≤0.05) by 
examining the parameter estimates and their corresponding t-test values in addition to the 95% 
confidence intervals (CI) of the t-statistic. The covariates were dropped one at a time from the 
regression model if they were not significant (with highest p-value greater than p >0.05). 
However, if the main independent variable (reported history of breastfeeding) was not significant 
it was retained in the model regardless of its significance.  
We report both standardized and unstandardized regression coefficients in order to assist 
in interpretation of the findings. The squared multiple correlations, R², and adjusted R² were 
interpreted as the effect sizes of the regression model (magnitude of the association). The study 
also performed the regression analysis with and without the main predictor variable (i.e., reported 
history of breastfeeding) in order to calculate the amount of variance shared between reported 
history of breastfeeding and CVD risk factors by calculating the change in R² for outcomes 
assessed in model 3 only. Furthermore, the interaction between age and sex was also assessed and 
dropped from the model if they were not significant.  
For the maternal CVD risk factors (TC, LDL, HDL, non-HDL, and TG), we first assessed 
for the bivariate relationship between the binary categorical variable ‘reported history of 
breastfeeding’ and maternal CVD risk factors (continuous variables) using Spearman 
correlations. Independent samples t-tests were used to compare the means of dependent variables 
for the two breastfeeding groups, and the magnitude of this association was calculated using 
Cohen’s d effect size for significant differences only. If the bivariate relationships were 
significant, then multiple regression analysis was planned to regress the outcome variable on the 
reported history of breastfeeding variable adjusting for additional covariates.  
Sensitivity analyses. To explore whether there were sex differences we performed chi-
square tests on breastfeeding groups, in addition to including the interaction term between sex 
and reported history of breastfeeding in the linear regression analysis. Many researchers believe 
that preterm and term infants are two separate populations with different rates and risks of 
morbidity and mortality in later life.106-110 The percentage of all infants who were reported to 
being breastfed was 43.03% in this population overall, and the frequency of reported history of 
breastfeeding was similar in full-term (43.17%) and preterm (41.75%) infants. Therefore, we 
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performed all the analyses with children born both preterm and full-term combined to determine 
if there were any observed differences in the outcomes assessed. We also performed a sensitivity 
analysis on the missing data, and used multiple imputation techniques to address the missing data 
for the maternal lipid data. Lastly, we performed a post-hoc sensitivity analysis by adjusting for 
fasting levels in the regression analysis for children. There is a recent debate on whether to 
require prescreening fasting when assessing lipids in children in population based studies. Steiner 
and colleagues using data from NHANES 1999-2008 (N= 12,744) found that the lipid and 
lipoprotein test results for fasting and non-fasting children were minor and do not have clinical 
relevance. They concluded that prescreening fasting should not be required for children in order 
to decrease the burden of childhood lipid screening.129 Nearly 20% of our study population in 
fifth grade was not fasting before screening.  
 
Results 
 
A total of 11,980 participants were available for analysis with the merged data. After 
excluding the infants born preterm (i.e. <37 weeks of gestation: 1,190 (10.2%)), the final number 
of participants for this study was 10,457. The study had lipid profiles on only 131 mothers, of 
which 127 were biological mothers in the complete dataset. For data restricted to full-term infants 
only, the study had lipid profile on 115 mothers, of which 112 were biological mothers.  
From the CARDIAC project data, the mean age of the children in fifth grade was 10.97 
(±0.47), 55% were female, 94% infants were white. The mean BMI percentile of fifth graders 
was 72.58% (±28) and 43.2% of the parents reported breastfeeding the index child at birth. The 
CVD risk factor data was available for approximately 93% of children. However, the maternal 
lipid data was available for only 1% of the mothers. The detailed population characteristics of the 
children as well as the mothers’ characteristic are available in Table 2.  
Children who had a reported history of breastfeeding compared to children with no 
reported history of breastfeeding had significantly lower mean SBP, DBP, and TG and 
significantly higher for mean HDL in fifth grade. The mean difference was -1.3 mmHg (95% CI: 
-1.97, -0.81), -0.81 mmHg (95% CI: -1.26, -0.33), -0.08 mg/dL (95% CI: -0.10, -0.05), and 0.9 
mg/dL (95% CI: 0.33, 1.56) for SBP, DBP, TG, and HDL cholesterol levels respectively (Table 
3). The effect size calculated using the Cohen’s d formula ranged from 0.07 to 0.16 for the 
significant outcomes (SBP, DBP, TG and HDL). The mean differences were not significant for 
TC, LDL, and non-HDL among children who were reported to be breastfed compared to children 
who were not breastfed. For the mothers, none of the mean lipid levels were significantly related 
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to mothers who reported to have breastfed as compared to mothers who did not report 
breastfeeding the index child.  
Consistent with the t-test results, the correlations between reported history of 
breastfeeding (yes vs. no) and SBP (N=6647, r = -0.06, p = 0.0001), DBP (N=6648, r = -0.04, p = 
0.0007) and TG (N=6435, r = -0.07, p = 0.0001) were significant and negative, whereas the 
correlation between reported history of breastfeeding (yes vs. no) and HDL was significant and 
positive (N=6647, r = 0.04, p = 0.0011) (Table 4). The correlation between reported history of 
breastfeeding and child’s TC, LDL, and non-HDL was not significant. Maternal lipid levels were 
not significantly correlated to reported history of breastfeeding (yes vs. no) (Table 4). However 
the direction of associations was consistent with the literature that suggests a protective 
association between breastfeeding and maternal lipid levels. The results demonstrated a positive 
correlation between mothers who reported to have breastfed vs. not breastfed and TC, LDL, non-
HDL, and TG and a negative correlation between these two groups and maternal HDL levels. 
The unadjusted regression analysis showed that children who had a reported history of 
breastfeeding compared to children with no reported history of breastfeeding had significantly 
lower SBP (b = -1.39 mmHg; 95% CI: -1.97, -0.81; p <0.0001), DBP (b = -0.79 mmHg; 95% CI: 
-1.26, -0.33; p = 0.0009), log-TG (b = -0.08 (95% CI: -0.1, -0.05; p <0.0001), and higher HDL (b 
= 0.95 mg/dL (95% CI: 0.33, 1.56; p <0.0001) (Table 5, model 1). However, adjustments for the 
child’s current BMI decreased the associations of reported history of breastfeeding to SBP (b = -
0.77 mmHg; 95% CI: -1.32, -0.23; p = 0.005) and log-TG (b = -0.05; 95% CI: -0.07, -0.03; p = 
0.048), but eliminated the association to DBP (b = -0.44 mmHg; 95% CI: -0.89, 0.02; p = 0.06) 
and HDL (b = 0.28mg/dL (95% CI: -0.29, 0.86; p = 0.335) (Table 5, model 2). Adjustments for 
additional socio-demographic variables eliminated the association between reported history of 
breastfeeding and SBP (b = -0.43 mmHg; 95% CI: -0.98, -0.13; p = 0.1349) and attenuated the 
association with log-TG but remained significant (b = -0.04; 95% CI: -0.06, -0.01; p = 0.008) 
(Table 5, model 3).  
The results of the multiple regression analysis showed that reported history of 
breastfeeding was significantly and inversely associated with TG of children with inclusion of 
covariates in the model (F (8, 5339) = 118.84; p <0.0001; adjusted R2= 0.1499). Covariates 
including BMI percentile in fifth grade, child's age, sex, race, maternal education at birth, number 
of previous pregnancies, and family history of cholesterol were statistically significant in 
predicting variance in TG of the child at 11 years of age (Table 6). The regression model showed 
that among children who had a reported history of breastfeeding there was a 0.04 (b = -0.04; 95% 
CI: -0.06, -0.01, t = -2.65, p = 0.008) decrease in the log-transformed TG levels compared to 
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children who did not have a reported history of breastfeeding. The amount of variance shared 
between reported history of breastfeeding and childhood TG levels was 0.13% (change in R2).  
No sex differences were observed in the additional (sensitivity) analysis that examined 
the interaction of reported history of breastfeeding by sex on blood pressure and lipid levels of 
children (b= -0.03; 95% CI: -0.08, 0.02, t = -1.15, p = 0.2495). The results of the sensitivity 
analyses that included all infants (preterm and full term) showed similar findings for both the 
children and the mothers’ data. For example, the regression results for children born both preterm 
and full-term combined showed that reported history of breastfeeding was significantly and 
inversely associated with log-TG of children in fifth grade (-0.03; 95% CI: -0.0513, -0.0005, p = 
0.046) with inclusion of covariates in the model (F (8, 6146) = 139.58; p <0.0001; adjusted R2= 
0.1527). After multiple imputation for the missing data for the mothers, none of the lipid levels 
were significantly correlated with mothers’ reported history of breastfeeding (mothers who 
reported to have breastfed compared to mothers who did not) (supplemental files tables S1-5). 
We performed a sensitivity analysis (post-hoc) and adjusted for the child’s pre-screening fasting 
status. The regression results showed similar findings when adjusted for pre-screening fasting 
status vs. not adjusting for fasting status [for e.g. the beta coefficient for the association between 
breastfeeding and log-TGs adjusting for fasting was -0.035 (95% CI: -0.06, -0.01; p = 0.0113) 
compared to -0.036 without adjusting for fasting status (95% CI: -0.06, -0.01; p = 0.008)].  
 
Discussion 
 
Overall, the results showed that children who had a reported history of breastfeeding (yes 
vs. no) had significantly lower SBP, DBP, TG, and higher HDL at the bivariate level (based on 
the results of the t-test, Spearman correlation and unadjusted linear regression results). When 
adjusted for the child’s current BMI percentile in fifth grade, the association attenuated for SBP 
and TG but remained significantly and positively associated with reported history of 
breastfeeding. Thus, results suggest that BMI is a potential mediator for the association between 
reported history of breastfeeding and DBP and HDL levels. However, adjustments for additional 
covariates eliminated the association of reported history of breastfeeding to SBP but remained 
significant for TG levels.  
 
Blood Pressure in Children  
Our results are consistent with studies that found no differences in the mean SBP and 
DBP of children who were breastfed as compared to those not breastfed during infancy.29-36 
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However, several studies have found the opposite23-26 including two earlier systematic reviews 
with meta-analysis.27,28 These systematic reviews concluded that the pooled mean difference in 
SBP (but not DBP) was significantly lower among infants who were breastfed,27 while the later 
systematic review with meta-analysis found significant reduction in both SBP and DBP.28 
Systematic reviews with meta-analysis occupy the highest levels of evidence in the hierarchy of 
study designs.111 The Cochrane Collaboration, an organization dedicated to the conduct of 
systematic reviews in healthcare, recommends that reviews on a given topic be updated every two 
years.112,113 Our results on both SBP and DBP are consistent with the evidence provided by the 
most recent systematic review with meta-analysis published in 2015.37 Horta and colleagues 
demonstrated based on 10 studies for age groups 10-19 that SBP was lower but not significant 
among those subjects who had been breastfed [mean difference: -1.03mmHg (95%CI: -2.07; 
0.02)], whereas no association was observed for DBP based on 8 studies for age groups 10-19 
[mean difference: -0.1mmHg (95%CI: -0.65; 0.45)]. Furthermore, this meta-analysis showed that 
the mean difference was inversely related to study size. Studies with more than 1000 participants 
included the null value. Our study further demonstrated that the association between reported 
history of breastfeeding and childhood blood pressure (SBP and DBP) is not independent of 
child’s current BMI and socio-demographic variables, thus suggesting the role of child’s current 
BMI as a potential mediator. Breastfeeding has shown to be protective for childhood obesity as 
demonstrated by several studies18-21,37,114 including our earlier work with WV fifth grade 
children.115 
 
Lipid in Children 
The results of the current study are also consistent with studies that found no association 
between TC,37,42,43 LDL,43 and non-HDL levels among breastfed vs. non-breastfed children. The 
results of two systematic reviews with meta-analysis using random effects model showed that the 
mean TC and LDL levels in children were not significantly different comparing breastfed infants 
to non-breastfed infants [(mean difference TC= 0.00 mmol/L; 95% CI: -0.07, 0.07) and (mean 
difference LDL= 0.01 mmol/L; 95% CI: -0.07, 0.08)].43 The most recent meta-analysis also found 
no significant difference in the mean TC levels for children ages 10-19 between breastfed and 
non-breastfed infants (mean difference TC= 0.01mmol/L; 95% CI: -0.06, 0.08).37 
Of greater interest to us were the relationships that proved significant: in particular, HDL 
and TG. For HDL our study found a significant positive association among fifth grade children 
who were reported to have been breastfed during infancy, with a mean difference of 0.9 mg/dL 
(95% CI: 0.33, 1.56). However, the association attenuated after adjustment for the child’s current 
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BMI and became non-significant. The non-significant results are consistent with other studies 42,44 
that also adjusted for the child’s current BMI.42 This finding also suggests that BMI is a potential 
mediator for the association between breastfeeding and HDL levels in this population.  
We found a significant association between log-transformed TG levels among fifth grade 
children who had a positive history of breastfeeding independent of the child’s BMI, socio-
demographic and lifestyle characteristics. To our knowledge very few studies have examined this 
association for childhood TG levels. One study found a significant negative association in 17 
years old boys but not among girls 116 and another study among 18-year-old boys did not find any 
difference in never vs. ever breastfed adolescents.44 Yet, another population based study found 
that among 6 year old children this association was not significant after adjusting for age, sex, 
family-based socio-demographic, maternal lifestyle-related and childhood factors.117 We did not 
find any differences by gender for the association between breastfeeding and TG levels. The 
mean difference was significantly lower among children who had a reported history of 
breastfeeding (yes vs. no) during infancy -0.08 (95% CI: -0.10, -0.05), and the correlation was 
small (r = -0.07, p <0.0001) but also significant. The standardized regression coefficient of the 
unadjusted association was -0.07, which attenuated but remained significant after adjusting for 
childhood BMI percentile (-0.05) and remained significant after adjusting for additional 
covariates as well (-0.03) (covariates included BMI percentile, child's age, sex, race, maternal 
education at birth, number of previous pregnancies, family history of cholesterol). Based on these 
results, we hypothesize that this association is potentially partially mediated by the child’s current 
BMI levels. However, the change in R2 showed that reported history of breastfeeding accounted 
for less than 0.2% of unique variance in TG levels of fifth grade children, suggesting a small 
effect size.  
Interpreting significant covariates included in the study may be of some interest (Table 
5). The results suggest that boys have lower TG levels compared to girls in fifth grade. Some 
studies have noted that boys have lower TG levels compared to girls at ages 10-14118 and other 
studies have found that TG levels in girls and boys are generally similar during early childhood, 
but in adolescence girls have lower TG levels than boys.119,120 These studies also noted that TG 
values increase sequentially with the increase in pubertal stage. Although this study did not have 
information on pubertal status we can hypothesize that perhaps more girls had reached puberty in 
fifth grade compared to boys in this cohort, explaining the higher TG levels in girls in fifth grade 
WV children. Although the age range in our study was only 5 years (9.3 to 14.14), we observed 
that there was a significant increase in the level of TGs with age as observed in other studies as 
well.121 The results also showed that white children had higher TG levels compared to other racial 
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groups, which is also consistent in the literature as well.121,122 Although most of the previous 
research compared whites to blacks, this study collapsed the minority racial groups in one group 
based on the population distribution of WV as well as our study (i.e., 94% white). 90 Our study 
demonstrates that increasing years of maternal education at time of the child’s birth was 
associated with lower child’s TG levels. Although previous studies examining this association 
(between maternal education and child’s TG level) have shown inconsistent results.123,124 Our 
results also demonstrated that multiparous mothers at birth of the index child had children with 
lower TG levels compared to nulliparous mothers, which is also consistent with the literature.100 
Lastly, children who had a family history of hypercholesterolemia had significantly higher TG 
levels in fifth grade WV children, a finding echoed by previous research as well.125 
As mentioned earlier that there were significant differences in TG level by gender but no 
significant interaction between gender and reported history of breastfeeding was observed. 
Furthermore the results of the sensitively analysis performed on the complete data that included 
all infants found similar results to the data restricted to full term birth infants only.  
 
Lipid in Mothers 
The results of our study found no significant correlation or significant mean difference in 
any of the lipid levels of mothers who reported to have breastfed as compared to mothers who did 
not breastfeed. Although the results were not significant it is important to note that the direction 
for the association was positive for TC, LDL, non-HDL, and TG and negative for HDL. To our 
knowledge very few studies have examined this association. Our results contrast with few studies 
that have found a protective association between breastfeeding and maternal lipid profile.11,48,53 
However, our results are in concordance with the results of a prospective cohort study that did not 
find an association between breastfeeding duration and any of the serum lipid markers (TC, LDL, 
HDL, and TG) at 3 years postpartum.56 Several factors may explain our disparate results. The 
earlier studies examined lifetime lactation duration of at least 3 month54 or lifetime duration of 
lactation of more than 1 or 2 years to demonstrate this protective association.11,48 Our study did 
not have information on lactation duration or lifetime duration of lactation, which is the basis of 
most previous research. Since our study asked mothers if they breastfed or not, it is possible that 
most mothers who initiated breastfeeding, failed to continue to breastfeed for longer durations. 
Data from the National Immunization Survey 2011 show that 59% of the mothers ever breastfed 
their infant while only 12.2% of the mothers in WV exclusively breastfeed for the first six months 
and nearly 16% breastfed for up to one year.13 Additionally, only a small percent of mothers of 
participating CARDIAC students took advantage of the free vouchers for lipid testing, resulting 
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in very low participation rates among this particular sample. Furthermore, experts in the field also 
suggest that no existing study has collected comprehensive data to explain the apparent 
association between lifetime lactation and maternal metabolic risk adjusting for several 
confounding factors.70 It has been noted in the U.S. as well as in WV that mothers who breastfeed 
belong to higher SES and engage in healthy behaviors.126,127 Thus future studies need to collect 
wide ranged longitudinal data to examine this association in mothers accounting for several 
socio-demographics, genetic and lifestyle factors.  
 
Limitations of the Study 
Some of the limitations of the study include lack of information on possible important 
confounder variables such as parental adiposity status, maternal pre-pregnancy weight, rapid 
weight gain during the first year of life, pubertal status of the child, family history of 
hypertension, physical activity, and dietary behaviors. Furthermore, the CARDIAC project only 
collects parental lipid data and thus the maternal CVD risk factors were limited to lipid profile 
only. Additionally, maternal lipid data was available for a very small sample of the population as 
few mothers took advantage of the free vouchers for lipid testing, thus limiting the 
generalizability of the maternal sample population. Moreover, information on history of 
breastfeeding was obtained retrospectively and thus is subject to recall bias and also to social 
desirability bias. The measure also did not inquire about the method, extent, or the lifetime 
duration of lactation. Lastly, due to the unique population characteristics of this state, the results 
may not be generalizable beyond the participants included in this study.  
 
Strengths of the Study 
Despite these limitations, this study afforded the strengths of examining the association 
between reported history of breastfeeding and CVD health outcomes in a large dataset, 
longitudinally, using linked data from two cross-sectional studies and adjusting for numerous 
important covariates. Although all the associations attenuated after adjustment for the child’s 
BMI, the association remained significant for TG levels independent of the child’s current BMI, 
socio-demographic, genetic and other lifestyle factors. In addition, the results from the regression 
analysis showed that although the predictors accounted for nearly 15% of the variance in TG 
levels, reported history of breastfeeding uniquely accounted for less than 1% of the variance in 
TG levels. Although this effect size is small, it is a novel finding in 11-year-old children. Earlier 
studies included 6-year-old children or older adolescents or young adults ranging from ages 17-
25.116 44,117,128 Lastly, for the maternal CVD risk factors; the current study demonstrates some 
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important preliminary results (i.e., correlations in the correct direction for lipid levels and 
breastfeeding). Thus, providing an essential contribution for expanding the research examining 
the associations between breastfeeding as a protective perinatal factor and maternal 
cardiovascular health in subsequent years.  
 
Conclusion 
 
Breastfeeding has been shown to have numerous health benefits for both the mother and 
the child. Our earlier work has shown that breastfeeding is protective for childhood obesity. This 
study further adds that breastfeeding is protective for child’s TG levels at 11 years of age after 
accounting for several demographic and maternal characteristics, thus adding to the argument of 
promoting breastfeeding as a preventive measure against future CVD. The observed effects of 
breastfeeding as an early-life determinants or a distal protective factor for the child’s TG lipid 
level was small. However, these small changes can impact the burden of CVD risk factors 
prevalence in rural Appalachian state of WV. The fact that we were not able to show the 
protective effect on blood pressure and other child or maternal lipid levels does not mean that 
breastfeeding promotion should be ignored. Future large prospective studies are needed to assess 
and understand the association of breastfeeding with both maternal and child CVD risks factors at 
various life stages.  
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Chapter 4: Childhood obesity and adult cardiovascular disease risk factors: a systematic 
review with meta-analysis. 
 
Abstract 
 
Introduction: Previous systematic reviews have led to conflicting findings regarding the 
relationship between childhood obesity and adult cardiovascular disease risk factors. The purpose 
of this study was to use the aggregate data meta-analytic approach to address this gap.  
Methods: Studies were included if they met the following criteria: (1) longitudinal and 
cohort studies (including case-cohort), (2) childhood exposure and adult outcomes collected on 
the same individual over time, (3) childhood obesity, as defined by the authors, (4) English-
language articles, (5) studies published up to June, 2015, (6) one or more of the following CVD 
risk factors [systolic blood pressure (SBP), diastolic blood pressure (DBP), total cholesterol (TC), 
high-density lipoprotein cholesterol (HDL), low-density lipoprotein cholesterol (LDL), non-high-
density lipoprotein cholesterol (non-HDL), and triglycerides (TG)] (7) outcome(s) not self-
reported, and (8) exposure measurements (child’s adiposity) assessed by health professionals, 
trained investigators, or self-reported. The search strategy included (1) electronic searches in 
multiple databases (PubMed (MEDLINE), Web of Science, and Scopus) on June 5, 2015, and (2) 
cross-referencing from the reference lists of all retrieved articles (citation tracking). Fisher’s r to z 
score was calculated for each study for each outcome. Pooled effect sizes were calculated using 
random-effects models while risk of bias was assessed using the STROBE instrument. 
Heterogeneity was assessed based on fixed-effect models. In order to try and identify sources of 
heterogeneity, random-effects meta-regression was also performed.  
Results: Of the 4875 citations reviewed, a total of 23 studies were included in the 
systematic review and 21 in the meta-analysis. The findings suggest that childhood obesity is 
significantly and positively associated with adult SBP (Zr = 0.11; 95% CI: 0.07, 0.14), DBP (Zr = 
0.11; 95% CI: 0.07, 0.14), and TG (Zr = 0.08; 95% CI: 0.03, 0.13), and significantly and 
inversely associated with adult HDL (Zr = -0.06; 95% CI: -0.10, -0.02). For 3-6 studies that 
adjusted for adult body mass index (BMI), associations were reversed for all outcomes, 
suggesting that adult BMI may be a potential mediator. Nine studies had more than 33% of items 
that placed them at an increased risk for bias.  
Conclusions: Childhood obesity is a risk factor for adult SBP, DBP, HDL, and TG. 
Well-designed, longitudinal studies with high quality of reporting as well as data on both 
unadjusted and adjusted (for adult adiposity) associations are needed before any definitive 
conclusions can be reached 
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Introduction 
 
Overview 
Overweight and obesity during childhood and adolescence is a major public health 
problem. One of the immediate health implications of childhood and adolescent obesity includes 
the development of cardiovascular disease (CVD) risk factors during childhood and 
adolescence.1-4 According to the World Health Organization, CVD mortality increased globally 
from 14.4 million in 1990 to 17.5 million in 2005 and is projected to rise to more than 23.6 
million by 2030.5-8 However, in the United States (U.S.), CVD mortality has been decreasing 
from 34.3% deaths in 2006 to 30.8% of all deaths in 2013.5,9 Nevertheless, it is still the leading 
cause of death.10 According to the 2016 Heart Disease and Stroke Statistics update, more than one 
third of U.S. adults have at least one type of CVD,5 which is also projected to rise to more than 
40% by 2030.5,11 Several well-established adult CVD risk factors have been found during 
childhood. These include, but are not necessarily limited to, high blood pressure (BP), poor lipid 
profile, impaired glucose tolerance, and metabolic syndrome.12-14 Importantly, data shows that 
these risk factors are amplified in the presence of pediatric obesity, referred to by Ford et al. as 
‘obesity-associated risk factors for CVD.’13,14 Most notably, a population-based study estimated 
that 70% of obese children and adolescents between the ages of 5 to 17 have at least one risk 
factor for CVD.1  
Despite the high prevalence of both childhood and adolescence obesity and adult CVD, 
studies examining the relationship between childhood obesity and adult CVD have yielded 
conflicting results.13,15-18 However, adult adiposity is an established risk factor for developing 
adult CVD19,20 and there is much evidence to suggest that overweight adolescents have a 40%-
80% chance of becoming overweight or obese adults.21-23 Thus, it remains unclear whether 
childhood obesity is an independent risk factor for adult CVD risk factors or whether childhood 
obesity persists as adult obesity and indirectly increases the risk of adult CVD.24,25  
 
Obesity and CVD Risk Factors 
High BP and poor lipid profile are independent risk factors for CVD. However, pediatric 
obesity is also an independent risk factor for high BP and poor serum lipid and lipoprotein 
concentrations (higher total cholesterol (TC), triglycerides (TG), low-density lipoprotein 
cholesterol (LDL) and lower high-density lipoprotein cholesterol (HDL) concentrations) during 
childhood and adolescence.26-31 Children and adolescents with less than optimal BP or cholesterol 
levels are more likely to develop high BP and less than optimal cholesterol levels during 
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adulthood compared to children/adolescents with a normal BP and lipid profile 32-34. Moreover, 
abnormal serum lipoprotein concentrations due to pediatric obesity and its correlation with poor 
lipid profile during adulthood also remain a controversial topic in the literature 3,35. Data also 
shows that childhood CVD risk factors may persist into adulthood, 25 however, the mechanism 
from transition from CVD risk factors from childhood to adulthood is still unclear.36 Recent 
systematic reviews suggest that the relationship between childhood obesity and adult high BP or 
poor lipid profile is weak, possibly because the results are confounded by adult obesity.18,37 Given 
that childhood obesity as an independent risk factor for CVD in adults is not well established, we 
aim to investigate the association between childhood obesity and select adult CVD risk factors, 
i.e., BP, lipids, and lipoproteins.  
 
Critical Evaluation of Existing Knowledge  
When proposing to conduct a systematic review (SR) with meta-analysis (MA) on a 
topic, it is important to examine previous SRs and MA on this topic. To the best of the 
investigative team’s knowledge, four SRs and one MA have been conducted on the relationship 
between childhood obesity and adult CVD risk factors.18,37-40 A brief description of these studies 
is shown in Table 1. The SRs and MA found were based on a systematic literature search in 
PubMed on February 2, 2015, using the following search strategy: ((obes* OR overweight) AND 
(child* OR adolesc*) AND (systematic review OR meta-analy*) AND (blood pressure OR 
cholesterol OR lipids OR lipoproteins OR cardiovascular) AND adult*). The search strategy can 
found in Additional file 1.   
To the best of our knowledge, we are not aware of any meta-analytic research that 
utilized a systematic way for critically appraising the association between childhood obesity and 
adult CVD risk factors based on current guidelines.41 As can be seen in Table 1, four SRs 
published on this topic from 2010-2012 provided qualitative evidence but did not show any 
quantitative evidence on the association between childhood obesity and adult CVD risk factors 
(BP and lipid profile). While one MA was conducted four years ago on this topic, it was limited 
to a select four cohorts only, 40 thereby possibly biasing results. Moreover, this MA did not 
calculate the association between childhood obesity and TC as well as between childhood obesity 
and adult non-high-density lipoprotein cholesterol (non-HDL) levels. This is important since non-
HDL (non-HDL = TC minus HDL) has been shown to be better marker of risk for coronary artery 
disease and stroke compared to LDL.42,43  
Of the four SRs listed in Table 1, two included hypertension as one of the main 
outcomes37,38,44 while the other reported results for resting SBP and DBP.37 Another study focused 
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on the lipid profile as the main outcome of interest.18 With respect to years covered for those 
studies that included hypertension, Park et al, included studies published between 1980-2011,38 
Reilly et al. included studies from January 2002 to mid-June 2010,39 while Lloyd et al, searched 
online electronic databases, i.e., PubMed (MEDLINE) and ISI Web of Science from their 
inception up to July 2008 for the SR with hypertension as the outcome,37 and up to July 2010 for 
the SR with serum cholesterol levels as the outcome.18 The Cochrane Collaboration, an 
organization dedicated to the conduct of SRs in healthcare, recommends that SRs on a given topic 
be updated every two years.45,46 Based on this recommendation, the last SR was published in 
2012, thus suggesting that this work needs to be updated. In addition, all previous SRs included 
data where adiposity was measured using BMI for both children and adults.18,37-40 However, 
research has shown that BMI is not an ideal marker for adiposity47,48 and including other 
definitions or classifications of adiposity may help in identifying other potentially eligible studies 
that have looked at this association. Finally, the methodological quality of these previous 
systematic reviews could have been better.18,37-40 Using the Assessment of Multiple Systematic 
Reviews (AMSTAR) Instrument,49 we evaluated the methodological quality of the previously 
described SRs. Item-by-item results for these studies are shown in Table 2. As can be seen, the 
overall score for each SR ranged from 40% to 80% while scores for each question ranged from 
0% to 100%. The questions with the three lowest scores included: (1) status of publication, (2) 
including a list of both published and unpublished studies, and (3) assessment for the likelihood 
of publication bias. These findings provide further support for an updated, high-quality SR with 
MA on the relationship between childhood obesity and selected adult CVD risk factors, i.e., BP, 
lipids, and lipoproteins. 
 
Significance of the Topic 
SRs with MA occupy the highest levels of evidence in the hierarchy of study designs.50 
This structured and standardized approach has been used to make health care decisions and 
inform policy makers by analyzing prior findings as well as summarizing, synthesizing and 
critically appraising evidence on a specific topic in the literature.51 While several SRs,18,37-39 and 
one MA,40 have examined the association between childhood obesity and adult CVD, the 
investigative team is not aware of any current and thorough SR with MA on this topic. Thus, the 
specific aim of this study was to conduct a SR and MA to critically evaluate the available 
evidence regarding the relationship between childhood obesity and selected adult CVD risk 
factors. The results of this study can contribute to the planning and implementation of preventive 
strategies for promoting cardiovascular health during the various life stages as well as provide 
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direction for the future conduct and reporting of research on this topic.  
 
Research Design and Methods 
 
Purpose 
The purpose of this study was to conduct a SR and MA of studies that have examined the 
association between childhood obesity and the following adult CVD risk factors: (1) resting 
systolic blood pressure (SBP), (2) resting diastolic blood pressure (DBP), (3) TC, (4) HDL, (5) 
LDL, (6) non-HDL and (7) TG. A secondary aim of the study was to examine whether this 
association persists after adjusting for adult obesity. 
We conducted a SR with MA by following the Cochrane Collaboration’s 
recommendations and guidelines for conducting SRs and MA for observational studies,45,52 as 
well as the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA)53,54 
statement. In addition, we registered this study in PROSPERO, an international registry for SRs 
(Protocol number: PROSPERO 2015:CRD42015019763).55  
 
Study Eligibility 
The eligibility criteria for the studies included or excluded in the MA need to be well 
defined and established a priori.56 The Cochrane acronym PICO(S) (population, intervention, 
comparison, outcomes, study design or study setting), was utilized to ensure that all key 
components are covered prior to starting the review process. The eligibility criteria for the study 
included: (1) longitudinal and cohort studies (including case-cohort), (2) childhood exposure and 
adult outcomes collected on the same individual over time, (3) main exposure variable of the 
child’s overweight and obesity status (BMI age-and sex-specific percentiles, percent body fat, fat 
mass, waist circumference (WC), waist-to-hip ratio, visceral adipose tissue, skin fold thickness, 
body weight, BMI z-score, BMI or other measures used to assess overweight and obesity in 
populations),57 (4) studies available in English-language, (5) studies published up to June, 2015, 
(6) one or more of the following CVD risk factors as the primary outcome measure: (SBP, DBP, 
TC, LDL, HDL, non-HDL, and TG), (7) outcome measurements taken by health professionals or 
trained investigators but not based on self-report data, (8) exposure measurements (child’s 
adiposity) assessed by health professionals, trained investigators, or self-reported. Exclusion 
criteria included the following: (1) review articles, (2) cross-sectional study designs, (3) case-
control study designs, (4) case reports, (5) comments, (6) letters, (7) animal studies, (8) studies 
published in non-English language sources, (9) presentations from conference meetings, (10) 
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unpublished studies (abstracts, master theses, dissertations, etc.), (11) studies in which the 
outcome(s) were self-reported and, (12) studies outside general population. 
We utilized a number of various sources and methods to identify the maximum number 
of eligible articles. These included electronic database searches as well citation tracking from the 
retrieved articles. We also assessed for publication bias, which occurs when the published 
literature is systematically unrepresentative of the population of all completed studies.58,59 Grey 
literature refers to unpublished reports, conference abstracts, thesis and dissertations, articles in 
obscure journals, reports, rejected or un-submitted manuscripts.60 Due to limited resources, we 
did not search the grey literature but utilized numerous sources to identify the published 
literature. While MA that exclude grey literature may tend to overestimate ESs,60-62 some 
researchers have argued that the methodological quality of grey literature is low compared to 
published literature due to a lack of formal quality control and peer review, 63,64 and thus, can 
jeopardize the quality of MA given that the quality of MA is dependent on the quality of the 
studies included in the analysis.65 Alternatively, others have argued that there is limited evidence 
that grey literature is of lower quality than published trials.62 However, as previously mentioned, 
we excluded grey literature because of limited resources as well as the difficulty to access this 
type of literature, the latter of which can also potentially bias results. 
In order to control for multiple publication bias (multiple publications from the same 
population), only one set of data that included the greatest amount of relevant information on the 
participants was included. Given the lack of resources, we also excluded studies that were not 
published in the English language. Meta-analyses that restrict studies by language can potentially 
overestimate the outcome effects by only 2%, and the percentage of non-English studies 
traditionally included in meta-analyses is very small.66  
 
Data Sources 
A SR provides a comprehensive search for all potentially relevant literature for a specific 
research question.67 For the current study, we searched multiple electronic databases and cross-
referenced from the bibliographies of all retrieved articles (citation tracking). An information 
retrieval specialist (Health Sciences librarian, JS) assisted in the planning of the literature search 
and in identifying and creating correct Boolean operators and search strings for the different 
electronic database searches.68 All aspects of the searches were documented with respect to name 
of the data source, journal, date of the search, person responsible etc. For this study, we searched 
the following electronic databases on June 5, 2015: (1) PubMed (MEDLINE), (2) Web of 
Science, and (3) Scopus. We first conducted a preliminary search in PubMed and searched 
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forward from the date of the first study that met our search criteria (1975). The PubMed search 
string used was as follows: “(obesity OR obese OR overweight OR fat OR adipos* OR “body 
mass index” OR BMI) AND (child* or adolesc*) AND (“blood pressure” OR hypertension OR 
cholesterol OR lipid OR lipids OR lipoprotein OR lipoproteins OR cardiovascular) AND 
(observational OR cohort OR longitudinal) AND adult* AND (human OR humans).” Each search 
was conducted separately and then downloaded as a separate file using Endnote X7.69 All 
duplicates were removed electronically and then manually. 
 
Study Selection  
In order to minimize selection bias, two researchers (AU and CL) independently screened 
studies for eligibility by reviewing the titles and abstracts of articles based on the pre-defined 
eligibility criteria (see previous section on study eligibility). If the inclusion or exclusion criteria 
could not be decided based on the title and abstract, full-text articles were retrieved and the 
decision was made accordingly. After independent study selection was performed, the two 
reviewers met and reviewed every selection for agreement. Cohen’s kappa statistic70 was used to 
measure inter-selection agreement and discrepancies were resolved by consensus. If a decision 
could not be achieved, a content area and MA expert (GK) resolved any disagreement(s). Using 
Cohen’s kappa statistic, the overall agreement rate prior to correcting discrepancies was 0.75.  
 
Data Abstraction.  
Prior to data abstraction, a detailed codebook that could hold up to 200 items per study 
was developed by the research team in Microsoft Excel software (version 2011).71 The codebook 
included continuous variables, categorical variables, and free text information. The codebook 
developed was pilot-tested and revised by the investigative team. In order to avoid data 
abstraction bias, two authors (AU and CL) coded or extracted data from each selected article 
independently. The researchers then compared every data point for accuracy and consistency until 
100% agreement was reached. If agreement could not be reached, a content area and MA expert 
(GK) resolved any disagreement(s). 
 
Risk of Bias Assessment  
The term ‘risk of bias’ is used to describe “a systematic error or deviation from the truth, 
in results or inferences.”45 The Cochrane Collaboration emphasizes that risk of bias assessment 
should clearly differentiate between the quality of reporting and the quality of the underlying 
conduct of the research.45 Biases similar to randomized controlled trials (RCT) may also be 
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present in a non-randomized study (NRS). These include selection bias, attrition bias, 
performance bias, detection bias, outcome-reporting bias, publication bias and dissemination bias. 
However, the nature and variety of NRS makes it more difficult for the groups to be comparable.  
Several of the important biases in longitudinal studies include (1) selective dropout bias, (2) 
participation bias, (3) selection bias (sampling frame, recruitment, consent rates, retention, loss to 
follow-up, item non-response), (4) interviewer bias, (5) response bias, (6) social desirability bias, 
(7) measurement bias, and (8) the role of potential confounders and residual confounding in 
explaining the findings from NRS. Numerous tools that have evaluated study quality or risk of 
bias of observational studies72 i.e., Downs and Black, 73 Reisch, 74 and Zaza 75 still require 
modifications as there is no gold standard for assessing the risk of bias of observational 
studies.72,76 However, one tool, Strengthening the Reporting of Observational Studies in 
Epidemiology (STROBE), has been cited by several SR and MA for assessing the reporting of 
observational studies.77 The STROBE instrument consists of a checklist of 22 items that provides 
guidance on the reporting of observational studies to facilitate critical assessment and 
interpretation of results.78 For this study, we used the STROBE instrument to assess the quality of 
reporting of the included observational studies. This checklist facilitates in assessing the risk of 
potential bias in the title and abstract, introduction, methods, results, and discussion sections of 
articles. Each item was classified as “yes” (low risk), “no” (high risk), or “unclear”. Two 
researchers (AU and CL) conducted all assessments independent of each other and examined the 
results at the study level as well as for each item. They then compared their selections for 
accuracy and consistency. Inter-rater agreement was assessed using Cohen’s kappa statistic. Any 
disagreements were discussed and resolved until 100% agreement was reached. Using Cohen’s 
kappa statistic, the overall agreement rate prior to correcting discrepancies ranged from 0.70 to 
0.94 (mean =0.89, SD = 0.03). 
 
Statistical Analysis 
Descriptive statistics. Using Microsoft Excel 201171 and after data cleaning, descriptive 
statistics were generated for continuous [sample sizes, means, medians, standard deviations, 
standard errors, 95% confidence intervals (CI)] and categorical (frequencies and percentages) 
variables. Seven separate Microsoft excel sheets were generated for all seven outcomes [(1) SBP, 
(2) DBP, (3) TC, (4) HDL, (5) LDL, (6) non-HDL, and (7) TG)]. Any outcome with only one 
study was excluded from the meta-analysis. Each outcome was further analyzed separately if it 
was adjusted for adult adiposity.  
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Calculation of effect sizes from each study. The effect size (ES) is the strength of an 
association between two variables. The two previous SRs by Lloyd et al. presented the correlation 
statistics for the individual studies,18,37 whereas Reilly et al.39 and Park et al.38 presented odds 
ratios (OR). However, the one MA on this topic used risk ratios (RR), also known as relative 
risks, as their ES measure.40 The a priori plan was to use RR as our ES in order to examine the 
association between childhood obesity and selected adult CVD risk factors (SBP, DBP, TC, 
HDL, LDL, non-HDL, and TG). However, because most studies reported a correlation between 
two continuous variables, a post hoc decision was made to use correlation statistics (Fishers r to z 
score) instead of RR to serve as the main ES index.79 All other ESs (OR, mean differences) were 
converted to correlation statistics using Comprehensive Meta-Analysis (version 3.0).80 This 
software program allows for the automatic calculation of different data into correlation statistics. 
Additionally, standardized beta coefficients from individual studies were used as the correlation 
statistics. This decision was based on previous research showing that the correlation between the 
beta coefficient and correlation coefficient is linear, having a correlation of 0.84 if the coefficients 
reside in the interval ±0.50.81 Studies that presented unstandardized beta-coefficients were first 
converted to standardized regression coefficients by multiplying the unstandardized coefficient by 
the ratio of the standard deviations of the independent variable and the dependent variable. 
Studies where unstandardized regression coefficients could not be converted to standardized 
regression coefficients and no other ES was provided were excluded from the MA. 
Pooling of ES’s. Results for the association between childhood obesity and selected 
CVD risk factors (SBP, DBP, TC, HDL, LDL, non-HDL, and TG) were pooled separately using 
random-effects, method-of-moments models.82 The correlation metric was converted to Fisher’s z 
scale (Fisher's r-to-z transformation), and all analyses performed using the transformed values.79 
These results included an overall effect estimate as well as 95% CI.82 If the 95% CI did not 
include zero (null=0 for correlation coefficient/Fishers r to z score), we considered our results to 
be statistically significant. We chose a random-effects model over a fixed-effect model because 
the former incorporates heterogeneity into the model. Random-effects models in MA assume that 
the true ESs are normally distributed and that studies are drawn from populations that differ from 
each other in ways that could impact the outcome.83 Moreover, several researchers suggest that 
when studies are gathered from the published literature, the random-effects model is generally a 
more appropriate model.79 This model takes into account both within and between-study variation 
while the fixed-effect model only takes into account within-study variation. In other words, a 
fixed-effect model assumes that all studies are drawn from a common population84 while a 
random-effects model does not. If there is no significant heterogeneity, the random-effects model 
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and the fixed-effect model will produce similar results.59 If significant heterogeneity does exist, a 
random-effects model usually yields wider CI’s. Forest plots were used to visually display the 
estimated ES of each study and their corresponding 95% CI’s. In addition, an overall pooled 
effect as well as 95% CI’s was generated. Furthermore, 95% prediction intervals (PI’s) were also 
calculated as a measure of dispersion in order to identify how the true value is likely to vary from 
one study to the next.  
Stability and validity of changes in ES’s. A primary purpose of MA is to investigate 
potential sources of heterogeneity of results in existing studies.85 For this study, we estimated 
heterogeneity for each outcome using the I2 statistic.86,87 The I2 statistic provides a useful 
summary of the impact and extent of heterogeneity, which helps in determining the robustness of 
drawing overall conclusions.86,87 I2 is calculated as 100% ×(Q - df)/Q, where Q is Cochran's 
heterogeneity statistic and df is the degrees of freedom. Statistical significance for Q was set at an 
alpha level of ≤0.10 versus ≤0.05 because the Q statistic suffers from power issues.87 A value of 
0% indicates no observed heterogeneity while larger values show increasing heterogeneity. 
Negative values of I2 are set to zero.87 For this study, heterogeneity for I2 was classified as trivial 
(0%–25%), low (25.1%–50%), moderate (50.1%–75%), or high (75.1%–100%).87 The results 
were also interpreted with respect to the clinical implications of the degree of inconsistency as 
well as the magnitude and direction across studies, including the strength of evidence for 
heterogeneity.87 
 Publication bias is the tendency for authors to submit, and journals to accept and 
publish, manuscripts based on statistically significant findings.88 For this study, we followed the 
general guidelines of Sterne et al.,89 for assessing publication bias, one of the potential reasons for 
what is known as “small-study effects”, i.e., the tendency for smaller studies to show greater 
effects than larger studies. This includes a qualitative test, the funnel plot (inverse of standard 
error on the y axis and ES on the x axis) and a quantitative test, Egger’s linear regression test.90 
As recommended by Sterne et al.,89 the test for funnel plot asymmetry was not used when there 
were fewer than 10 studies because power is usually low in identifying chance from real 
asymmetry.89 The Egger regression test is a regression of the standardized effect estimates against 
their precision (inverse standard error) and quantifies the funnel plot asymmetry by determining 
whether the intercept deviates significantly from zero. If the intercept is not significantly different 
from zero there is no evidence of funnel plot asymmetry.90-92 Influence analysis was used to 
examine the effects of each study on the overall results. This analysis excludes one study at a time 
in order to determine the influence of each study on the overall results.93 Cumulative MA, ranked 
by the year the study started, was used to examine the accumulation of findings over time by 
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adding one study at a time and the results summarized as each new study is added.94 A sensitivity 
analysis was also performed by pooling the ESs from studies that only used childhood BMI as the 
exposure. This was performed in order to determine if any differences existed in the pooled 
results that included any definition for childhood exposure, including BMI.  
Meta-regression. Because of missing data for different predictor variables from different 
studies, simple weighted least squares meta-regression (random-effects, method of moments 
approach) was used to examine the relationship between each outcome and selected covariates. 
Meta-regression is analogous to individual study regression except that the outcome variable is 
the effect estimate, i.e., unit of analysis is the study, rather than individual participant scores.59 
This analysis is exploratory and used to indicate the magnitude and direction of association 
between variables as well as explore which factors, if any, best account for changes in outcomes. 
The slope of the regression coefficients along with their 95% CIs were also calculated. CIs that 
did not cross zero were considered statistically significant. Planned covariates to examine a priori 
included: (1) country in which the study was conducted (USA, other), (2) bias due to loss to 
follow up, (3) type of analysis, (4) type of definitions used for adiposity, (5) exposure measure 
(self-report or not), (6) subject characteristics (sex, race/ethnicity), (7) studies that examined the 
association between childhood obesity and CVD risk factors while controlling or not controlling 
for adult adiposity, (8) time to follow up, (9) age categories of adults, (10) age categories of 
children, (11) comorbid conditions for both the child and the adult (diabetes, metabolic syndrome, 
etc.), (12) lipid lowering medication, (13) hypertensive medication, (14) family history of CVD, 
(15) smoking status/alcohol or drug use of both the child and the adult, (16) socio-economic 
status related variables, (17) diet, (18) physical activity, (19) fasting vs. non-fasting lipid profile, 
(20) child’s pubertal status, (21) perinatal risk factors, and (22) study design. Where there was 
insufficient data (fewer than 3 results per group) for potential predictor variables, we performed a 
sensitivity analysis without the predictor to see if it had an effect on our overall findings. For 
categorical variables, less than three results for any one category were used as the cut-off for 
analysis. The results of the meta-regression tests need to be interpreted with caution since they are 
considered observational and exploratory inquiries, i.e., non-experimental comparisons, designed 
to generate hypotheses about potential sources of heterogeneity to be tested in original studies.59 
In addition to statistical significance, the results of our study were also interpreted with respect to 
practical significance.  
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Results 
 
Study Characteristics 
A general description of the characteristics of each study is shown in Table 3. Of the 
4875 citations reviewed, a total of 23 were included in the SR4,95-116 and 21 in the MA.4,95-100,102-
110,112-116 A description of the search process, including the reasons for excluded studies, is shown 
in Figure 1. A list of all excluded studies and reasons for exclusion are shown in Additional file 2. 
The year that each study started varied considerably, ranging from 1923 to 1989 while the year 
that studies were published ranged from 1971 to 2014.  
Studies were conducted in eleven different countries; six in the U.S.,4,95,97,98,104,106 three in 
United Kingdom (England, Wales, Scotland and Newcastle),107,114,116 three in Finland,96,99,112 two 
in Australia,108,113 and one in Sweden,100 India,102 Lithuania,103 Poland,105 the Republic of 
Seychelles,109 Japan,110 and Six Solomon Island.115 Most studies used a prospective longitudinal 
study design except for two studies that used a retrospective study design.96,104 None of the 
studies used a case-cohort study design.  
The length of follow-up for the studies ranged from 4.5 to 60 years. As most of the 
studies were prospective longitudinal studies, the number of subjects at baseline was often greater 
than the number of participants at follow-up due to loss to follow-up. Seven studies included 
information on loss to follow-up.4,99,100,102,103,108,113 Reasons for loss to follow-up included the 
following: (1) refused to participate, (2) inability to locate, (3) did not respond to contact, (4) 
participants out of country or town at time of follow-up, (5) death, (6) difficult to contact married 
girls in India who left their native village, (7) social disadvantage (less well educated and having 
lower family income). Two studies specified that participants who were lost to follow-up did not 
have significantly different childhood BMI’s when compared to those who were available at 
follow-up in adulthood.4,116 
As for the exposure, most studies used BMI as a measure of adiposity in childhood in 
addition to other measures used.4,96-100,102,103,105-110,112-116 However, two studies used relative 
overweight95 and sub-scapular skinfold thickness measures only.104 Most studies did not use a 
cut-off point to define childhood obesity, but rather, used childhood BMI as a continuous 
variable.  
Sixteen studies examined the association between childhood obesity and adult SBP,4,95,97-
100,102-104,106-110,113,116 14 examined the association between childhood obesity and adult DBP,4,95,98-
100,102,103,106-110,113,116 8 examined the association between childhood obesity and adult 
TC,4,95,98,110,112,114-116 5 examined the association between childhood obesity and adult 
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LDL,4,109,112,114,116 8 examined the association between childhood obesity and adult HDL, 
4,98,99,109,112-114,116 and 9 examined the association between childhood obesity and adult 
TG.4,98,99,102,109,112,113,115,116 However, data from one study that assessed TG could not be used for 
MA because the study’s main outcome was blood pressure and there was not enough information 
provided for TG to calculate an effects size.102 Only one study (Pereira et al., 2013) included data 
for the association between childhood adiposity and adult non-HDL cholesterol.111 However, the 
study by Pereira et al. was excluded from the MA due to the inability to retrieve data for meta-
analytic use for other outcomes as well. Another study by Holland and colleagues was excluded 
from the MA for the same reason.101 Of the 21 studies, only six (28.6%) included data on the 
association between childhood obesity and adult CVD risk factors while adjusting for adult 
BMI.4,96,105,107,109,116 Two of these six studies reported adjusted associations only.96,105  
 
Participant Characteristics 
As previously stated, a description of the participant characteristics is shown in Table 3. 
The majority of studies included information on both males and females,97,100,103-106,109,110,112,115,116 
two were limited to men only,95,102 while 9 included combined data for both men and 
women.4,96,98,99,107-109,113,114 No study was limited to women. One study included combined results 
as well as results according to sex.109 However, for the current MA, we used the results reported 
according to sex.109 Moreover, while one study had data on both males and females, data from 
only males was used for the current MA because the regression model for females included 
change of BMI over time i.e., from childhood to adulthood.97  
The participants’ ages at baseline when the exposure was measured ranged from 2 to 18 
years. The age at follow-up when the outcome was measured also varied substantially between 
studies, ranging from 19 to 62 years. Some studies used one childhood age or average of a range 
of childhood ages as their exposure, while some studies categorized children based on different 
age groups. Furthermore, some studies used longitudinal data for the same children over time.   
Most of the studies provided some level of information on comorbid conditions of adults. 
These included hypertension,95 arteriosclerotic heart disease,95 CV renal disease,95 coronary heart 
disease,96 diabetes, insulin or glucose levels,4,99,109 metabolic syndrome,100 medication for heart 
diseases,107 medication for hypertension,9,105,107 and uric acid level.109 One study excluded 
participants who were on hypertension (HT) medication,104 whereas one study found no 
difference in any of the analyses after performing sensitivity analysis and excluding those 
subjects who were taking cholesterol-lowering drugs.114 For women, additional information on 
the use of oral contraceptives, menstruation, menopausal status, and use of hormonal replacement 
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therapy was provided by a five studies.105-107,112,114 Family history of CVD or CVD risk factors 
was available in 2 studies.104,106 Information on smoking, alcohol, and drug use was provided by 
six studies.100,102,106,107,112,113 Perinatal risk factors such as birth weight and/or gestational age were 
presented in approximately one third of the studies.97,99,107,108,110,114,116 Information on diet and 
physical activity was provided by 4 studies,100,107,112,113 while information on the child’s pubertal 
status was provided by one study.103 It is important to note that these variables were not 
necessarily adjusted for in the analyses performed by the individual studies.  
 
Risk of Bias Assessment 
Overall study-level risk of bias results are shown in Figure 2 while results for each item 
from each study are shown in Additional file 3. More than 50% of the studies did not provide an 
adequate description of participant characteristics while almost 70% did not describe any efforts 
to address potential sources of bias, explain how loss to follow-up was addressed, or provide 
reasons for non-participation at each stage. More than 80% did not explain how missing data was 
addressed. At the study level, nine studies had more than one third of items that were at an 
increased risk of bias for reporting of items for observational studies.95,97,101,102,104-106,112,116 
 
Primary Outcomes 
The results of the random-effects MA for the association between childhood obesity and 
adult CVD risk factors are presented below. The forest plots displaying the effect estimates along 
with the 95% CI for each outcome is shown in Figures 3-14. The forest plots for influence 
analyses, cumulative MA, and funnel plots are shown in Additional file 4. Exploratory random-
effects meta-regression analyses for the association between childhood obesity and adult CVD 
risk factors and selected covariates (categorical and continuous) in which adequate data were 
available are shown in Additional file 5.  
 
Systolic Blood Pressure (unadjusted for adult adiposity). Overall, there was a 
statistically significant and positive association between childhood adiposity and adult SBP 
(Table 4 and Figure 3). Heterogeneity was also statistically significant and large. However, 95% 
PIs were non-significant. Funnel plot results for small-study effects showed a lack of asymmetry 
and were reinforced by a lack of statistical significance based on Egger et al.’s regression 
intercept test (p = 0.42). With each study deleted from the model once, results remained 
statistically significant across all deletions. The associations ranged from approximately 0.10 to 
0.11. Cumulative MA, ranked by the year the study started, demonstrated that results have been 
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statistically significant since examining the birth cohort of 1958. Random-effects meta-regression 
revealed statistically significant evidence for an association between pooled ES (Fisher’s r to z 
score for the association between childhood obesity and adult SBP) and baseline age (β = 0.01, p 
= 0.01; I2 reduced from 91% to 88%), studies conducted in the United States versus other 
countries (β = 0.07, p = 0.05) and studies that used BMI versus alternative methods for assessing 
adiposity (β = 0.05, p = 0.05).  
 
Systolic Blood Pressure (adjusted for adult adiposity). When examining studies that 
adjusted for adult BMI, a statistically significant and negative association was observed between 
childhood adiposity and adult SBP (Table 4 and Figure 4). Heterogeneity was also statistically 
significant and considered large. However, 95% PIs were non-significant. Because there were 
less than 10 studies, small-study effects were not assessed. With each study deleted from the 
model once, results remained statistically significant across all deletions. The associations ranged 
from approximately -0.10 to -0.13. Cumulative MA, ranked by the year the studies started, 
demonstrated that results have been statistically significant since the first study was conducted in 
1934. Random-effects meta-regression revealed statistically significant evidence for an 
association between pooled ES (Fisher’s r to z score for the association between childhood 
obesity and adult SBP for studies that adjusted for adult BMI) and follow-up age (β = -0.005, p = 
0.002; I2 reduced from 89% to 69%) as well as length of follow-up (follow-up age – baseline age) 
(β = -0.004, p = 0.008; I2 reduced from 89% to 76%).  
 
Diastolic Blood Pressure (unadjusted for adult adiposity). Overall, there was a 
statistically significant and positive association between childhood adiposity and adult DBP 
(Table 4 and Figure 5). Heterogeneity was also statistically significant and large. However, 95% 
PIs were non-significant. Funnel plot results for small-study effects showed a lack of asymmetry 
and were reinforced by a lack of statistical significance based on Egger et al.’s regression 
intercept test (p = 0.37). With each study deleted from the model once, results remained 
statistically significant across all deletions. The associations ranged from 0.094 to 0.113. 
Cumulative MA, ranked by the year the study started, demonstrated that results have been 
significant since examining the birth cohort of 1966. Random-effects meta-regression revealed 
statistically significant evidence for an association between pooled ES (Fisher’s r to z score for 
the association between childhood obesity and adult DBP) and baseline age (β = 0.01, p = 0.01; I2 
reduced from 90% to 87%).  
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Diastolic Blood Pressure (adjusted for adult adiposity). When examining studies that 
adjusted for adult BMI, a statistically significant and negative association was observed between 
childhood adiposity and adult DBP (Table 4 and Figure 6a). Heterogeneity was also statistically 
significant and considered large. However, 95% PIs were non-significant. Because there were 
less than 10 studies, small-study effects were not assessed. The results of the influence analysis 
showed that when two studies (Koziel et al, 2011 and Li et al., 2007) were deleted separately 
from the model, results were slightly non-significant.105,107 The results remained statistically 
significant when deleting the rest of the studies individually. The associations ranged from 
approximately -0.081 to -0.131. Cumulative MA, ranked by the year the studies started, 
demonstrated that results have been statistically significant since the first study was conducted in 
1947. Random-effects meta-regression revealed statistically significant evidence for an 
association between pooled ES (Fisher’s r to z score for the association between childhood 
obesity and adult DBP for studies that adjusted for adult BMI) and follow-up age (β = -0.006, p 
<0.0001; I2 reduced 92% to 58%), and length of follow-up (β = -0.006, p <0.0001; I2 reduced 
from 92% to 56%).  
 
Total Cholesterol (unadjusted for adult adiposity): Overall, there was a positive 
association between childhood adiposity and adult TC (Table 4 and Figure 7). However, the 
association was not statistically significant. The 95% PIs were also non-significant. The 
heterogeneity was statistically significant and large. Because there were less than 10 studies, 
small-study effects were not assessed. With each study deleted from the model once, results 
remained statistically non-significant across all deletions. The associations ranged from 
approximately -0.01 to 0.02. Cumulative meta-analysis, ranked by the year the study started, 
demonstrated that results have been negative since the start of the first study in 1923 up to the 
sixth study that started in 1970 after which the cumulative results showed a positive association. 
Random-effects meta-regression revealed statistically significant evidence for an association 
between pooled ES (Fisher’s r to z score for the association between childhood obesity and adult 
TC) and follow-up age (β = -0.004, p = 0.04; I2 reduced from 91% to 76%), and length of follow-
up (β = -0.004, p = 0.01; I2 reduced from 91% to 67%).  
 
Total Cholesterol (adjusted for adult adiposity). When examining studies that adjusted 
for adult BMI, a negative and non-significant association was observed between childhood 
adiposity and adult TC (Table 4 and Figure 8). The 95% PIs were non-significant as well. 
Heterogeneity was statistically significant and considered large. Because there were less than 10 
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studies, small-study effects were not assessed. With each study deleted from the model once, 
results remained statistically non-significant across all deletions except when one study by Barker 
et al., 2005 was deleted, resulting in statistically significant results. The associations ranged from 
approximately -0.036 to -0.090. Cumulative meta-analysis, ranked by the year the studies started, 
demonstrated that results have been negative since examining the birth cohort of 1947. Random-
effects meta-regression revealed statistically significant evidence for an association between 
pooled ES (Fisher’s r to z score for the association between childhood obesity and adult TC for 
studies that adjusted for adult BMI) and baseline age (β = -0.32, p <0.0001; I2 reduced from 86% 
to 0%) and sex (β = -0.32, p <0.0001; I2 reduced from 77% to 35%).  
 
Low-density Lipoprotein  (unadjusted for adult adiposity): Overall, there was a 
positive association between childhood adiposity and adult LDL (Table 4 and Figure 9). 
However, the results were not statistically significant. The 95% PIs were non-significant as well. 
Heterogeneity was statistically significant and large. Because there were less than 10 studies, 
small-study effects were not assessed. With each study deleted from the model once, results 
remained statistically non-significant across all deletions. The associations ranged from 
approximately 0.095 to -0.085. Cumulative meta-analysis, ranked by the year the study started, 
demonstrated that results have been statistically non-significant since examining the birth cohort 
of 1947. The results were negative with the first three studies added and became positive after the 
fourth and fifth studies were included. Random-effects meta-regression revealed statistically 
significant evidence for an association between pooled ES (Fisher’s r to z score for the 
association between childhood obesity and adult LDL) and follow-up age (β = -0.005, p = 0.0001; 
I2 reduced from 94% to 39%), and length of follow-up (β = -0.004, p = 0.005; I2 reduced from 
94% to 59%).  
 
Low-density Lipoprotein  (adjusted for adult adiposity): When examining the three 
studies that adjusted for adult BMI, a statistically significant and negative association was 
observed between childhood adiposity and adult LDL (Table 4 and Figure 10). Heterogeneity was 
also statistically significant and considered large. However, 95% PIs were significant. Because 
there were less than 10 studies, small-study effects were not assessed. With each study deleted 
from the model once, results remained statistically significant across all deletions. The 
associations ranged from approximately -0.07 to -0.09. Cumulative meta-analysis, ranked by the 
year the studies started, demonstrated that results have been statistically significant since the first 
study was conducted in 1947. Random-effects meta-regression revealed no statistically 
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significant evidence for an association between pooled ES (Fisher’s r to z score for the 
association between childhood obesity and adult LDL for studies that adjusted for adult BMI) and 
sex. None of the other variables were examined because of insufficient data.  
 
High-density Lipoprotein  (unadjusted for adult adiposity): Overall, there was a 
statistically significant and negative association between childhood adiposity and adult HDL 
(Table 4 and Figure 11). Heterogeneity was also statistically significant and large. However, 95% 
PIs were non-significant. Because there were less than 10 studies, small-study effects were not 
assessed. With each study deleted from the model once, results remained statistically significant 
across all deletions except when one study by Schmidt et al., 2011 was deleted. Deleting this 
study resulted in a negative non-significant association. The associations ranged from 
approximately -0.04 to -0.07. Cumulative meta-analysis, ranked by the year the study started, 
demonstrated that results have been statistically significant since examining the birth cohort of 
1985. Random-effects meta-regression revealed no statistically significant evidence for an 
association between pooled ES (Fisher’s r to z score for the association between childhood 
obesity and adult HDL) for all the covariates examined.  
 
High-density Lipoprotein (adjusted for adult adiposity): When examining studies that 
adjusted for adult BMI, a positive but non-significant association was observed between 
childhood adiposity and adult HDL (Table 4 and Figure 12). Heterogeneity was statistically 
significant and considered large. However, 95% PIs were non-significant. Because there were 
less than 10 studies, small-study effects were not assessed. With each study deleted from the 
model once, results remained statistically non-significant across all deletions. The associations 
ranged from approximately -0.009 to 0.079. Cumulative meta-analysis, ranked by the year the 
studies started, demonstrated that results have been statistically non-significant since the first 
study was conducted in 1947. However, it is important to note that these results are based on only 
four studies and the direction of association changed from positive to negative and then positive 
over time. Random-effects meta-regression revealed statistically significant evidence for an 
association between pooled ES (Fisher’s r to z score for the association between childhood 
obesity and adult HDL for studies that adjusted for adult BMI) and follow-up age (β = -0.007, p = 
0.004; I2 reduced from 94% to 74%), length of follow-up, (β = -0.007, p = 0.004; I2 reduced from 
94% to 76%) and sex (males vs. female, β = -0.13, p = 0.01; I2 reduced from 66% to 59%).  
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Triglycerides (unadjusted for adult adiposity): Overall, there was a statistically 
significant and positive association between childhood adiposity and adult TG (Table 4 and 
Figure 13). Heterogeneity was also statistically significant and large. However, 95% PIs were 
non-significant. Because there were less than 10 studies, small-study effects were not assessed. 
With each study deleted from the model once, results remained statistically significant across all 
deletions except when Freedman et al., 2001 and Schmidt et al., 2011 were deleted. The 
associations ranged from approximately 0.07 to 0.11. Cumulative meta-analysis, ranked by the 
year the study started, demonstrated that results have been statistically significant since 
examining the birth cohort of 1985. Random-effects meta-regression revealed statistically 
significant evidence for an association between pooled ES (Fisher’s r to z score for the 
association between childhood obesity and adult TG) and follow-up age (β = -0.001, p <0.0001; 
I2 reduced from 83% to 50.35%), and length of follow-up (β = -0.007, p = 0.0001; I2 reduced 
from 83% to 50%).  
 
Triglycerides (adjusted for adult adiposity): When examining studies that adjusted for 
adult BMI, a negative association was observed between childhood adiposity and adult TG (Table 
4 and Figure 14). However, the association was not statistically significant. The 95% PIs were 
non-significant as well. Heterogeneity was statistically significant and considered large. Because 
there were less than 10 studies, small-study effects were not assessed. With each study deleted 
from the model once, results remained statistically non-significant across all deletions. The 
associations ranged from approximately -0.05 to -0.13. Cumulative meta-analysis, ranked by the 
year the studies started, demonstrated that results have been statistically non-significant since 
examining the cohort of 1947. Random-effects meta-regression revealed statistically significant 
evidence for an association between pooled ES (Fisher’s r to z score for the association between 
childhood obesity and adult TG for studies that adjusted for adult BMI) and follow-up age (β = 
0.006, p = 0.05; I2 reduced from 95% to 92%), length of follow-up, (β = 0.004, p = 0.02; I2 
reduced from 95% to 90%) and sex (male vs. females, β = 0.05, p = 0.002; I2 reduced from 60% 
to 45%).  
 
Non-High-density Lipoprotein.  Our study was not able to perform MA on the 
association between childhood obesity and non-HDL levels due to lack of data.  
 
Sensitivity Analysis 
The results of the sensitivity analysis for all the outcomes using only BMI as the 
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exposure showed that childhood obesity is significantly and positively associated with adult SBP 
(Zr = 0.10; 95% CI: 0.06, 0.13), DBP (Zr = 0.11; 95% CI: 0.07, 0.14), and TG (Zr = 0.10; 95% 
CI: 0.02, 0.17), and significantly and inversely associated with adult HDL (Zr = -0.06; 95% CI: -
0.11, -0.01) (Table 5).  
 
Discussion 
 
Findings 
The purpose of this study was to conduct a SR and MA of studies that have examined the 
association between childhood obesity and adult CVD risk factors (SBP, DBP, TC, HDL, LDL, 
non-HDL, and TG). The overall, unadjusted findings suggest that childhood obesity is 
significantly and positively associated with adult SBP, DBP, and TG and significantly and 
negatively associated with adult HDL. This interpretation is supported by: (1) 95% CI for 
overall results that do not include the null, (2) consistency of overall results when each study was 
deleted from the model once (influence analysis), (3) significance of results over a long time 
period in which the included studies were conducted (cumulative meta-analysis), and (4) non-
significant small study effects. 
When examining studies that adjusted for adult obesity, the overall findings suggest that 
the association was significant and negative for SBP, DBP, and LDL while the associations 
between childhood obesity and adult HDL and TG became non-significant when adult BMI was 
accounted for. However, it is important to point out that less than one third of studies adjusted for 
adult adiposity measures.4,96,105,107,109,116 For the studies that adjusted for adult BMI, the 
associations became reversed, suggesting that the association between childhood adiposity and 
adult CVD risk factors is potentially mediated by adult adiposity. The correlation coefficient for 
childhood adiposity from childhood to adulthood ranged from 0.3 to 0.8 (mean = 0.6, SD = 0.1), 
demonstrating a medium to strong tracking of adiposity across the lifespan. This is also consistent 
with previous research suggesting that children who are obese have a 40%-80% chance of 
becoming overweight or obese adults.21-23 
Several factors need to be taken under consideration when examining the results of this 
study. First, we used random-effects models that incorporate heterogeneity into the analysis. 
However, based on the fixed-effect model, we observed a moderate to large amount of 
heterogeneity in all the outcomes assessed. While a random-effects model incorporates 
heterogeneity into the analysis, it does not explain the sources of heterogeneity. Second, the 95% 
PIs were not statistically significant as they overlapped the null (0). As previously noted, the 95% 
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CI are centered around the point estimate of the between study variation. A 95% PI is based on 
the random mean effect, and is an interval/range in which 95% of the true study’s expected 
effects are found. This is the area where the true effect measure of the new study lies, or 
simultaneously the predicted parameter value in a new study can be deduced, thus giving more 
confidence in the overall results of the study.117,118 Third, many studies were considered to be at 
an increased risk of bias for the quality of reporting on several items of the STROBE instrument 
(Figure 2 and Additional file 3). More specifically, nearly 70% of the studies were considered to 
be at a high risk of bias for the following elements: (1) describing any efforts to address potential 
sources of bias, (2) explaining how missing data were addressed, (3) explaining how loss to 
follow-up was addressed, (4) describing any sensitivity analyses, (5) providing reasons for non-
participation at each stage, (6) considering the use of a flow diagram, (7) considering translating 
estimates of relative risk into absolute risk for a meaningful time period, and (8) not providing 
adequate information on participants characteristics. Fourth, loss to follow-up is one of the main 
sources of bias in longitudinal studies. The potential bias occurs when the participants who are 
lost to follow-up are different from participants who remain in the study.119 Research suggests 
that more than a 20% loss to follow-up is a potential threat to the internal validity of the study.120 
Only seven studies included information on loss to follow-up.4,99,100,102,103,108,113 Lastly, some of 
the associations observed in the exploratory covariates from the results of the meta-regression 
analyses suggest that some factors may potentially impact the overall conclusions. These include 
different factors for different outcomes. The significant factors included: (1) baseline age for 
adult SBP and DBP, (2) follow up age for TC, LDL, and TG (3), length of follow-up for TC, 
LDL, and TG, (4) country study was conducted for SBP, and (5) type of exposure used to assess 
adiposity for SBP. For the studies that adjusted for adult BMI, the factors included (1) baseline 
age for TC, (2) follow up age for SBP, DBP, HDL, and TG (3) length of follow-up for SBP, 
DBP, HDL, and TG and (4) sex for TC, HDL, and TG. The statistically significant findings of the 
meta-regression are discussed below.  
The results from the meta-regression analysis revealed that the association between 
childhood obesity and adult SBP and DBP increases as the baseline age increases. For TC, LDL, 
and TG the association decreases as the follow-up age and length of follow-up increases. The 
association was higher in U.S. compared to other countries, and higher for studies that used BMI 
to measure the exposure compared to other measures of adiposity for SBP only. For studies that 
adjusted for adult BMI the association between childhood obesity and adult TC increases as the 
baseline age increases. For SBP, DBP, and HDL the association decreases as the follow-up age 
and length of follow-up increases. The association was lower in males compared to females for 
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TC and HDL, and higher in males compared to females for TGs. However, the results found one 
unusual finding for the association between childhood obesity and adult TG (adjusted for adult 
BMI) that increased with the increase in the follow-up age/length of follow-up. We hypothesize 
that this odd finding could have been due to the play of chance given all the tests that were 
conducted. However, the results of the meta-regression tests should be interpreted with caution 
since they are considered observational and exploratory in nature, i.e., non-experimental 
comparisons, designed to generate hypotheses about potential sources of heterogeneity.59 Thus, 
these would need to be tested and confirmed in original studies.  
 
Critical Evaluation of Results compared to Previous Systematic Reviews and Meta-analysis 
on the Topic 
As discussed earlier, four SRs published on this topic from 2010-2012 provided 
qualitative evidence but did not provide any quantitative evidence on the association between 
childhood obesity and adult CVD risk factors (BP and lipid profile). While one quantitative 
analysis was conducted four years ago on this topic, it was limited to a select four cohorts only 
and thus, not considered a true MA.40 The results of our study as well as similarities and 
differences from these previously conducted SRs and MA are discussed below.  
 
Previous systematic reviews18,37-39 The SR by Lloyd and colleagues37 found little 
evidence that childhood obesity is an independent risk factor for adult SBP and DBP. They 
concluded that the relationships observed are dependent on the tracking of BMI from childhood 
to adulthood. They found that the positive association between childhood BMI and adult blood 
pressure was attenuated or became negative when taking into account adult BMI. The results of 
our study are in congruence with the findings of this SR. Notably, the second SR by Lloyd and 
colleagues18 also found little evidence that childhood obesity is an independent risk factor adult 
TC, LDL, HDL, and TG. They found that the association between childhood BMI and adult lipid 
levels was attenuated or inversed when taking into account adult BMI. The results of our study 
are also consistent with the findings of this SR.   
The SR by Reilly and colleagues39 reported a significant and positive association between 
childhood adiposity and adult HT. However, the SR did not mention if the studies included in the 
review adjusted for adult adiposity. The SR by Park and colleagues38 also found a significant and 
positive association between childhood adiposity and adult HT. Two out of five studies described 
in this SR38 that adjusted for adult BMI found no association. We believe that the present study is 
perhaps answering a different research question (SBP and DBP versus HT). However, since HT is 
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based on both SBP and DBP, it appeared important to mention these differences in findings.38,39 
Along those lines, Park and colleagues suggested in their SR that since adult BMI is on the causal 
pathway for the association between childhood obesity and adult disease, adjusting for adult BMI 
has methodological limitations. One of the main limitations being that adjusting for variables on 
the casual pathway can lead to spurious associations (over-adjustment biases) that can draw 
estimates towards the null. The study also cited a simulation study that showed that a true positive 
association between birth weight and adult BP was diminished after adjusting for current adult 
weight status, something that could be reversed if the correlation between birth weight and 
current weight was increased.121 As childhood adiposity and adult adiposity are strongly 
correlated, this can be a potential issue. However, this debate has been both criticized by other 
researchers as well as supported.122-124 Some of the main differences of our study from these 
earlier SRs include: (1) combining the ESs of the included studies using the meta-analytic 
approach, (2) using SBP and DBP instead of HT,38,39 (3) performing MA on systematically 
finding 16 studies for SBP and 14 studies for DBP, 8 studies each for TC, HDL, and TG, and 5 
studies for LDL, (4) including additional studies published up to June, 2015, (5) utilizing 
numerous definitions for childhood adiposity (exposure), (6) excluding studies that examined 
change of exposure from childhood to adulthood,18,37 (7) excluding special populations,18,37 (8) 
excluding gestational hypertension39 and, (9) excluding studies that used self-reported 
outcomes.39 
 
Previous Meta-analysis40 The MA by Juonala and colleagues used data from four 
cohorts: the Bogalusa Heart Study (BHS) the Muscatine Study (MS), the Childhood Determinants 
of Adult Health (CDAH) study, and the Cardiovascular Risk in Young Finns Study (YFS). The 
results from the random effects MA showed a significant association between childhood obesity 
in predicting the following adult CVD outcomes using risk ratios: HT = 2.1 (95% CI: 1.8, 2.5), 
LDL = 1.6 (95% CI: 1.3, 2.0), high risk HDL = 1.7 (95% CI: 1.5, 1.9), and TG = 1.8 (95% CI: 
1.5, 2.2). The direction of effect for the association between childhood obesity and adult CVD 
risk factors in the current MA is consistent with the previous meta-analytic work by Juonala et 
al.40 Juonala and colleagues used pooled data from all 4 studies and showed that childhood 
obesity was significantly associated with HT even after adjustment for adult obesity (relative risk, 
1.5; 95% CI: 1.1, 2.1; P = 0.009). For dyslipidemias, the effect of childhood adiposity was 
reduced and became non-significant when adult obesity was taken into account. The results of our 
MA are consistent with the pooled results for dyslipidemias. However, this previous study was 
not a true MA.40 Some of the main differences in our study compared to this previous 
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investigation include: (1) using a systematic approach to find studies published until June 2015 
that have examined these selected associations, (2) using SBP and DBP instead of HT, (3) 
examining the association for TC, (4) finding a positive but non-significant association for LDL, 
(5) performing MA on systematically finding 16 studies for SBP and 14 studies for DBP, 8 
studies each for TC, HDL and TG and 5 studies for LDL, (6) performing MA on studies that 
adjusted for BMI, and (7) utilization of numerous definitions for childhood adiposity (exposure).  
 
Implications for Research 
The results of the current SR with MA have several implications for reporting of future 
longitudinal studies. First, based on the STROBE instrument, it is recommended that future 
longitudinal studies improve their reporting with respect to several potential sources of bias. 
These include: (1) describing any efforts to address potential sources of bias, (2) explaining how 
missing data were addressed, (3) explaining how loss to follow-up was addressed, (4) describing 
any sensitivity analyses conducted, (4) reporting the numbers of individuals at each stage of the 
study, (5) providing reasons for non-participation at each stage, (6) considering the use of a flow 
diagram, (7) describing the characteristics of study participants, and (8) considering translating 
estimates of relative risk into absolute risk for a meaningful time period. Because longitudinal 
studies have a criterion for initially selecting participants that chose to participate or not, have 
varied response rates, different numbers of participants at baseline and follow-up, as well as 
varied participation and response rates at follow-up time point(s), it is important to demonstrate 
this information using a flow diagram. However, only one study used a flow diagram. Therefore, 
it is suggested that future longitudinal studies include a flow diagram in order to clearly 
demonstrate their study design, participation and response rates. Second, complete information on 
the population characteristics should be presented (usually in Table 1 of most articles). 
Unfortunately, more than 50% of the studies did not provide adequate information on the 
population characteristics. Third, as loss to follow-up is a potential threat to the internal validity 
of the study,120 this information should also be provided. Only seven studies included information 
on loss to follow-up. Fourth, only one study reported on the association between childhood 
obesity and adult non-HDL. This is important since non-HDL has been shown to be better marker 
of risk for coronary artery disease and stroke compared to LDL.42,43 It is suggested that future 
studies collect and report this information. Fifth, only one third of the studies adjusted for adult 
adiposity. Given the former, it would appear prudent to suggest that future studies collect this 
information and present both crude and adjusted associations. Sixth, some studies presented 
results with unstandardized regression coefficients only. Among those studies that only provided 
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unstandardized regression coefficients, we were able to calculate standardized regression 
coefficients using the standard deviations of the exposure and the outcome. However, there were 
some studies where the standard deviations were not provided. As a result, we were unable to use 
data from these studies for our MA. Given the former, it is suggested that future studies provide 
information for both standardized and unstandardized regression coefficients. Seventh, while the 
majority of studies included information on males and females,97,100,103-106,109,110,112,115,116 two were 
limited to men only 95,102 while 9 combined data for both men and women.4,96,98,99,107-109,113,114 
Given biological differences between men and women, it would appear plausible to suggest that 
future studies include separate as well as combined results for both men and women. Eighth, only 
one study provided information on the pubertal status of children. It is important to collect and 
adjust for pubertal status in future studies as previous studies have shown an association between 
childhood obesity and pubertal developmental,125 as well as between pubertal timing and adult 
cardio-metabolic risk factors.126 Ninth, most studies used BMI as a measure of adiposity for the 
childhood exposure.4,96-100,102,103,105-110,112-116 However, since prior research has shown that BMI is 
not an ideal marker for adiposity,47,48 it is suggested that future studies collect information on 
additional markers for adiposity, for example percent body fat, in addition to BMI. Lastly, the 
negative associations in the adjusted analysis for all outcomes, and a positive association for HDL 
provides the basis for future research to explore whether children at the lower end of BMI during 
childhood are at a higher risk for developing CVD risk factors compared to children at the higher 
end of the BMI spectrum during childhood and after adjusting for adult BMI.  
 
Implications for Practice 
The results of the current MA have relevant implications for practice. Overall, it appears 
that childhood obesity is positively associated with adult SBP, DBP, and TG and negatively 
associated with adult HDL. Given the former, prevention of childhood obesity should remain a 
priority for public health interventions for preventing negative health outcomes during childhood 
as well as reducing the burden of adult obesity. Furthermore, this study adds to the argument that 
obese children who become normal weight adults are probably not at any higher risk of CVD risk 
factor development if they become non-obese in adulthood. However, these findings need to be 
interpreted with caution given that only one third of the studies adjusted for adult BMI.  
 
Strengths of the Study 
To the best of our knowledge, this is the first MA and most recent SR that has 
systematically appraised studies examining these associations. The present study is based on a 
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greater number of studies (published up to June 2015) that included both the crude associations as 
well as studies that adjusted for adult adiposity. This study also included any definition of 
adiposity measure that was utilized for the exposure. Research has shown that BMI is not an ideal 
marker for adiposity47,48 and including other definitions or classifications of adiposity helped us in 
identifying other potentially eligible studies that have looked at this association. Although we 
performed the main MA using studies that utilized varied childhood adiposity measure, the results 
of our sensitivity analysis using only BMI as the exposure showed similar findings (Table 5). In 
addition, we also used SBP and DBP instead of HT to examine for independent associations 
between childhood obesity and components of HT (i.e. high SBP and/or DBP). Lastly, we 
performed meta-regression analysis on covariates that may potentially impact this association and 
to inform future research on these factors.  
 
Limitations of the Study 
The results of the current MA should be viewed with respect to the following potential 
limitations. First, only one third of the included studies adjusted for adult BMI. Second, some of 
the pre-planned analyses to identify sources of heterogeneity were not performed due to lack of 
data. Third, the sample sizes for many of the analyses were probably underpowered to find a true 
effect. Fourth, due to the small sample sizes for some analyses, small-study effects (e.g. potential 
publication bias) were not conducted. Fifth, the a priori plan of the current study did not include 
an age range for childhood exposure. A post hoc decision was made to limit the age range from 2-
19. However, due to including this age range the investigative team faced an additional challenge 
i.e. some outcomes were assessed where the mean age of the participants at the follow-up time 
point was greater than 19 but the age range included less than 19 year old participants as well. 
There were four studies in our review where the mean age was 27 but the age ranged from 18-
37,4 mean age 24 and age ranged from 18-26,102 mean age 21 and age ranged from 18-24,108 and 
mean age 20 and age ranged from 18-21.109 Sixth, MA cannot make up for the poor quality of the 
original studies and is inherently vulnerable to the biases in the original studies. Seventh, in order 
to retrieve information on missing data, we contacted the corresponding authors via email in 
order to obtain necessary information. Nearly 30% of the corresponding authors replied but no 
author provided any additional information. Eighth, we excluded studies that were not published 
in the English language, which could potentially introduce language bias. However, we do not 
believe that this was a major problem since previous research has shown that meta-analyses that 
restrict studies by language overestimate the effect of the outcomes by only 2%.66 Ninth, like any 
SR, literature search bias is a potential problem where some relevant literature is not identified 
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during the search process. However, we performed an exhaustive search according to pre-defined 
criteria examining nearly 5000 citations. Thus, we expect this bias to be minimal. Finally, given 
the large number of analyses we conducted, one or more of our findings may have been due to the 
play of chance. However, no adjustment for multiple tests were made given that we did not want 
to miss potentially important findings that could be tested in future original studies.127 Though the 
study had several limitations, to the best of the investigative team’s knowledge, this is the first 
MA to examine the association between childhood obesity and adult CVD risk factors as well as 
examine this association in studies that adjusted for adult BMI.  
 
Conclusion 
 
The results of the current MA suggest that childhood obesity is significantly and 
positively associated with adult SBP, DBP, and TG and negatively associated with adult HDL. 
However, additional, well-designed, longitudinal studies with improved reporting as well as data 
analysis that includes both unadjusted and adjusted associations for adult adiposity are needed 
before any definitive conclusions can be reached. 
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Chapter 5: Discussion 
 
Summary of Key Findings 
 
Overview 
The current set of studies aimed to examine three distinctive distal determinants of 
cardiovascular (CVD) risk factors during childhood and adulthood. We focused on two distal 
perinatal factors (birth weight of the infant and reported history of breastfeeding) and later 
childhood and maternal CVD risk factors for the first two studies. For the third study we focused 
on childhood obesity as the distal determinant of adult CVD risk factors. The CVD risk factors 
included: (1) blood pressure including both systolic blood pressure (SBP) and diastolic blood 
pressure (DBP), (2) lipids including total cholesterol (TC), high-density lipoprotein cholesterol 
(HDL), non-high-density lipoprotein cholesterol (non-HDL), low-density lipoprotein cholesterol 
(LDL), and triglycerides (TG), and (3) obesity as assessed by body mass index (BMI). Previous 
studies that have examined these distal exposures and CVD risk factors at various life stages 
typically have shown inconsistent results. Thus, the overall objective of this project as a whole 
was to determine the associations between perinatal risk factors (birth weight and breastfeeding) 
and childhood and maternal cardiovascular health, and determine the relationship between 
childhood obesity and adult CVD risk factors.  
For the first two studies we used data from three projects, including West Virginia (WV) 
Birth Certificates, the Working in Appalachia to Track High Birth Score, Critical Congenital 
Heart Disease and Hearing Loss (WATCH)/Birth Score project, and the Coronary Artery Risk 
Detection in Appalachian Communities (CARDIAC) project. For the first study, children 
participating in the Birth-Score project (all of whom are merged with the Birth Certificate data) 
born in 1994-2000 were merged with data collected by the CARDIAC project in years 2004-2010 
and restricted to full-term birth infants only (N=19,583). For the second study, children 
participating in the WATCH/Birth-Score project at birth (all of whom are merged with the Birth 
Certificate data) born between in 1997-2004 were merged with data collected by the CARDIAC 
project in years 2008-2014 (N=10,457). For the third study we conducted a systematic review and 
meta-analysis to critically evaluate the evidence regarding the relationship between childhood 
obesity and adult CVD risk factors. A total of 4,840 citations were reviewed utilizing numerous 
resources. The inclusion criteria were: (1) longitudinal study-design, (2) childhood exposure and 
adult outcomes collected on the same individual over time, (3) childhood obesity, as defined by 
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the authors, (4) English language articles, (5) studies published by June, 2015, (6) the primary 
outcome measures included SBP, DBP, TC, HDL, LDL, non-HDL, TG, and (7) outcome not self-
reported. The search strategy included (1) electronic searches in multiple databases (PubMed 
(MEDLINE), Web of Science, and Scopus) on June 5, 2015, and (2) cross-referencing from the 
reference lists of all retrieved articles (citation tracking). The summaries of the key findings from 
all three studies are discussed below.  
 
Birth Weight and CVD Risk Factors 
The aim of the first study was to investigate the association between infant’s birth weight 
and childhood CVD risk factors (SBP, DBP, TC, LDL, HDL, non-HDL, and TG) at 11 years of 
age (controlling for child’s current BMI), and the subsequent risk of developing maternal CVD 
risk factors (TC, LDL, HDL, non-HDL, and TG) 11 years post partum in infants born full-term 
only. 
The final study sample after excluding infants born pre-term (i.e., <37 weeks of gestation: 
N=2,097, 9.67%) was 19,583. In this sample, nearly 3% of the infants were low birth weight 
(LBW) and 11% were high birth weight (HBW). Whereas current literature on the association 
between birth weight and CVD risk factors shows inconsistent results, the results of this current 
study were generally consistent with the Barker’s hypothesis for all outcomes except for DBP. 
The results showed a linear inverse association between birth weight and SBP, TC, LDL, non-
HDL, and TG, and a positive association with HDL at 11 years of age after adjusting for child 
BMI and additional covariates. However, the associations were not statistically significant for 
SBP and TC in the adjusted models. Although the direction of the association between SBP and 
birth weight was consistent with previous studies,1-5 unlike most studies the adjusted association 
was not significant (b = -0.02 mmHg; 95% CI: -0.06, 0.03; p = 0.5295 for 1,000 g increase in 
birth weight). The findings suggest that the negative association between birth weight and SPB is 
most likely not independent of the child’s current BMI. The direction of the association between 
birth weight and DBP was not consistent with the Barker’s hypothesis for both the crude and the 
adjusted analysis (b = 0.01 mmHg; 95% CI: -0.02, 0.04; p = 0.4913 for 1,000g increase in birth 
weight). However, the results for DBP are consistent with other studies that also found a 
significant positive association between birth weight and childhood DBP for the unadjusted 
analysis6,7 that became non-significant after adjusting for the child’s current BMI.8 Our results 
found a significant positive association between birth weight and childhood HDL (b = 0.06 
mg/dL; 95% CI: 0.02, 0.09; p = 0.0035 for 1,000 g increases in birth weight), and a negative 
association with TG levels (b = -0.003 mg/dL; 95% CI: -0.05, -0.001; p = 0.0005 for 1,000 g 
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increases in birth weight) which is are also consistent with other studies for HDL2,9 and TG levels 
respectively.10 When adjusted for the child’s current BMI the direction of association for HDL (b 
= 0.14 mg/dL; 95% CI: 0.11, 0.18; p <0.0001 for 1,000 g increases in birth weight) and log-TG (b 
= -0.007; 95% CI: -0.008, -0.005; p <0.0001 for 1,000 g increases in birth weight) remained the 
same and the magnitude of the association increased. LDL and non-HDL were not significant in 
the unadjusted analysis but became significant and negatively associated with birth weight after 
accounting for the child’s BMI and additional covariates [LDL (b = -0.1 mg/dL; 95% CI: -0.19, -
0.16; p = 0.0196 for 1,000 g increases in birth weight; and for non-HDL (b = - 0.18 mg/dL; 95% 
CI: -0.28, -0.09; p = 0.0002 for 1,000 g increases in birth weight)], consistent with the findings of 
other studies.2,5  
The results from the current study are consistent with the Barker’s hypothesis, as LBW is 
associated with higher LDL, non-HDL, and TGs and lower mean HDL levels independent of the 
child’s current BMI and additional covariates. The results of the sensitivity analysis using spline 
regression model further verified that the association between birth weight and lipid levels was 
linear in our population and not U-shaped as demonstrated by some studies.10-12 Based on these 
results, we hypothesize that the association between birth weight and lipids is independent of the 
child’s current BMI levels. Although the observed effect of birth weight as a distal risk factor for 
the child’s lipid levels was small but significant during childhood, this can have a potential 
amplified impact as these children enter adulthood.  
The association between birth weight and maternal CVD risk factors is an active area of 
research. Only one study conducted in India that examined the relationship between birth weight 
and maternal lipid levels 8 years post partum found a significant positive association for maternal 
TG levels only, after adjusting for additional covariates including maternal BMI.13 Our study 
found no significant mean differences in the any of the lipid levels of mothers by birth weight 
categories of the infant. However, the unadjusted association between birth weight and maternal 
TC was significant and positive but became non-significant when adjusted for additional 
covariates in the regression analysis. None of the other lipid levels were significant in either the 
unadjusted or the adjusted models. However, the direction of association in our study suggests 
that mothers who give birth to HBW infants seemed to demonstrate a trend towards poor 
maternal lipid levels 11 years post-partum and is consistent with the previous study.13 Whether 
maternal lipid levels are associated with giving birth to LBW or HBW infants, or whether the 
birth weight of the infant is a potential risk factor for maternal lipid level in later years, or 
whether the mother’s own birth weight impacted their lipid profile is difficult to establish at this 
point. The research on this topic is still in its infancy and needs further exploration.  
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Breastfeeding and CVD Risk Factors 
The aim of the second study was to investigate the association between infants who were 
breastfed during infancy and childhood CVD risk factors (SBP, DBP, TC, LDL, HDL, non-HDL, 
and TG) at 11 years of age (controlling for child’s current BMI), and the subsequent risk of 
developing maternal CVD risk factors (TC, LDL, HDL, non-HDL, and TG) 11 years post partum. 
The final study sample after excluding infants born pre-term (i.e. <37 weeks of gestation: 
N=1,190, 10.2%) was 10,457. Nearly 43% of the mothers self-reported that they breastfed their 
index child during infancy. The results showed that children whose mother reported to have 
breastfed compared to children who were not breastfed in infancy had significantly lower SBP (b 
= -1.39 mmHg; 95% CI: -1.97, -0.81; p <0.0001) and DBP (b = -0.79 mmHg; 95% CI: -1.26, -
0.33; p = 0.0009) in unadjusted models. However, adjustments for the child’s current BMI 
attenuated the association between report of breastfeeding and DBP (b = -0.44 mmHg; 95% CI: -
0.89, 0.02; p = 0.06). Adjustment for the child’s current BMI also slightly attenuated the 
association of breastfeeding to SBP (b = -0.77 mmHg; 95% CI: -1.32, -0.23; p = 0.005), but 
adjustments for additional socio-demographic variables eliminated the association of 
breastfeeding to SBP (b = -0.43 mmHg; 95% CI: -0.98, -0.13; p = 0.1349). The results of the 
current study for both SBP and DBP are consistent with the evidence provided by the most recent 
systematic review with meta-analysis published in 2015.14 Horta and colleagues demonstrated 
that SBP and DBP were lower but not significant in children and adolescents aged 10-19 years 
who had been breastfed [SBP mean difference= -1.03 (95%CI: -2.07; 0.02) and DBP mean 
difference= -0.1 (95%CI: -0.65; 0.45)]. Our study further demonstrated that the child’s current 
BMI is a potential mediator for the association between breastfeeding and childhood blood 
pressure. Breastfeeding has shown to be protective for childhood obesity as demonstrated by 
several studies,14-19 including earlier work with WV fifth grade children.20 The results of this 
current study are also consistent with individual studies as well as with systemic reviews and 
meta-analyses that found no association between infants who were breastfed vs. non-breastfed 
and TC,14,21,22 LDL,22 and non-HDL levels in childhood. However, the results of this current study 
showed that children whose mother reported to have breastfed compared to children who were 
not breastfed in infancy had significantly lower TG. The regression coefficient of the unadjusted 
association was -0.07 (95% CI: -0.1, -0.05; p <0.0001). Adjustment for the child’s current BMI in 
fifth grade attenuated the association of reported history of breastfeeding to TG (b= -0.05; 95% 
CI: -0.07, -0.03; p = 0.048), which further diminished in magnitude but remained significant after 
adjusting for additional covariates as well (b= -0.04; 95% CI: -0.06, -0.01; p = 0.01). The final 
model for TG included, the child’s BMI percentile in fifth grade, age, sex, race, maternal 
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education at birth, number of previous pregnancies, and family history of cholesterol. However, 
previous research on this association remains inconclusive with one study finding a significant 
association only among boys only23 or no association at all.24,25 This study did not find any 
differences by gender for the association between breastfeeding and childhood TG levels. Based 
on the results for TGs, we hypothesize that this association is independent of the child’s current 
BMI. Although the associations were partially attenuated by childhood BMI but remained 
significant suggests that childhood BMI may be a potential partial mediator. Additionally the 
unique amount of variance shared between reported history of breastfeeding and TG levels of 
fifth grade WV children was less than 0.2%, suggesting a small effect size. 
The association between maternal history of breastfeeding their infants and maternal 
CVD risk factors is also an active area of research. Our results are not consistent with studies that 
found a protective association between breastfeeding and maternal lipid profile.26-28 However, it is 
important to note that for the current study the direction of association was positive for TC, TG, 
non-HDL, and LDL and negative for HDL, which is consistent with the hypothesis that 
breastfeeding is protective for maternal cardiovascular health. Some of the potential reasons for 
the contrasting results could be lack of information on lactation duration or lifetime duration of 
lactation, which is the basis of most previous research.26,27,29 Furthermore, the exposure was 
assessed retrospectively via parental recall and is subject to self-report bias. It is also possible that 
most mothers who initiated breastfeeding, failed to continue to breastfeed for longer durations. 
Additionally, the sample size for the maternal outcomes was small due to very low participation 
rates. However, Stuebe and colleagues suggest that currently there is no study that has collected 
comprehensive data to explain the apparent association between breastfeeding and maternal CVD 
risk factors.30 Thus, future studies are needed to collect longitudinal data with wide-ranging 
information on several socio-demographics, genetic and lifestyle factors in order to examine and 
understand these associations in mothers. 
 
Childhood Obesity and Adult CVD Risk Factors 
The purpose of the third study was to conduct a comprehensive systematic review (SR) 
and meta-analysis (MA) to critically evaluate the available evidence regarding the relationship 
between childhood obesity and adult CVD risk factors (SBP, DBP, TC, LDL, HDL, non-HDL, 
and TG).  
The final number of studies included in the SR was 2331-53 and 21 studies were included 
in the MA.31-37,39-47,49-53 The findings suggest that childhood obesity is significantly and positively 
associated with adult SBP (Zr = 0.11; 95% CI, 0.07, 0.14), DBP (Zr = 0.11; 95% CI, 0.07, 0.14), 
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and TG (Zr =0.08; 95% CI, 0.03, 0.13), and significantly and inversely associated with adult 
HDL (Zr =-0.06; 95% CI, -0.10, -0.02). However, the pooled results of studies that adjusted for 
adult BMI32,35,42,44,46,53 showed that these associations were significant but negative for SBP (Zr = 
-0.13; 95% CI, -0.07, -0.14), DBP (Zr = -0.11; 95% CI, -0.17, -0.04), and LDL (Zr = -0.08; 95% 
CI, -0.12, -0.05). Furthermore, the associations between childhood adiposity measure and adult 
HDL and TG became non-significant when pooling studies that adjusted for adult BMI. However, 
it is important to point out that less than one third of studies adjusted for adult adiposity measures. 
The results of our study are consistent with two systematic reviews by Lloyd and 
colleagues.54,55 Lloyd and colleagues found little evidence that childhood obesity is an 
independent risk factor for adult blood pressure55 and adult lipid levels.54 The SR by Park and 
colleagues56 and by Reilly and colleagues,57 which focused on hypertension and not individual 
components of hypertension (i.e. SBP and DBP), also found a significant and positive association 
between childhood adiposity and adult hypertension. However, two out of five studies that 
adjusted for adult BMI found no association.56 The results from the random effects MA by 
Juonala and colleagues using data from four cohorts showed a significant association between 
childhood obesity and adult hypertension, LDL, high risk HDL, and TG. When the study adjusted 
for adult obesity, hypertension remained significant but the effect of childhood adiposity was 
reduced and became non-significant for dyslipidemias.58 The direction of effect for the 
association between childhood obesity and adult CVD risk factors in the current MA is consistent 
with the meta-analytic work by Juonala et al.58 
The results also demonstrated that more rigorous science is needed. For example, the risk 
of bias assessment was performed using the ‘Strengthening the Reporting of Observational 
studies in Epidemiology’ (STROBE) instrument. The results showed that at the study level, nine 
studies had more than one third of items that were at an increased risk of bias.31,33,38,39,41-43,49,53 
Other differences between studies may be driven by geographic, gender, or time related 
covariates. For example, results from the meta-regression analysis revealed that the association 
between childhood obesity and adult SBP and DBP increases as the baseline age increases. For 
SBP, DBP, TC, HDL, and LDL the association decreases as the follow-up age and length of 
follow-up increases. For TC and HDL (for studies that adjusted for adult BMI) the association 
was lower in males compared to females. For SBP only, the association was higher in United 
States compared to other countries.  
To the best of the investigative team’s knowledge, this is the first MA to examine the 
association between childhood obesity and adult CVD risk factors as well as examine this 
association in studies that adjusted for adult BMI. The results of the current MA suggest that 
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childhood obesity is significantly and positively associated with adult SBP, DBP, and TG and 
negatively associated with adult HDL. However, additional, well-designed, longitudinal studies 
are needed before any definitive conclusions can be reached.  
 
Limitations of the Dissertation 
Some of the limitations of the first two studies include lack of information on potential 
factors that are known to influence the relationship between perinatal exposures and childhood 
and maternal CVD risk factors. These include but are not limited to: parental adiposity status, 
maternal pre-pregnancy weight, maternal lipid status at before and during pregnancy, maternal 
birth weight, rapid weight gain during the first year of life, pubertal status of the child, family 
history of hypertension, physical activity, and dietary behaviors. Secondly, maternal CVD risk 
factors were limited to lipid profile only, which was available for a small sample of the 
population thus limiting the generalizability of the sample. Although the childhood data can be 
generalizable to WV children, the results may not be generalizable beyond the participants 
included in this study due to the unique population characteristics of this state. Lastly, for the 
second study information on actual breastfeeding was obtained retrospectively via parental recall 
and did not inquire about the method, extent, or the lifetime duration of maternal lactation.  
Some of the main limitations of the third study included having a small sample size for 
most of the outcomes assessed. Due to the small number of included studies we were not able to 
assess for small-study effects (e.g. potential publication bias) for all the lipid outcomes, and were 
perhaps underpowered to find a true effect for many of the analyses. Some of the pre-planned 
analyses to identify sources of heterogeneity were not performed due to the small sample size as 
well. Lastly, less than one third of the included studies adjusted for adult BMI, which further 
decreased the sample size of the pooled analysis for the outcomes that examined the relationship 
between childhood obesity and adult CVD risk factors adjusting for adult adiposity.  
 
Strengths of the Dissertation 
One of the main strengths of the first two studies included using a large longitudinal 
dataset with information available for important covariates. To our knowledge this is the first 
study that has examined these associations in Appalachia, as an initial step to reduce the CVD 
burden by identifying the linkages between perinatal risk factors and later CVD risk factors. 
Other strengths include the use of directly measured distal exposure (birth weight) and all study 
outcomes (i.e., they were not based on recall or self-report). Furthermore, the effect size of 
breastfeeding and childhood TGs levels is a novel finding in 11-year-old children as earlier 
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studies included younger or older adolescent populations.23-25,59 For the third study, to the best of 
our knowledge this is the first MA to examine the association between childhood obesity and 
adult CVD risk factors as well as examine this association in studies that adjusted for adult BMI. 
Earlier SRs54-57 on the topic included studies published up to 2011, thus this SR provides a more 
updated review of studies examining this association in studies published up to 2015. The current 
SR also included any definition or classification used in individual studies to measure childhood 
adiposity, which facilitated in identification of additional eligible studies that examined these 
associations.  
 
Potential Public Health Implications and Future Recommendations 
CVD is the leading cause of death globally, nationally as well in the state of WV.60-62 
According to the 2016 Heart Disease and Stroke Statistics update, more than one third of 
American adults have ≥1 types of CVD62 and it is projected that 43.9% of the US population will 
have some form of CVD by 2030.62 For 2011-12, the estimated cost of CVD (direct and indirect) 
was $316.6 billion, which is also projected to increase to $918 billion by 2030.62 High blood 
pressure and poor cholesterol are well-established risk factors for CVD.63-67 Hypertension in 
children is linked to end-organ damage and poor cholesterol is associated with preclinical 
atherosclerosis during childhood.68-71 These risk factors also track from childhood into 
adulthood.49,72-78 Childhood adiposity is another risk factor for developing CVD risk factors 35,79-81 
and obese children have a higher risk of becoming overweight/obese adults,82-84 which is an 
independent predictor of adult CVD and its risk factors.85-89 Over weight and obesity is prevalent 
in one third of the youth in the U.S. and nearly two third of the adult population.90 Research 
shows that early prevention of CVD risk factors such as obesity, high blood pressure, and 
cholesterol levels can reduce the risk of CVD in subsequent years.64,91 
The current set of studies was able to explore the association between perinatal factors 
(birth weight and breastfeeding) and childhood and maternal CVD risk factors in the state of WV. 
This rural Appalachian population has one of the highest prevalence of CVD and CVD risk 
factors in the nation. Thus, there is vital need to first and foremost identify these determinants and 
their long-term cardiovascular impact in this state as a first step geared towards health promotion 
and implementation of early preventative interventions for reducing the burden of CVD.  
The findings revealed that perinatal exposures such as LBW in full-term infants was 
associated with worse lipid levels, and breastfeeding as a protective early life exposure was 
associated with lower lipid levels during childhood. Childhood BMI was a potential mediator 
between perinatal factors (birth weight and breastfeeding) and childhood CVD risk factors. 
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Though the association between perinatal factors as the distal determinant of CVD risk factors 
was small, these risk factors have the ability to track and potentially amplify, as these children 
become adults. The results of the study can guide future research to identify early life exposures 
that may potentially restrict fetal growth resulting in LBW babies in full-term infants in this state. 
Moreover, biomedical research should focus on identifying complex mechanisms, which underlie 
the physiological changes in infants who were not breastfed or who were born with LBW that are 
responsible for less than optimal cardiovascular health in later life. The results from this study can 
guide future interventions to create targeted prevention or screening programs for children who 
are born LBW for less than optimal levels of lipids and lipoproteins. Considering the role of BMI 
as a potential mediator the study can also serve a guide to targeted screening interventions for 
children who are born LBW and are overweight or obese during childhood for high blood 
pressure and less than optimal levels of lipids and lipoproteins. Furthermore, future research 
should focus on establishing different birth cut-offs for diverse populations to increase the 
sensitivity of identifying infants with higher risk of future CVD as suggested by a recent 
systematic review as well.92 The observed impact of breastfeeding as a distal protective factor for 
the child’s CVD risk factors was small; nonetheless it adds to the argument of promoting 
breastfeeding practices in this rural Appalachian state of WV. For the maternal CVD risk factors, 
the current study demonstrates some important preliminary results. The direction of association in 
the first study suggested that mothers who give birth to HBW babies have higher risk of poor 
lipid levels and for the second study the direction of correlations suggested breastfeeding to be 
protective for maternal lipid levels 11 years post-partum. Thus, providing an essential 
contribution for expanding the research examining the associations between perinatal factors and 
maternal CVD health in subsequent years.  
The results of the current SR with MA have several implications as well. Some of the 
main implications for research include recommendation for future longitudinal studies to improve 
their reporting with respect to several potential sources of bias. Additionally, it is recommended 
that future studies examining the association between childhood obesity and adult CVD risk 
factors to also report their findings for non-HDL level. This is important because non-HDL has 
been shown to be better marker of risk for CVD compared to LDL.93,94 Moreover, less than one 
third of the studies included in the SR adjusted for adult adiposity. It is suggested that future 
studies collect this information and present both crude and adjusted associations. The inverse 
associations in the adjusted analysis provides the basis for future research to explore whether 
children at the lower end of the BMI are at a higher risk for developing CVD risk factors 
compared to children at the higher end of the BMI spectrum during childhood after adjusting for 
 85
adult BMI. Furthermore, this finding adds to the argument that perhaps obese children who 
become normal weight adults are probably not at any higher risk of CVD risk factor development 
if they become non-obese in adulthood. However, future robust studies are needed to confirm 
these results in diverse populations. Overall childhood obesity was a risk factor for select adult 
CVD risk factors (SBP, DBP, HDL, and TG). These findings can guide future interventions to 
create screening programs for high blood pressure and less than optimal levels of lipids and 
lipoproteins in adults who were overweight or obese during childhood and adolescence. 
Prevention of childhood obesity should remain a priority for public health interventions for 
preventing negative health outcomes during childhood as well as reducing the burden of adult 
obesity.  
 
Conclusion 
 
The main findings of the study demonstrated that LBW is a risk factor for poor lipid levels in 
childhood (LDL, HDL, non-HDL, and TG) and breastfeeding is a protective factor for childhood 
lipid level (TG) in fifth grade West Virginian children born full term. No significant associations 
were observed for perinatal factors (birth weight and breastfeeding) and maternal lipid profile. 
Well-designed longitudinal studies are needed to understand the complex pathways examining 
these associations at different life stages. The results of the systematic review with meta-analysis 
suggest that childhood obesity is significantly and positively associated with adult SBP, DBP, and 
TG and negatively associated with adult HDL. However, additional, well-designed longitudinal 
studies with improved reporting as well as data on both unadjusted and adjusted associations for 
adult adiposity are needed before any definitive conclusions can be reached. 
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Tables 
Chapter 2 
 
Table 1: Maternal and child characteristics at birth and in fifth grade using merged data from the 
Birth Score Project (1994-2000) and the CARDIAC Project (2004-2010) for all infants who were 
born Full-Term (N=19583) 
 
Variable N Missing  Frequency (%)/ 
Mean (SD) 
Sex 19583  0   
Female     10713 (54.71) 
Male     8870 (45.29) 
Race (child in fifth grade) 19049 534   
Others     931 (4.89) 
White     18118 (95.11) 
Race (mother at birth) 19583  0   
Others     482 (2.46) 
White     19101 (97.54) 
Marital Status (at birth) 19583  0   
Single     5072 (25.9) 
Married     14511 (74.1) 
Health Insurance  10657 8926   
Medicaid     5937 (55.71) 
Non-Medicaid     4720 (44.29) 
Maternal Education at Birth  19516 67   
Less than or equal to 12 years     12642 (64.78) 
Greater than 12 years     6874 (35.22) 
Maternal Education when child in 5 grade 17820 1763   
Less than or equal to 12 years     7769 (43.6) 
Greater than 12 years     10051 (56.4) 
Family History of Cholesterol  15781 3802   
No     10055 (63.72) 
Yes     5726 (36.28) 
Family History of CVD 19583  0   
No     13098 (66.88) 
Yes     6485 (33.12) 
Family History of Diabetes 17897  1686   
No     8513 (47.57) 
Yes     9384 (52.43) 
Smoking during Pregnancy (maternal) 19428 155   
Yes     4839 (24.91) 
No     14590 (75.09) 
Smoking in the house when child in 5 grade 18564 1019   
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No     12316 (66.34) 
Yes     6248 (33.66) 
No. of Prenatal care visits 19239 344   
<12     7453 (38.74) 
≥12     11786 (61.26) 
Month prenatal care visits 19015 568   
<3months     11772 (61.91) 
≥3months     7243 (38.09) 
No. of Previous pregnancy 19583  0   
0     6893 (35.2) 
≥1     12690 (64.8) 
Breastfeeding Intention 19583  0   
Both (Breast or Bottle)      11201 (57.2) 
Breastfed     8382 (42.8) 
Birth weight (grams)       
<2500 19583  0 515 (2.63) 
2500 - 4000     16963 (86.62) 
>4000     2105 (10.75) 
Age of Child 19583 0 10.95 (0.48) 
Maternal Age at Birth  19558 25 25.35 (5.5) 
Maternal Age when child in 5 grade 19555 28 36.3 (5.49) 
Maternal Education at Birth  19517 66 12.58 (2.06) 
Weight Gain during Pregnancy (lbs) 18105 1478 30.43 (13.93) 
Gestational Age (weeks) 19583 0 39.25 (1.16) 
Child SBP  19397 186 108.85 (11.96) 
Child DBP 19344 239 68.8 (9.31) 
Child TC 16122 3461 160.3 (28.13) 
Child LDL 15964 3619 92.92 (24.7) 
Child HDL 16066 3517 49.98 (12.05) 
Child NON-HDL 16066 3517 110.3 (28.45) 
Child TG 15951 3632 91.79 (54.46) 
Child log TG 15951 3632 4.39 (0.5) 
BMI-Percentile 19281 302 73.05 (27.84) 
Birth Weight (grams) 19583 0 3414.05 (483.33) 
Maternal TC 1121 18462 189.18 (34.67) 
Maternal LDL 1082 18501 113.38 (30.22) 
Maternal HDL 1116 18467 52.65 (13.28) 
Maternal NON-HDL 1116 18467 136.59 (35.94) 
Maternal TG 1115 18468 119.15 (82.99) 
Maternal log TG 1115 18468 4.62 (0.54) 
CVD-Cardiovascular Disease; SBP-systolic blood pressure; DBP-diastolic blood pressure; TC-
total cholesterol; LDL-low-density lipoprotein cholesterol; HDL-high-density lipoprotein; non-
HDL-non-high-density lipoprotein cholesterol; cholesterol; TG-triglycerides 
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Table 2: Results one-way analysis of variance (ANOVA) for the mean difference in blood 
pressure and lipid levels in both fifth grade children and mothers by low birth weight (<2500g) 
normal birth weight (2000-4000g) and high birth weight (>4000g) groups using merged data from 
the Birth Score Project (1994-2000) and the CARDIAC Project (2004-2010) for all infants who 
were born Full-Term (N=19583) 
 
  
Child CVD risk factors 
 
Mother CVD risk factors 
Birth weight 
categories 
(grams) 
 
>2500 
 
2500-4000 
 
>4000 
 
>2500 
 
2500-
4000 
 
>4000 
BMI (N) 504 16707 2070    
Mean (SD)* 66.04 
(30.64) 
72.51  
(28.07) 
79.14 
(24.13) 
   
SBP (N) 510 16800 2087    
Mean (SD)* 108.3 
(11.75) 
108.79 
(11.98) 
109.58 
(11.89) 
   
DBP (N) 509 16754 2081    
Mean (SD)* 68.44 
(9.14) 
68.74  
(9.34) 
69.36 
(9.14) 
   
TC (N) 437 13982 1703 26 970 120 
Mean (SD) 161.33 
(30.21) 
160.21 
(28.18) 
160.8 
(27.17) 
188.74 
(28.92) 
188.52 
(35.27) 
194.71 
(30.47) 
LDL (N) 433 13844 1687 26 970 120 
Mean (SD) 94.08 
(26.63) 
92.79 
(24.63) 
93.74 
(24.81) 
188.74 
(28.92) 
188.52 
(35.27) 
194.71 
(30.47) 
HDL (N) 436 13933 1697 25 970 121 
Mean (SD) 49.61 
(11.99) 
49.97  
(12.08) 
50.18 
(11.89) 
51.4 
(11.55) 
52.79 
(13.41) 
51.82 
(12.61) 
Non-HDL (N) 436 13933 1697 25 970 121 
Mean (SD) 111.66 
(29.62) 
110.23 
(28.47) 
110.58 
(27.97) 
138.4 
(30.15) 
135.84 
(36.63) 
142.2 
(30.85) 
Log-TG (N) 432 13841 1678 25 969 121 
Mean (SD) 4.4  
(0.52) 
4.39 
(0.5) 
4.36  
(0.51) 
4.57  
(0.51) 
4.62  
(0.54) 
4.67  
(0.58) 
*P <0.05 (omnibus F-test) 
Post hoc test (Tukeys) were performed where the omnibus F-test was significant to explore which 
means were significantly different between groups. All comparisons were significant for BMI. 
For SBP and DBP only high birth weigh (>4000g) was significantly greater than normal birth 
weigh (2500-4000g) (p <0.05) 
CVD-Cardiovascular Disease; SBP-systolic blood pressure; DBP-diastolic blood pressure; TC-
total cholesterol; LDL-low-density lipoprotein cholesterol; HDL-high-density lipoprotein; non-
HDL-non-high-density lipoprotein cholesterol; cholesterol; TG-triglycerides 
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Table 3: Pearson correlation between birth weight and CVD risk factors for mothers and children 
using merged data from the Birth Score Project (1994-2000) and the CARDIAC Project (2004-
2010) for all infants who were born Full-Term (N=19,583) 
 
Childhood CVD risk factors N Correlation Coefficient r P-value 
BMI percentile 19281 0.10284 <0.0001 
SBP 19397 0.02647 0.0002 
DBP 19344 0.03224 <0.0001 
TC 16122 0.00568 0.4704 
LDL 15964 0.00336 0.6709 
HDL 16066 0.02305 0.0035 
Non-HDL 16066 -0.00565 0.4742 
Log-TG 15951 -0.02768 0.0005 
 
Maternal CVD risk factors 
 
   
TC 1116 0.06193 0.0386 
LDL 1082 0.04892 0.1078 
HDL 1116 -0.00539 0.8574 
Non-HDL 1116 0.04932 0.0996 
Log-TG 1115 0.03763 0.2093 
CVD-Cardiovascular Disease; SBP-systolic blood pressure; DBP-diastolic blood pressure; TC-
total cholesterol; LDL-low-density lipoprotein cholesterol; HDL-high-density lipoprotein; non-
HDL-non-high-density lipoprotein cholesterol; cholesterol; TG-triglycerides 
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Table 4a: Results of the multiple regression analysis for the association between birth weight and CVD risk factors of fifth-grade WV children 
using merged data from the Birth Score Project (1994-2000) and the CARDIAC Project (2004-2010) for all infants who were born Full-Term 
(N=19,583) 
  
Model 1 
 
Model 2 
 
Model 3 
  N Unstandardized 
regression 
coefficients (95% 
CI) 
Standardiz
ed (Beta) 
N Unstandardized 
regression 
coefficients (95% 
CI) 
Standardiz
ed (Beta) 
N Unstandardized 
regression 
coefficients (95% 
CI) 
Standar
dized 
(Beta) 
SBP  
Birth weight 
1939
7 
0.0007                   
(0.0003- 0.001)** 
0.026 1911
3 
-0.0002 
(-0.0005 - 0.0001) 
-0.009 8289 -0.0002 
(-0.0006 - 0.0003) 
-0.007 
 
LBW 
 -0.49                               
(-1.54 - 0.56) 
-0.007  0.55 
(-0.44 - 1.56) 
0.007  0.48 
(-0.91 - 1.86) 
0.007 
 
HBW 
 0.80                              
(0.25 - 1.34)** 
0.021  -0.13 
(-0.64 - 0.39) 
-0.003  0.05 
(-0.71 - 0.82) 
0.001 
DBP  
Birth weight 
1934
4 
0.0006 
(0.0003 - 0.0008)** 
0.032 1906
3 
0.00009 
(-0.0001 - 0.0004) 
0.005 1501
8 
0.00010 
(-0.0002 - 0.0004) 
0.005 
 
LBW 
 -0.31                                    
(-1.13 - 0.52) 
-0.005  0.35 
(-0.45 - 1.15) 
0.006  0.38 
(-0.52 - 1.29) 
0.007 
 
HBW 
 0.62                              
(0.19 - 1.04)** 
0.021  0.034  
(-0.38 - 0.45) 
0.001  0.13 
(-0.33 - 0.59) 
0.004 
TC  
Birth weight 
1612
2 
0.0003                            
(-0.0006 - 0.001) 
0.006 1606
6 
-0.0002 
(-0.001 - 0.0007) 
-0.004 1327
1 
-0.0007 
(-0.0017 - 0.0002) 
-0.013 
 
LBW 
 1.12                                 
(-1.56 - 3.80) 
0.006  1.83 
(-0.84 - 4.49) 
0.011  1.71 
(-1.23 - 4.64) 
0.01 
 
HBW 
 0.59 
(-0.82 - 2.00) 
0.006  -0.02 
(-1.44 - 1.39) 
0  -0.36 
(-1.90 - 1.19) 
-0.004 
LDL  
Birth weight 
1596
4 
0.0002 
(-0.0006 - 0.001) 
0.003 1590
8 
-0.0006 
(-0.001 - 0.0002) 
-0.011 1313
9 
-0.0010 
(-0.0019- -
0.00016)* 
-0.02 
 
LBW 
 1.29 
(-1.08 - 3.65) 
0.008  2.20 
(-0.14 - 4.54) 
0.014  2.61  
(0.05 - 5.18)* 
0.017 
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HBW 
 0.95 
(-0.30 - 2.2) 
0.012  0.10 
(-1.14 - 1.34) 
0.001  0.08 
(-1.27 - 1.43) 
0.001 
HDL 
Birth weight 
1606
6 
0.0006 
(0.0002 - 0.0009)** 
0.023 1601
0 
0.0014 
(0.0011 - 0.0018)** 
0.057 1549
1 
0.0009 
(0.0005 - 0.0012)* 
0.036 
 
LBW 
 -0.36 
(-1.50 - 0.79) 
-0.005  -1.25 
(-2.34 - -0.17)* 
-0.017  -0.85 
(-1.95 - 0.26) 
-0.011 
 
HBW 
 0.21 
(-0.39 - 0.82) 
0.005  1.19 
(0.62 - 1.77)** 
0.03  0.71 
(0.12 - 1.30)* 
0.018 
Non-HDL  
Birth weight 
1606
6 
-0.0003 
(-0.001 - 0.0006) 
-0.006 1601
0 
-0.0017 
(-0.0026- -
0.0008)** 
-0.029 1541
9 
-0.0018 
(-0.0028 - -
0.0009)** 
-0.032 
 
LBW 
 1.43 
(-1.28 - 4.15) 
0.008  3.02 
(0.38 - 5.67)* 
0.017  3.18 
(0.27 - 6.08)* 
0.018 
 
HBW 
 0.35 
(-1.08 - 1.78) 
0.004  -1.25 
(-2.65 - 0.16) 
-0.013  -1.07  
(-2.60 - 0.45) 
-0.012 
Log-TG  
Birth weight 
1595
1 
-0.00003 
(-0.00004 – 
- 0.00001)** 
-0.028 1589
6 
-0.00007 
(-0.00008 – 
-0.00005)** 
-0.064 1277
6 
-0.00005 
 (-0.00006 - -
0.00003)** 
-0.048 
 
LBW 
 0.014 
(-0.033 - 0.062) 
0.005  0.054 
(0.009 - 0.099)* 
0.018  0.046 
(-0.003 - 0.097) 
0.015 
 
HBW 
 -0.02 
(-0.05 - 0.005) 
-0.013  -0.065 
(-0.089 - -0.042)** 
-0.04  -0.05 
(-0.08 - -0.02)* 
-0.031 
* <0.05; ** <0.01 
LBW (<2,500 grams), HBW (>4000grams), Referent: normal birth weight (2500-4000grams).  
Variables included in the model: Model 1: All the outcomes were regressed on birth weight (both linear and categorical). Model 2: All the 
outcomes were regressed on birth weight variable and the child's BMI percentile in fifth grade. Model 3: All the outcomes were regressed on birth 
weight and the child's BMI percentile and additional covariates. Only covariates that were significant in the Spearman’s correlation were used in 
the multiple regression analysis. Each non-significant covariate was deleted from the regression model one at a time. Variables retained in model 
for SBP: child's age, race (white vs. other), maternal health insurance status at time of delivery (non-Medicaid vs. Medicaid), and family history of 
cholesterol (yes vs. no); DBP: child's age, race (white vs. other), and family history of cholesterol (yes vs. no); TC: child's age, race (white vs. 
other), and family history of cholesterol (yes vs. no); LDL: child's age, gender, interaction between age*gender, and family history of cholesterol 
(yes vs. no); HDL: child's age, gender, race (white vs. other), family history of CVD (yes vs. no), maternal smoking status during pregnancy (yes 
vs. no), and maternal age at time of delivery; Non-HDL: child's age, family history of cholesterol (yes vs. no), and breastfeeding intention 
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(breastfeed vs. both); TG: child's age, sex, race (white vs. other), family history of cholesterol (yes vs. no), family history of CVD (yes vs. no), and 
maternal education at birth.  
CVD-Cardiovascular Disease; SBP-systolic blood pressure; DBP-diastolic blood pressure; TC-total cholesterol; LDL-low-density lipoprotein 
cholesterol; HDL-high-density lipoprotein; non-HDL-non-high-density lipoprotein cholesterol; cholesterol; TG-triglycerides 
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Table 4b: Table 4a: Results of the multiple regression analysis for the association between birth weight and CVD risk factors of mothers using 
merged data from the Birth Score Project (1994-2000) and the CARDIAC Project (2004-2010) for all infants who were born Full-Term 
(N=19583) 
 
   
Model 1 
 
Model 2 
  N Unstandardized 
regression coefficients 
(95% CI) 
Standa
rdized 
(Beta) 
P-
Value 
Adj-R2  N Unstandardized 
regression 
coefficients (95% CI) 
Standar
dized 
(Beta) 
P-
Value 
Adj-R2  
TC  
Birth weight 
1116 0.005                         
(0.0002 – 0.00904) 
0.062 0.039 0.0029 1115 0.004  
(-0.0001 – 0.0087) 
0.057 0.0553 0.0246 
 
LBW 
 0.22                                        
(-13.29 – 13.73) 
0.001 0.975 0.0013  -0.87 
(-14.25 – 12.50) 
-0.004 0.898 0.0231 
 
HBW 
 6.19                                            
(-0.38 – 12.77) 
0.055 0.065   5.74 
 (-0.78 – 12.27) 
0.051 0.0845  
LDL  
Birth weight 
1082 0.003                                   
(-0.0007 – 0.007) 
0.049 0.108 0.1078 1060 0.003 
 (-0.0007 – 0.0072) 
0.050 0.1019 0.0191 
 
LBW 
 3.69                                    
(-8.56 – 15.94) 
0.018 0.555 0.0014  1.602 
(-10.74 – 13.94) 
0.008 0.7989 0.0188 
 
HBW 
 5.39                                  
(-0.46 – 11.25) 
0.055 0.071   5.49 
 (-0.36 – 11.35) 
0.056 0.0662  
HDL 
Birth weight 
1116 -0.0002                            
(-0.002 – 0.002) 
-0.005 0.857 -0.0009 1016 -0.001  
(-0.003 – 0.0004) 
-0.045 0.1444 0.0563 
 
LBW 
 -1.38                                        
(-6.66 – 3.90) 
-0.015 0.608 -0.0011  1.73 
(-3.60 – 7.06) 
0.019 0.5252 0.0551 
 
HBW 
 -0.96                                  
(-3.48 – 1.55) 
-0.023 0.453   -1.55 
(-4.09 – 0.98) 
-0.037 0.2297  
Non-HDL  
Birth weight 
1116 0.004                                  
(-0.001 - 0.008) 
0.049 0.100 0.0015 1093 0.00426  
(-0.0003 – 0.0088) 
0.054 0.07 0.0226 
 
LBW 
 2.56                                           
(-11.71 - 16.83) 
0.011 0.725 0.0013  0.48 
 (-14.20 – 15.17) 
0.002 0.9486 0.0221 
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HBW 
 6.35                                  
(-0.44 - 13.14) 
0.055 0.067   6.66 
(-0.156 – 13.48) 
0.058 0.0555  
Log-TG  
Birth weight 
1115 0.00004                            
(-0.00002 - 0.0001) 
0.038 0.209 0.0005 1114 0.00005  
(-0.000017 – 0.00012) 
0.044 0.139 0.005 
 
LBW 
 -0.06                                          
(-0.27 – 0.16) 
-0.016 0.604 -0.0008  -0.062  
(-0.275 – 0.151) 
-0.017 0.5675 0.0034 
 
HBW 
 0.04                                      
(-0.06 - 0.15) 
0.026 0.391   0.051 
(-0.049 – 0.153) 
0.030 0.3171  
LBW (<2,500 grams), HBW (>4000grams), Referent: normal birth weight (2500-4000grams).  
Variables included in the model: Model 1: All the outcomes were regressed on birth weight (both linear and categorical). Model 2: All the 
outcomes were regressed on birth weight and additional covariates. Only covariates that were significant in the Spearman’s correlation were used 
in the multiple regression analysis. Each non-significant covariate was deleted from the regression model one at a time. Variables retained in 
model for TC: mothers age when child in fifth grade, and breastfeeding intention (breastfeed vs. both); LDL: mothers age when child in fifth 
grade, breastfeeding intention (breastfeed vs. both), and smoking in the house (yes vs. no); HDL: mothers age when child in fifth grade, smoking 
in the house (yes vs. no), family history of CVD (yes vs. no), family history of diabetes (yes vs. no), number of previous pregnancies (≥1 vs. 0); 
Non-HDL: mothers age when child in fifth grade, breastfeeding intention (breastfeed vs. both), and smoking in the house (yes vs. no); TG: 
mothers age when child in fifth grade and breastfeeding intention (breastfeed vs. both).  
CVD-Cardiovascular Disease; SBP-systolic blood pressure; DBP-diastolic blood pressure; TC-total cholesterol; LDL-low-density lipoprotein 
cholesterol; HDL-high-density lipoprotein; non-HDL-non-high-density lipoprotein cholesterol; cholesterol; TG-triglycerides 
 
 
 
 
 
 
 
 
 
 
 129
Table 5a:  Results of the multiple regression analysis for the association between birth weight (continuous) and LDL, HDL, non-HDL, and TG 
levels of fifth-grade WV children born full term using merged data from the Birth Score Project (1994-2000) and the CARDIAC Project (2004-
2010) for all infants who were born Full-Term (N=19583) 
 
    N Unstandardized 
regression coefficients 
and 95% CI 
Standardiz
ed (Beta) 
t 
Value 
P-
value 
Adj-
R2 
Reduce
d model 
Adj-R2 
Chan
ge in 
Adj-
R2 
LDL Intercept 13139 142.72 (128.72 - 156.71) 0 19.99 0.0001 0.036
5 
0.0361 0.0004 
  Child's age in fifth grade  -5.23 (-6.47 - -3.995) -0.11 -8.3 0.0001    
  Sex (male vs. female)  -23.32 (-42.57 - -4.07) -0.47 -2.37 0.0176    
  Child's sex*age  2.25 (0.49 - 3.992) 0.5 2.51 0.0122    
  Family history of 
cholesterol 
 5.38 (4.52 - 6.25) 0.11 12.21 0.0001    
  BMI percentile in fifth 
grade 
 0.12 (0.11 - 0.14) 0.14 15.61 0.0001    
  Birth weigh (grams)  -0.0011 (-0.0019 - -
0.0002) 
-0.02 -2.33 0.0196    
HDL Intercept 15491 68.8 (64.25 - 73.35) 0 29.66 0.0001 0.124 0.1228 0.0012 
  Child's age in fifth grade  -0.97 (-1.35 - -0.59) -0.04 -5.02 0.0001    
  Sex (male vs. female)  2.18 (1.82 - 2.54) 0.09 11.75 0.0001    
  Race (white vs. other)  -2.71 (-3.53 - -1.89) -0.05 -6.48 0.0001    
  Family history of CVD  -0.75 (-1.12 - -0.38) -0.03 -3.93 0.0001    
  Maternal smoking 
(pregnancy) 
 -0.74 (-1.17 - -0.32) -0.03 -3.41 0.0007    
  Maternal age at birth   0.05 (0.02 - 0.09) 0.03 2.86 0.0042    
  BMI percentile in fifth 
grade 
 -0.15 (-0.16 - -0.14) -0.34 -43.96 0.0001    
  Birth weigh (grams)  0.001 (0.0006 - 0.0013) 0.04 4.59 0.0001    
Non-
HDL 
Intercept 13221 137.4 (125.8-148.99) 0 23.22 0.0001 0.066
8 
0.0659 0.0009 
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  Child's age in fifth grade  -3.57 (-4.56 - -2.57) -0.06 -7.04 0.0001    
  Family history of 
cholesterol 
 6.45 (5.47 - 7.43) 0.11 12.91 0.0001    
  Feeding intention   -0.99 (-1.94 - -0.03) -0.02 -2.02 0.0435    
  BMI percentile in fifth 
grade  
 0.23 (0.22 - 0.25) 0.23 26.31 0.0001    
  Birth weigh (grams)  -0.002 (-0.003 - -0.001) -0.032 -3.75 0.0002    
Log-TG Intercept 12776 3.7 (3.49 - 3.92) 0 33.85 0.0001 0.142
1 
0.1401 0.002 
  Child's age in fifth grade  0.04 (0.02 - 0.06) 0.04 4.03 0.0001    
  Sex (male vs. female)  -0.11 (-0.13 - -0.1) -0.11 -12.9 0.0001    
  Race (white vs. other)  0.15 (0.11 - 0.19) 0.07 7.67 0.0001    
  Family history of 
cholesterol 
 0.06 (0.04 - 0.08) 0.06 6.38 0.0001    
  Family history of CVD  0.02 (0.01 - 0.04) 0.02 2.18 0.0296    
  Maternal education at birth   -0.01 (-0.02 - -0.01) -0.04 -4.18 0.0001    
  BMI percentile in fifth 
grade 
 0.006 (0.0059 - 0.0065) 0.35 41.98 0.0001    
  Birth weigh (grams)  -0.00005 (-0.00007 - -
0.00004) 
-0.05 -5.66 0.0001    
Only covariates that were significant in the Spearman’s correlation were used in the multiple regression analysis. Each non-significant covariate 
was deleted from the regression model one at a time. Variables retained in model for LDL: child's age, gender, interaction between age*sex, and 
family history of cholesterol (yes vs. no); HDL: child's age, gender, race (white vs. other), family history of CVD (yes vs. no), maternal smoking 
status during pregnancy (yes vs. no), and maternal age at time of delivery; Non-HDL: child's age, family history of cholesterol (yes vs. no), and 
breastfeeding intention (breastfeed vs. both); TG: child's age, sex, race (white vs. other), family history of cholesterol (yes vs. no), family history 
of CVD (yes vs. no), and maternal education at birth. 
CVD-Cardiovascular Disease; LDL-low-density lipoprotein cholesterol; HDL-high-density lipoprotein; non-HDL-non-high-density lipoprotein 
cholesterol; cholesterol; TG-triglycerides 
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Table 5b:  Results of the multiple regression analysis for the association between birth weight (categorical) and LDL, HDL, non-HDL, and TG 
levels of fifth-grade WV children born full term using merged data from the Birth Score Project (1994-2000) and the CARDIAC Project (2004-
2010) for all infants who were born Full-Term (N=19583) 
 
    N Unstandardized 
regression 
coefficients and 95% 
CI 
Standardiz
ed (Beta) 
t 
Value 
P-value Adj-R2 Reduce
d model 
Adj-R2 
Change 
in Adj-
R2 
LDL Intercept 13139 138.95 (125.41 - 
152.49) 
0 20.12 <0.0001 0.0363 0.0361 0.0002 
  Child's age in fifth grade  -5.21 (-6.44 - -3.97) -0.11 -8.26 <0.0001    
  Sex (male vs. female)  -23.54 (-42.79 - -4.29) -0.48 -2.4 0.0166    
  Child's sex*age  2.25 (0.5 - 4.01) 0.51 2.52 0.0118    
  Family history of 
cholesterol 
 5.39 (4.53 - 6.25) 0.11 12.23 <0.0001    
  BMI percentile in fifth 
grade 
 0.12 (0.11 - 0.14) 0.14 15.46 <0.0001    
  LBW (<2500 gram)  2.62 (0.05 - 5.18) 0.02 2 0.046    
  HBW (>4000 grams)  0.09 (-1.27 - 1.44) 0.01 0.12 0.9022    
HDL Intercept 15491 71.93 (67.59 - 76.27) 0 32.5 <0.0001 0.1232 0.1228 0.0004 
  Child's age in fifth grade  -1 (-1.37 - -0.62) -0.04 -5.15 <0.0001    
  Sex (male vs. female)  2.26 (1.9 - 2.62) 0.1 12.25 <0.0001    
  Race (white vs. other)  -2.66 (-3.47 - -1.84) -0.05 -6.35 <0.0001    
  Family history of CVD  -0.75 (-1.13 - -0.38) -0.03 -3.94 <0.0001    
  Maternal smoking 
(pregnancy) 
 -0.88 (-1.3 - -0.46) -0.04 -4.09 <0.0001    
  Maternal age at birth   0.06 (0.02 - 0.09) 0.03 3.01 0.0026    
  BMI percentile in fifth 
grade 
 -0.15 (-0.15 - -0.14) -0.34 -43.77 <0.0001    
  LBW (<2500 gram)  -0.85 (-1.96 - 0.26) -0.02 -1.5 0.1327    
  HBW (>4000 grams)  0.72 (0.13 - 1.31) 0.02 2.37 0.0177    
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Non-HDL Intercept 13221 130.81 (119.82 - 
141.8) 
0 23.33 <0.0001 0.0662 0.0659 0.0003 
  Child's age in fifth grade  -3.53 (-4.52 - -2.54) -0.06 -6.97 <0.0001    
  Family history of 
cholesterol 
 6.46 (5.48 - 7.44) 0.11 12.92 <0.0001    
  Feeding Intention   -1.07 (-2.02 - -0.12) -0.02 -2.2 0.0281    
  BMI Percentile in fifth 
grade 
 0.23 (0.21 - 0.25) 0.23 26.14 <0.0001    
  LBW (<2500 gram)  3.19 (0.28 - 6.09) 0.02 2.15 0.0316    
  HBW (>4000 grams)  -1.08 (-2.61 - 0.46) -0.02 -1.38 0.1671    
Log-TG Intercept 12776 3.54 (3.34 - 3.75) 0 33.5 <0.0001 0.1411 0.1401 0.001 
  Child's age in fifth grade  0.04 (0.02 - 0.06) 0.04 4.17 <0.0001    
  Sex (male vs. female)  -0.12 (-0.13 - -0.1) -0.12 -13.4 <0.0001    
  Race (white vs. other)  0.15 (0.11 - 0.19) 0.07 7.52 <0.0001    
  Family history of 
cholesterol 
 0.06 (0.04 - 0.08) 0.06 6.42 <0.0001    
  Family history of CVD  0.02 (0.01 - 0.04) 0.02 2.17 0.0302    
  Maternal education at birth   -0.01 (-0.02 - -0.01) -0.04 -4.66 <0.0001    
  BMI percentile in fifth 
grade 
 0.006 (0.0059 - 
0.0065) 
0.35 41.8 <0.0001    
  LBW (<2500 gram)  0.05 (-0.01 - 0.1) 0.02 1.82 0.0684    
  HBW (>4000 grams)  -0.06 (-0.08 - -0.03) -0.04 -3.77 0.0002    
Only covariates that were significant in the Spearman’s correlation were used in the multiple regression analysis. Each non-significant covariate 
was deleted from the regression model one at a time. Variables retained in model for LDL: child's age, gender, interaction between age*gender, 
and family history of cholesterol (yes vs. no); HDL: child's age, gender, race (white vs. other), family history of CVD (yes vs. no), maternal 
smoking status during pregnancy (yes vs. no), and maternal age at time of delivery; Non-HDL: child's age, family history of cholesterol (yes vs. 
no), and breastfeeding intention (breastfeed vs. both); TG: child's age, sex, race (white vs. other), family history of cholesterol (yes vs. no), family 
history of CVD (yes vs. no), and maternal education at birth. 
CVD-Cardiovascular Disease; LDL-low-density lipoprotein cholesterol; HDL-high-density lipoprotein; non-HDL-non-high-density lipoprotein 
cholesterol; cholesterol; TG-triglycerides 
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Supplemental Table S1: Results of the Spline regression analysis for the association between birth weight and CVD risk factors of fifth-grade 
WV children using merged data from the Birth Score Project (1994-2000) and the CARDIAC Project (2004-2010) for all infants who were born 
Full-Term (N=19,583) 
 
CVD risk 
factors  
BTW 
(grams) 
Model 1 Model 2 Model 3 
Child  
Unstandardized 
regression 
coefficients and 
95% CI 
P-
value 
Adjus
ted-
R2 
Unstandardized 
regression 
coefficients and 
95% CI 
P-
value 
Adju
sted-
R2 
Unstandardized 
regression 
coefficients and 
95% CI 
P-
value 
Adjus
ted-R2 
SBP < 2500 
-0.00009 
(-0.004 - 0.004) 
0.961
6 
0.000
7 
-0.00105 
(-0.0045 - 0.0023) 
0.543
7 
0.115
6 
0.00395 
(-0.0006 - 0.0085) 
0.087
4 
0.140
3 
  
2500 - 
4000 
0.0006 
(-0.0031 -0.0043) 
0.771
2 
0.00072 
(-0.0028 - 0.0042) 
0.687
1 
-0.0045 
(-0.009 - 0.0002) 
0.063
6 
  > 4000 
0.00156 
(-0.0003 - 0.0033) 
0.092
8 
0.00103 
(-0.0007 - 0.0028) 
0.239
1 
0.00157 
(-0.0001 - 0.004) 
0.224
5 
DBP < 2500 
-0.0009 
(-0.0037 -0.0019) 
0.512
5 0.001 
-0.00171 
(-0.004 - 0.001) 
0.218
2 
0.068
5 
-0.0008 
(-0.004 - 0.002) 
0.628
7 
0.073
2 
  
2500 - 
4000 
0.002 
(-0.001 - 0.004) 
0.302
9 
0.0018 
(-0.001 - 0.005) 0.204 
0.0009 
(-0.003 - 0.004) 0.601 
  > 4000 
0.0006 
(-0.0008 - 0.002) 
0.422
2 
0.0002 
(-0.0012 - 0.002) 
0.752
8 
0.0003 
(-0.001 - 0.002) 0.722 
TC < 2500 
-0.00935 
(-0.0184 -0.00021) 0.045 
0.000
1 
-0.0098 
(-0.019 - -0.0007) 
0.034
2 
0.009
3 
-0.012 
(-0.022 - -0.0017) 
0.022
4 
0.025
8 
  
2500 - 
4000 
0.01011 
(0.00061 -0.0196) 
0.036
8 
0.01008 
(0.0006 - 0.0195) 
0.036
4 
0.0119 
(0.0011 - 0.02264) 
0.030
7 
  > 4000 
-0.0008 
(-0.005 - 0.004) 0.728 
-0.0012 
(-0.006 - 0.004) 
0.623
5 
-0.0012 
(-0.006 - 0.004) 0.649 
LDL < 2500 -0.005 0.187 0 -0.006 0.137 0.021 -0.009 0.044 0.036
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(-0.013 - 0.0026) 4 (-0.014 - 0.0019) 9 7 (-0.018 - -0.0002) 5 6 
  
2500 - 
4000 
0.0055 
(-0.0028 - 0.0139) 
0.193
4 
0.005 
(-0.002 - 0.013) 0.195 
0.008 
(-0.001 - 0.017) 
0.083
8 
  > 4000 
0.00164 
(-0.00251 0.0058) 
0.438
4 
0.0012 
(-0.003 - 0.005) 0.585 
0.002 
(-0.003- 0.006) 
0.473
3 
HDL < 2500 
-0.002 
(-0.006 - 0.002) 0.369 
0.000
7 
-0.002 
(-0.005 - 0.003) 0.527 
0.110
9 
-0.0005 
(-0.004 - 0.003) 
0.806
8 0.124 
  
2500 - 
4000 
0.0028 
(-0.0013 - 0.0068) 
0.184
9 
0.0029 
(-0.0009 - 0.0067) 
0.138
4 
0.0016 
(-0.0023 - 0.0054) 
0.419
5 
  > 4000 
-0.00225 
(-0.0043 - 
0.00023) 
0.029
1 
-0.0012 
(-0.003 - 0.0004) 
0.108
8 
-0.0013 
(-0.003 - 0.0006) 
0.190
5 
Non-HDL < 2500 
-0.007 
(-0.016 - 0.002) 
0.123
3 0 
-0.008 
(-0.017 - 0.0007) 
0.068
9 
0.055
8 
-0.0117 
(-0.022 - -0.0015) 
0.024
8 
0.066
9 
  
2500 - 
4000 
0.0069 
(-0.0027 - 0.0165) 
0.157
1 
0.00674 
(-0.0026 - 0.0161) 
0.156
8 
0.01007 
(-0.0006 - 0.0207) 
0.063
3 
  > 4000 
0.0017 
(-0.003 - 0.0065) 
0.474
3 
0.0007 
(-0.0039 - 0.0054) 
0.762
5 
0.0008 
(-0.004 - 0.006) 
0.748
3 
Log-TG < 2500 
-0.00006 
(-0.00023 - 
0.0001) 
0.450
8 
0.000
7 
-0.00009 
(-0.00024 -
0.00006) 
0.254
7 
0.126
4 
-0.0001 
(-0.0003 - 
0.00004) 
0.128
8 
0.142
9 
  
2500 - 
4000 
0.00003 
(-0.00014 - 
0.0002) 
0.745
6 
0.00002 
(-0.00014 - 
0.00018) 
0.804
1 
0.00009 
(-0.00009 - 
0.00027) 
0.331
3 
  > 4000 
0.00005 
(-0.00003 - 
0.00014) 
0.209
8 
0.00003 
(-0.00005 - 
0.00011) 
0.518
8 
0.000004 
(-0.00009 - 
0.00008) 
0.927
5 
Spline Knots at LBW <2,500 grams and HBW >4000grams 
Variables included in the model: Model 1: All the outcomes were regressed on birth weight. Model 2: All the outcomes were regressed on birth 
weight variable and the child's BMI percentile in fifth grade. Model 3: All the outcomes were regressed on birth weight and the child's BMI 
percentile and additional covariates. Only covariates that were significant in the Spearman’s correlation were used in the multiple regression 
analysis. Each non-significant covariate was deleted from the regression model one at a time. Variables retained in model for SBP: child's age, 
race (white vs. other), maternal health insurance status at time of delivery (non-Medicaid vs. Medicaid), and family history of cholesterol (yes vs. 
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no); DBP: child's age, race (white vs. other), and family history of cholesterol (yes vs. no); TC: child's age, race (white vs. other), and family 
history of cholesterol (yes vs. no); LDL: child's age, gender, interaction between age*gender, and family history of cholesterol (yes vs. no); HDL: 
child's age, gender, race (white vs. other), family history of CVD (yes vs. no), maternal smoking status during pregnancy (yes vs. no), and 
maternal age at time of delivery; Non-HDL: child's age, family history of cholesterol (yes vs. no), and breastfeeding intention (breastfeed vs. 
both); TG: child's age, sex, race (white vs. other), family history of cholesterol (yes vs. no), family history of CVD (yes vs. no), and maternal 
education at birth. 
CVD-Cardiovascular Disease; SBP-systolic blood pressure; DBP-diastolic blood pressure; TC-total cholesterol; LDL-low-density lipoprotein 
cholesterol; HDL-high-density lipoprotein; non-HDL-non-high-density lipoprotein cholesterol; cholesterol; TG-triglycerides 
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Supplemental Table S2: Results of the Spline regression analysis for the association between birth weight and maternal CVD risk factors using 
merged data from the Birth Score Project (1994-2000) and the CARDIAC Project (2004-2010) for all infants who were born Full-Term 
(N=19,583) 
 
  
Model 1 Model 2 
Mothers’  
CVD risk 
factors  
BTW 
(grams) 
Beta-coefficient 
unstandardized 
(95%CI) 
Standardi
zed (Beta) P-value 
Adjust
ed-R2 
Beta-coefficient 
unstandardized 
(95%CI) 
Standard
ized 
(Beta) P-value 
Adjuste
d-R2 
TC < 2500  
-0.04  
(-0.107 - 0.027) -0.537 0.239 0.0027 
-0.031  
(-0.098 - 0.035) -0.418 0.356 0.0238 
  2500 - 4000  
0.046  
(-0.022 - 0.115) 0.608 0.186   
0.037  
(-0.031 - 0.105) 0.483 0.289   
  > 4000  
-0.005 
 (-0.03 - 0.02) -0.014 0.701   
-0.004  
(-0.029 - 0.02) -0.012 0.731   
LDL < 2500  
-0.045  
(-0.106 - 0.015) -0.689 0.141 0.002 
-0.036  
(-0.096 - 0.023) -0.554 0.234 0.0189 
  2500 - 4000  
0.049  
(-0.012 - 0.111) 0.738 0.118   
0.04 
 (-0.021 - 0.101) 0.603 0.198   
  > 4000  
0.001  
(-0.021 - 0.023) 0.003 0.938   
0.001  
(-0.02 - 0.023) 0.005 0.901   
HDL < 2500  
0.007  
(-0.019 - 0.033) 0.24 0.601 0.007 
0.001  
(-0.025 - 0.026) 0.02 0.965 0.055 
  2500 - 4000  
-0.006  
(-0.033 - 0.02) -0.219 0.635   
-0.001  
(-0.028 - 0.025) -0.05 0.916   
  > 4000  
-0.006  
(-0.016 - 0.003) -0.048 0.195   
-0.004  
(-0.013 - 0.006) -0.028 0.458   
Non-
HDL < 2500  
-0.047  
(-0.116 - 0.023) -0.599 0.191 0.0016 
-0.038  
(-0.109 - 0.033) -0.494 0.289 0.0221 
  2500 - 4000  
0.052  
(-0.02 - 0.123) 0.652 0.157   
0.044  
(-0.029 - 0.116) 0.551 0.24   
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  > 4000  
-0.001  
(-0.027 - 0.024) -0.004 0.91   
-0.001  
(-0.026 - 0.024) -0.003 0.942   
Log-TG < 2500  
-0.000104  
(-0.00115 - 
0.000941) -0.08978 0.8446 0.0012 
-0.000145 
 (-0.00119 - 0.0009) -0.12458 0.7857 0.0033 
  2500 - 4000  
0.000151  
(-0.000921 - 
0.00122) 0.12706 0.7829   
0.0002  
(-0.000872 - 
0.00127) 0.16901 0.7142   
  > 4000  
0.000006  
(-0.000375 - 
0.000387) 0.00113 0.9755   
0.000006  
(-0.000374 - 
0.000386) 0.00109 0.9763   
Spline Knots at LBW <2,500 grams and HBW >4000grams 
Variables included in the model: Model 1: All the outcomes were regressed on birth weight. Model 2: All the outcomes were regressed on birth 
weight and additional covariates. Only covariates that were significant in the Spearman’s correlation were used in the multiple regression analysis. 
Each non-significant covariate was deleted from the regression model one at a time. Variables retained in model for TC: mothers age when child 
in fifth grade, and breastfeeding intention (breastfeed vs. both); LDL: mothers age when child in fifth grade, breastfeeding intention (breastfeed vs. 
both), and smoking in the house (yes vs. no); HDL: mothers age when child in fifth grade, smoking in the house (yes vs. no), family history of 
CVD (yes vs. no), family history of diabetes (yes vs. no), number of previous pregnancies (≥1 vs. 0); Non-HDL: mothers age when child in fifth 
grade, breastfeeding intention (breastfeed vs. both), and smoking in the house (yes vs. no); TG: mothers age when child in fifth grade and 
breastfeeding intention (breastfeed vs. both). 
CVD-Cardiovascular Disease; SBP-systolic blood pressure; DBP-diastolic blood pressure; TC-total cholesterol; LDL-low-density lipoprotein 
cholesterol; HDL-high-density lipoprotein; non-HDL-non-high-density lipoprotein cholesterol; cholesterol; TG-triglycerides 
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Chapter 3 
 
Table 1: 2011 National Immunization Survey (NIS) and Pediatric Nutrition Surveillance System 
(PedNSS) breastfeeding rates nationally and in the state of WV.13,14 
 
 NIS 
 
PedNSS 
 National 
(%) 
WV 
(%) 
National  
(%) 
WV 
(%) 
WV Rank 
Ever breastfed 79.2 59.3 66.3 44.7 41 
Breastfed at least 6 months 49.4 29.3 26.0 13.5 38 
Breastfed at least 12 months 26.7 15.9 17.9 10.2 30 
Exclusive breastfeeding 3 months 40.7 28.3 10.8 2.9 27 
Exclusive breastfeeding 6 months 18.8 12.2 6.3 0.3 28 
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Table 2: Maternal and child characteristics at birth and in fifth grade using merged data from the 
Birth Score Project (1998-2003) and the CARDIAC Project (2010-2013) for all infants who were 
born Full-Term (N=10457) 
 
Variable N Missing  
Frequency 
(%)/Mean (SD) 
Sex 10457   
Female     5740 (54.89) 
Male     4717 (45.11) 
Race 10070 387 
Others     630 (6.26) 
White     9440 (93.74) 
Marital Status (at birth) 10457     
Single     2788 (26.66) 
Married     7669 (73.34) 
No. of previous pregnancy  (at 
birth) 10457 
  
  
0     3651 (34.91) 
≥1     6806 (65.09) 
Health Insurance of mother (at 
birth) 10457 
  
  
Medicaid     4841 (46.29) 
Non-Medicaid     5616 (53.71) 
Family History of Cholesterol  8879 1578   
No     6119 (68.92) 
Yes     2760 (31.08) 
Family History of CVD 10457     
No     6114 (58.47) 
Yes     4343 (41.53) 
Smoking during Pregnancy 10395 62   
Yes     2580 (24.82) 
No     7815 (75.18) 
No. of Prenatal care visits 10457     
<12     4641 (44.38) 
≥12     5816 (55.62) 
Breastfeeding  6833 3624   
No     3883 (56.83) 
Yes     2950 (43.17) 
Age of Child (years) 10457 0 10.97  (0.47) 
Maternal Age at Birth (years) 10424 33 25.79  (5.5) 
Maternal Education at Birth  10405 52 12.87  (2.12) 
Weight Gain during Pregnancy 9597 860 30.79  (14.66) 
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(lbs) 
Gestational Age (weeks) 10457 0 39.07  (1.12) 
Birth Weight (grams) 10452 5 3352.64  (481.55) 
BMI-Percentile 10444 13 72.58  (28) 
Child SBP (mmHg) 10254 203 108.43  (11.75) 
Child DBP  (mmHg) 10255 202 67.49  (9.53) 
Child TC (mg/dL) 9740 717 157.7  (27.51) 
Child LDL  (mg/dL) 9725 732 89.99  (24.41) 
Child HDL  (mg/dL) 9740 717 50.14  (12.37) 
Child NON-HDL  (mg/dL) 9740 717 107.56  (27.86) 
Child TG  (mg/dL) 9739 718 92.28 (54.99) 
Child log TG 9739 718 4.38  (0.52) 
Maternal TC  (mg/dL) 112 10345 182.67  (33.62) 
Maternal LDL  (mg/dL) 109 10348 110.64  (27.87) 
Maternal HDL  (mg/dL) 112 10345 51.55  (12.73) 
Maternal NON-HDL  (mg/dL) 112 10342 131.12  (33.64) 
Maternal TG  (mg/dL) 112 10342 106.47 (73.95) 
Maternal log TG 112 10342 4.47  (0.61) 
CVD-Cardiovascular Disease; SBP-systolic blood pressure; DBP-diastolic blood pressure; TC-
total cholesterol; LDL-low-density lipoprotein cholesterol; HDL-high-density lipoprotein; non-
HDL-non-high-density lipoprotein cholesterol; cholesterol; TG-triglycerides 
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Table 3: Results of the Independent Sample T-test for the mean difference in blood pressure and lipid levels in both fifth grade children who were 
breastfed vs. not breastfed and mothers who breastfed vs. did not breastfed for children born Full-Term using merged data from the Birth Score 
Project (1998-2003) and the CARDIAC Project (2010-2013)  
 
    Childhood CVD risk factors Maternal CVD risk factors 
  Breastfed Not 
Breastfed 
Mean 
Difference 
(95% CI) 
P-value Cohen's 
d effect 
size 
Breastf
ed 
Not 
Breastfed 
Mean 
Difference 
(95% CI) 
P-
value 
BMI 
(Percentile) 
(N) 2948 3877        
  Mean (SD) 70.2 
(28.6) 
74.2 
(27.5) 
-3.95* 
(-5.29, -2.62) 
<0.0001 0.14     
SBP  (N) 2866 3781        
  Mean (SD) 107.3 
(11.8) 
108.6 
(11.9) 
-1.3* 
(-1.97, -0.81) 
<0.0001 0.11     
DBP (N) 2867 3781        
  Mean (SD) 66.4 
 (9.5) 
67.2  
(9.7) 
-0.8* 
(-1.26, -0.33) 
0.0009 0.08     
TC (N) 2792 3644    31 21   
  Mean (SD) 157.5 
(27.8) 
157.8 
(27.9) 
-0.3 
(-1.71, 1.04) 
0.6285  182 
(34.1) 
187  
(41.2) 
-4.9 
(-26, 16.09) 
0.6385 
LDL (N) 2788 3639    31 20   
  Mean (SD) 89.4  
(24.6) 
89.3  
(24.8) 
0.1 
(-1.12, 1.31) 
0.8868  108.5 
(27.3) 
114.8 
(31.2) 
-6.3 
(-22.92, 10.35) 
0.4515 
HDL (N) 2792 3644    31 21   
  Mean (SD) 51.0 
(12.4) 
50.1  
(12.5) 
0.9* 
(0.33, 1.56) 
0.0026 0.07 52.7 
(11.1) 
50.4 
(12.7) 
2.3 
(-4.37, 8.99) 
0.49 
Non-HDL (N) 2792 3644    31 21   
  Mean (SD) 106.4 
(27.9) 
107.7 
(28.5) 
-1.3 
(-2.70, 0.11) 
0.0705  129.3 
(36.0) 
136.5 
(36.3) 
-7.3 
(-27.77, 13.24) 
0.4799 
Log-TG (N) 2791 3644    31 21   
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  Mean (SD) 4.35 (0.5) 4.43  
(0.5) 
-0.08* 
(0.33, 1.56) 
<0.0001 -0.16 4.4 (0.7) 4.5 (0.7) -0.1 
(-0.53, 0.24) 
0.4697 
CVD-Cardiovascular Disease; SBP-systolic blood pressure; DBP-diastolic blood pressure; TC-total cholesterol; LDL-low-density lipoprotein 
cholesterol; HDL-high-density lipoprotein; non-HDL-non-high-density lipoprotein cholesterol; cholesterol; TG-triglycerides 
 
 
 
 
 
 
 143
Table 4: Correlation between Breastfeeding and CVD risk factors for infants born Full-Term 
using merged data from the Birth Score Project (1998-2003) and the CARDIAC Project (2010-
2013)  
 
Childhood CVD risk 
factors 
N Correlation 
Coefficient r 
P-value 
BMI percentile 6825 -0.08 <0.0001 
SBP  6647 -0.06 <0.0001 
DBP 6648 -0.04 0.0007 
TC 6436 -0.008 0.4941 
LDL 6427 0.004 0.7731 
HDL 6436 0.04 0.0011 
Non-HDL 6436 -0.02 0.0632 
Log-TG 6435 -0.07 <0.0001 
Maternal CVD risk  
factors 
   
TC 52 -0.05 0.7406 
LDL 51 -0.08 0.5743 
HDL 52 0.12 0.3958 
Non-HDL 52 -0.11 0.4554 
Log-TG 52 -0.08 0.5935 
CVD-Cardiovascular Disease; SBP-systolic blood pressure; DBP-diastolic blood pressure; TC-
total cholesterol; LDL-low-density lipoprotein cholesterol; HDL-high-density lipoprotein; non-
HDL-non-high-density lipoprotein cholesterol; cholesterol; TG-triglycerides 
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Table 5: Results of the multiple regression analysis for the association between reported history of breastfeeding and CVD risk factors of Fifth-
Grade WV Children born Full-Term using merged data from the Birth Score Project (1998-2003) and the CARDIAC Project (2010-2013)  
 
Risk 
factor
s 
 
Model 1 
 
Model 2 
 
Model 3 
  Unstandardiz
ed Regression 
Coefficient 
(95% CI) 
P-value Stand
ardize
d 
Beta 
R2 Unstandardiz
ed Regression 
Coefficient 
(95% CI) 
P-value Standar
dized 
Beta 
Adjuste
d R2 
Unstandardi
zed 
Regression 
Coefficient 
(95% CI) 
P-
value 
Stan
dard
ized 
Beta 
Adjus
ted R2 
SBP  -1.39 
(-1.97 - -0.81) 
<0.0001 -0.06 0.003
3 
-0.77 
(-1.32 - -0.23) 
0.0052 -0.032 0.1188 -0.43 
(-0.98 - 0.13) 
0.134
9 
-0.02 0.1311 
DBP -0.79 
(-1.26 - -0.33) 
0.0009 -0.04 0.001
7 
-0.44 
(-0.89 - 0.02) 
0.06 -0.022 0.0633     
TC -0.34 
(-1.71 - 1.04) 
0.6285 -0.006 0.000 -0.001 
(-1.37 - 1.37) 
0.999 -
0.00001 
0.0069     
LDL 0.09 
(-1.13 - 1.31) 
0.8868 0.002 0.000 0.62 
(-0.59 - 1.83) 
0.3164 0.012 0.0231     
HDL 0.95 
(0.33 - 1.56) 
0.0026 0.04 0.001 0.28 
(-0.29 - 0.86) 
0.335 0.011 0.1378     
Non-
HDL 
-1.29 
(-2.68 - 0.11) 
0.0705 -0.02 0.000
5 
-0.28 
(-1.64 - 1.07) 
0.6824 -0.005 0.0611     
Log 
TG -0.08 
(-0.1 - -0.05) 
<0.0001 -0.07 0.005
3 -0.05 
(-0.07 - -0.03) 
<0.0001 -0.048 0.1302 -0.04 
(-0.06 - -
0.01) 
0.008 -0.03 0.1499 
Variables included in the model: Model 1: All the outcomes were regressed on breastfed variable (yes vs. no). Model 2: All the outcomes were 
regressed on breastfed variable and the child's BMI percentile in fifth grade. Model 3: All the outcomes were regressed on breastfed variable and 
the child's BMI percentile and additional covariates. Only covariates that were significant in the Spearman’s correlation were used in the multiple 
regression analysis. Covariates included child's age, gender, race, infant birth weight in grams, maternal education status at birth (1–17 years of 
education), maternal health insurance status at time of delivery (non-Medicaid vs. Medicaid), family history of hypercholesterolemia (yes vs. no), 
number of previous pregnancies assessed at birth (>=1 vs. 0), maternal smoking status during pregnancy (yes vs. no), weight gain during 
pregnancy in lbs. Covariates that were not significant in the Spearman’s correlation and were excluded: maternal age at birth of the index child, 
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infant birth weight in grams, marital status of the mother at birth, number of prenatal care visits. Each non-significant covariate was deleted from 
the regression model one at a time. Variables retained in model for SBP: child's age, maternal education at birth. For TG: Child's age, sex, race, 
maternal education at birth, number of previous pregnancies, and family history of cholesterol.  
CVD-Cardiovascular Disease; SBP-systolic blood pressure; DBP-diastolic blood pressure; TC-total cholesterol; LDL-low-density lipoprotein 
cholesterol; HDL-high-density lipoprotein; non-HDL-non-high-density lipoprotein cholesterol; cholesterol; TG-triglycerides 
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Table 6: Results of the multiple regression analysis for all the variables in the model to predict Triglyceride of Fifth-Grade WV Children born Full 
Term using merged data from the Birth Score Project (1998-2003) and the CARDIAC Project (2010-2013)  
 
   
Full Model 
 
Covariate Model 
 Unstandardized 
regression 
coefficients 
(95% CI) 
Standa
rdized 
Beta 
t 
Value 
P-value Adjusted 
R2 
Unstandardized 
regression 
coefficients 
(95% CI) 
Stand
ardiz
ed 
Beta 
t 
Value 
P-value Adjus
ted R2 
Intercept 3.31 
(2.97 - 3.64) 
0.00 19.3 <0.0001 0.1499 3.17 
(2.89 -3.44) 
0 22.56 <0.0001 0.1486 
Age (Years) 0.06 
(0.04 - 0.09) 
0.06 4.4 <0.0001  0.072 
(0.05 - 0.10) 
0.06 6.08 <0.0001  
Gender  
(Male vs. Female) 
-0.11 
(-0.14 - -0.08) 
-0.10 -8.24 <0.0001  -0.11 
(-0.13 - -0.09) 
-0.11 -10.48 <0.0001  
Race  
(White vs. Others) 
0.14 
(0.09 - 0.19) 
0.07 5.3 <0.0001  0.12 
(0.08 - 0.17) 
0.06 5.58 <0.0001  
History of 
hypercholesterolemia  
0.07 
(0.04 - 0.10) 
0.06 5.04 <0.0001  0.07 
(0.05 - 0.10) 
0.06 6.16 <0.0001  
Number of Previous 
pregnancies (≥1 vs. 0) 
-0.04 
(-0.07 - -0.02) 
-0.04 -3.12 0.0018  -0.03 
(-0.06 - -0.01) 
-0.03 -3.01 0.0026  
Maternal education 
(Years) 
-0.010 
(-0.017 - -0.004) 
-0.04 -3.16 0.0016  -0.008 
(-0.014 - -0.004) 
-0.04 -3.43 0.0006  
BMI percentile  0.0065 
(0.006 - 0.007) 
0.35 27.45 <0.0001  0.0065 
(0.006 - 0.007) 
0.35 33.72 <0.0001  
Breastfed  
(Yes vs. No) 
-0.04 
(-0.06 - -0.01) 
-0.03 -2.65 0.008       
Only covariates that were significant in the Spearman’s correlation were used in the multiple regression analysis. Covariates included child's age, 
gender, race, infant birth weight in grams, maternal education status at birth (1–17 years of education), maternal health insurance status at time of 
delivery (non-Medicaid vs. Medicaid), family history of hypercholesterolemia (yes vs. no), number of previous pregnancies assessed at birth (≥1 
vs. 0), maternal smoking status during pregnancy (yes vs. no), weight gain during pregnancy in lbs. Covariates that were not significant in the 
Spearman’s correlation and were excluded:  maternal age at birth of the index child, infant birth weight in grams, marital status of the mother at 
birth, number of prenatal care visits. Each non-significant covariate was deleted from the regression model one at a time. These included infant 
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birth weight in grams, family history of hypercholesterolemia (yes vs. no), number of previous pregnancies assessed at birth (≥1 vs. 0), maternal 
smoking status during pregnancy (yes vs. no), weight gain during pregnancy in lbs. WV, West Virginia; CI, confidence interval.  
CVD-Cardiovascular Disease; SBP-systolic blood pressure; DBP-diastolic blood pressure; TC-total cholesterol; LDL-low-density lipoprotein 
cholesterol; HDL-high-density lipoprotein; non-HDL-non-high-density lipoprotein cholesterol; cholesterol; TG-triglycerides 
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Supplemental Table Chapter 3 
 
Supplemental Table S1: Maternal and Child Characteristics at Birth and in Fifth Grade using 
merged data from the Birth Score Project (1998-2003) and the CARDIAC Project (2010-2013) 
for All infants  (N=11980) 
 
Variable N Missing  Frequency 
(%)/Mean (SD) 
Sex 11980     
Female     6553 (54.7) 
Male     5427 (45.3) 
Race 11531 449   
Others     729 (6.32) 
White     10802 (93.68) 
Marital Status (at birth) 11980     
Single     3181 (26.55) 
Married     8799 (73.45) 
No. of previous pregnancy  (at birth) 11981     
0     4193 (35) 
≥1     7787 (65) 
Health Insurance of mother (at birth) 11982     
Medicaid     5619 (46.9) 
Non-Medicaid     6361 (53.1) 
Family History of Cholesterol  10166 1814   
No     6940 (68.27) 
Yes     3226 (31.73) 
Family History of CVD 11980     
No     6978 (58.25) 
Yes     5002 (41.75) 
Smoking during Pregnancy 11901 79   
Yes     2960 (24.87) 
No     8941 (75.13) 
No. of Prenatal care visits 11980     
<12     5486 (45.79) 
≥12     6494 (54.21) 
Breastfeeding  7861 4119   
No     4478 (56.96) 
Yes     3383 (43.04) 
Age of Child (years) 11980 0 10.97 (0.47) 
Maternal Age at Birth (years) 11945 35 25.84 (5.54) 
Maternal Education at Birth  11919 61 12.87 (2.12) 
Weight Gain during Pregnancy (lbs) 10907 1073 30.58 (14.67) 
Gestational Age (weeks) 11647 333 38.59 (1.91) 
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Birth Weight (grams) 11975 5 3259.34 (569.19) 
BMI-Percentile 11967 13 72.31 (28.19) 
Child SBP (mmHg) 11741 239 108.44 (11.85) 
Child DBP  (mmHg) 11742 238 67.46 (9.52) 
Child TC (mg/dL) 11133 847 157.87 (27.65) 
Child LDL  (mg/dL) 11114 866 90.06 (24.54) 
Child HDL  (mg/dL) 11133 847 50.18 (12.42) 
Child NON-HDL  (mg/dL) 11133 847 107.69 (28.1) 
Child TG  (mg/dL) 11132 848 92.54 (55.46) 
Child log TG 11132 848 4.38 (0.53) 
Maternal TC  (mg/dL) 127 11853 181.1 (32.81) 
Maternal LDL  (mg/dL) 123 11857 109.0 (27.59) 
Maternal HDL  (mg/dL) 127 11853 51.28 (13.13) 
Maternal NON-HDL  (mg/dL) 127 11853 129.77 (33.24) 
Maternal TG  (mg/dL) 127 11853 106.0 (74.54) 
Maternal log TG 127 11853 4.47 (0.62) 
CVD-Cardiovascular Disease; SBP-systolic blood pressure; DBP-diastolic blood pressure; TC-
total cholesterol; LDL-low-density lipoprotein cholesterol; HDL-high-density lipoprotein; non-
HDL-non-high-density lipoprotein cholesterol; cholesterol; TG-triglycerides 
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Supplemental Table S2: Results of the Independent Sample T-test for the mean difference in blood pressure and lipid levels in both fifth grade 
children who were breastfed vs. not breastfed and mothers who breastfed vs. did not breastfed for all children (both pre-term and full-term) using 
merged data from the Birth Score Project (1998-2003) and the CARDIAC Project (2010-2013) 
 
    Childhood CVD risk factors  Maternal CVD risk factors  
  Breastfed Not 
Breastfed 
Mean 
Difference 
(95% CI) 
P-value Breastfed Not 
Breastfed 
Mean 
Difference 
(95% CI) 
P-value 
SBP  
  
(N) 3286 4357       
Mean (SD) 107.4  
(12.0) 
108.7 
(11.9) 
-1.3 
(-1.8 - -0.8) 
<0.0001     
DBP 
  
(N) 3287 4357       
Mean (SD) 66.4  
(9.6) 
67.2  
(9.6) 
-0.8 
(-1.2 - -0.3) 
0.0005     
TC 
  
(N) 3199 4194   34 25   
Mean (SD) 157.6  
(27.8) 
157.9 
(27.8) 
-0.3 
(-1.6 – 0.6) 
0.5845 180.0 
(33.1) 
186.0 
(39.3) 
-6.0 
(-25.0 – 12.0) 
0.527 
LDL 
  
(N) 3193 4188   34 24   
Mean (SD) 89.3  
(24.6) 
89.4  
(24.7) 
-0.1 
(-1.2 – 1.0) 
0.864 106.5 
(27.0) 
113.0 
(30.7) 
-6.5 
(-21.8 – 8.7) 
0.3961 
HDL 
  
(N) 3199 4194   34 25   
Mean (SD) 51.0  
(12.3) 
50.2  
(12.7) 
0.8 
(0.2 – 1.4) 
0.0066 52.5 
(11.8) 
51.1 
(12.4) 
1.4 
(-4.9 – 7.7) 
0.6593 
Non-HDL 
  
(N) 3199 4194   34 25   
Mean (SD) 106.5  
(28.1) 
107.7 
(28.4) 
-1.2 
(-2.5 – 0.1) 
0.0812 127.5 
(35.3) 
134.9 
(36.1) 
-7.4 
(-26.2 – 11.4) 
0.4327 
Log-TG 
  
(N) 3198 4194   36 25   
Mean (SD) 4.36 
(0.5) 
4.42 
(0.5) 
-0.06 
(-0.08 - -0.04) 
<0.0001 4.4  
(0.7) 
4.5  
(0.7) 
-0.12 
(-0.49 – 0.25) 
0.5152 
CVD-Cardiovascular Disease; SBP-systolic blood pressure; DBP-diastolic blood pressure; TC-total cholesterol; LDL-low-density lipoprotein 
cholesterol; HDL-high-density lipoprotein; non-HDL-non-high-density lipoprotein cholesterol; cholesterol; TG-triglycerides 
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Supplemental Table 3S: Correlation between breastfeeding and maternal and childhood CVD risk 
factors for all infants using merged data from the Birth Score Project (1998-2003) and the 
CARDIAC Project (2010-2013) as well examining the association for maternal variables using 
imputed dataset.  
 
  Childhood  
CVD risk factors 
Maternal 
 CVD risk factors 
Maternal CVD risk 
factors  
(Imputed Dataset) 
  N Correlation 
Coefficient 
r 
P-value N Correlation 
Coefficient 
r 
P-
value 
Correlation 
Coefficient 
r 
P-
value 
BMI 
percentile 
7853 -0.08 <0.0001      
SBP  7643 -0.05 <0.0001      
DBP 7644 -0.04 0.0007      
TC 7393 -0.01 0.496 59 -0.06 0.6276 -0.13 0.2571 
LDL 7381 0.00 0.9336 58 -0.08 0.5323 -0.16 0.1649 
HDL 7393 0.04 0.0013 59 0.05 0.6878 0.07 0.4093 
Non-
HDL 
7393 -0.02 0.0692 59 -0.11 0.4209 -0.16 0.18 
Log-TG 7392 -0.06 <0.0001 59 -0.06 0.6493 -0.08 0.3499 
CVD-Cardiovascular Disease; SBP-systolic blood pressure; DBP-diastolic blood pressure; TC-
total cholesterol; LDL-low-density lipoprotein cholesterol; HDL-high-density lipoprotein; non-
HDL-non-high-density lipoprotein cholesterol; cholesterol; TG-triglycerides 
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Supplemental Table S4: Results of the multiple regression analysis for the association between reported history of breastfeeding and CVD risk 
factors of Fifth-Grade WV Children for All infants (Preterm and Full term) using merged data from the Birth Score Project (1998-2003) and the 
CARDIAC Project (2010-2013) 
 
CVD 
risk 
factors 
 
Model 1 
 
Model 2 
 
Model 3 
  Unstandar
dized 
Regression 
Coefficient 
P-
value 
Standar
dized 
Beta 
R2 Unstandar
dized 
Regression 
Coefficient 
P-
value 
Standar
dized 
Beta 
Adjusted 
R2 
Unstandar
dized 
Regression 
Coefficient 
P-
value 
Stan
dardi
zed 
Beta 
Adjust
ed R2 
SBP  -1.39 0.0001 -0.054 0.003 -0.73 0.0046 -0.031 0.1195 -0.34 0.2042 -0.01 0.132 
DBP -0.75 0.0007 -0.039 0.0015 -0.41 0.0557 -0.021 0.0669     
TC -0.36 0.5845 -0.006 0.000 -0.03 0.9666 0.000 0.0078     
LDL -0.10 0.864 0.002 0.000 0.42 0.4663 0.008 0.0256     
HDL 0.80 0.0066 0.032 0.001 0.17 0.5402 0.007 0.1438     
Non-
HDL 
-1.16 0.0812 -0.020 0.0004 -0.28 0.762 -0.003 0.0657     
Log-TG -0.06 0.0001 -0.059 0.0034 -0.04 0.0015 -0.035 0.1328 -0.03 0.046 -0.02 0.1527 
Variables included in the model: Model 1: All the outcomes were regressed on breastfed variable. Model 2: All the outcomes were regressed on 
breastfed variable and the child's BMI percentile in fifth grade. Model 3: All the outcomes were regressed on breastfed variable and the child's 
BMI percentile and additional covariates. Only covariates that were significant in the Spearman’s correlation were used in the multiple regression 
analysis. Covariates included child's age, gender, race, infant birth weight in grams, maternal education status at birth (1–17 years of education), 
maternal health insurance status at time of delivery (non-Medicaid vs. Medicaid), family history of hypercholesterolemia (yes vs. no), number of 
previous pregnancies assessed at birth (>=1 vs. 0), maternal smoking status during pregnancy (yes vs. no), weight gain during pregnancy in lbs. 
Covariates that were not significant in the Spearman’s correlation and were excluded:  maternal age at birth of the index child, infant birth weight 
in grams, marital status of the mother at birth, number of prenatal care visits. Each non-significant covariate was deleted from the regression model 
one at a time. Variables retained in model for SBP: child's age, maternal education at birth. For TG: Child's age, sex, race, maternal education at 
birth, number of previous pregnancies, and family history of cholesterol. Additionally gestational age was adjusted for but was not significant.  
CVD-Cardiovascular Disease; SBP-systolic blood pressure; DBP-diastolic blood pressure; TC-total cholesterol; LDL-low-density lipoprotein 
cholesterol; HDL-high-density lipoprotein; non-HDL-non-high-density lipoprotein cholesterol; cholesterol; TG-triglycerides 
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Supplemental Table S5: Results of the multiple regression analysis for all the variables in the model to predict Triglyceride of Fifth-Grade WV 
Children for All infants (Preterm and Full term) using merged data from the Birth Score Project (1998-2003) and the CARDIAC Project (2010-
2013)  
  Full Model Covariate Model 
  Unstandardize
d regression 
coefficients 
(95% CI) 
Standa
rdized 
Beta 
t Value P-value Adjust
ed R2 
Unstandardize
d regression 
coefficients 
(95% CI) 
Standar
dized 
Beta 
t 
Value 
P-value Adjust
ed R2 
Intercept 3.33 
(3.02, 3.65) 
0.00 20.82 <0.0001 0.1527 3.184  
(2.928, 3.44) 
0.00 24.38 <0.0001 0.1518 
Age  0.06 
(0.03, 0.08) 
0.05 4.28 <0.0001  0.068  
(0.046, 0.089) 
0.06 6.16 <0.0001  
Gender  
(Male vs. Female) 
-0.11 
(-0.13, -0.08) 
-0.10 -8.50 <0.0001  -0.113  
(-0.133, -0.093) 
-0.11 -11.06 <0.0001  
Race  
(White vs. Others) 
0.14 
(0.09, 0.19) 
0.07 5.72 <0.0001  0.135  
(0.094, 0.176) 
0.06 6.46 <0.0001  
History of 
hypercholesterolemia  
(Yes vs. No) 
0.08 
(0.06, 0.11) 
0.07 6.07 <0.0001  0.08  
(0.058, 0.101) 
0.07 7.29 <0.0001  
Number of Previous 
pregnancies (>=1 vs. 0) 
-0.04 
(-0.06, -0.01) 
-0.03 -2.79 0.0053  -0.031  
(-0.052, -0.011) 
-0.03 -2.94 0.0032  
Maternal education 
(Years) 
-0.01 
(-0.01, -0.003) 
-0.04 -2.94 0.0033  -0.008  
(-0.013, -0.003) 
-0.03 -3.24 0.0012  
BMI percentile  0.01 
(0.01, 0.01) 
0.36 30.22 <0.0001  0.007  
(0.006, 0.007) 
0.35 36.60 <0.0001  
Breastfed  
(Yes vs. No) 
-0.03 
(-0.05, -0.0005) 
-0.02 -2.00 0.0460       
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Only covariates that were significant in the Spearman’s correlation were used in the multiple regression analysis. Covariates included child's age, 
gender, race, infant birth weight in grams, maternal education status at birth (1–17 years of education), maternal health insurance status at time of 
delivery (non-Medicaid vs. Medicaid), family history of hypercholesterolemia (yes vs. no), number of previous pregnancies assessed at birth (>=1 
vs. 0), maternal smoking status during pregnancy (yes vs. no), weight gain during pregnancy in lbs. Covariates that were not significant in the 
Spearman’s correlation and were excluded:  maternal age at birth of the index child, infant birth weight in grams, marital status of the mother at 
birth, No. of prenatal care visits. Each non-significant covariate was deleted from the regression model one at a time. These included infant birth 
weight in grams, family history of hypercholesterolemia (yes vs. no), number of previous pregnancies assessed at birth (>=1 vs. 0), maternal 
smoking status during pregnancy (yes vs. no), weight gain during pregnancy in lbs. WV, West Virginia; CI, confidence interval.  
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Chapter 4 
Table 1: Previous SRs and MA examining the association between childhood obesity and selected adult CVD risk factors  
Authors, year study 
published 
Type of 
study 
design 
 
No. of studies included 
and outcome of interest 
Conclusion 
Park et al., 201238 SR 5 studies for HT107,128-131 
 
Increase in BMI/overweight in childhood was associated with increased risk of 
HT. 2 out of 5 studies that adjusted for adult BMI found no association. The 
review was unable to confirm the presence of long-term health effects of 
childhood obesity independent of its effects on adult BMI. This conclusion was 
not made for HT exclusively but the authors made a general statement.  
Lloyd et al., 201218 SR 5 studies for lipids (TC, 
TG, LDL, and 
HDL)4,116,132-134 
Little evidence that childhood obesity is an independent risk factor for adult 
blood lipid status. 
Lloyd et al., 201037 SR 8 studies for blood 
pressure (SBP and 
DBP)4,107,116,131,133,135-137 
Little evidence that childhood obesity is an independent risk factor for CVD 
risk (SBP and DBP). The relationships observed are dependent on the tracking 
of BMI from childhood to adulthood. 
Reilly et al., 201139 SR 4 studies for 
HT107,131,138,139 
Significant increase in adult HT with overweight and obesity during childhood 
and adolescence. The SR did not mention if the studies included controlled for 
adult weight status.  
Juonala et al., 201140 MA Studies from 4-cohorts-
BHS, MS, CDAH, and 
YFS 
Childhood obesity was significantly associated with HT even after adjustment 
for adult obesity (relative risk, 1.5; 95% CI: 1.1, 2.1; P = 0.009). For 
dyslipidemias, the effect of childhood adiposity was reduced and became non-
significant when adult obesity was taken into account. 
MA-Meta-analysis; SR-Systematic Review; CVD-Cardiovascular Disease; HT-hypertension; SBP-systolic blood pressure; DBP-diastolic blood 
pressure; TC-total cholesterol; TG-triglycerides; LDL-low-density lipoprotein cholesterol; HDL-high-density lipoprotein cholesterol; BHS-
Bogalusa Heart Study; MS-Muscatine Study; CDAH-Childhood Determinants of Adult Health; YFS-Cardiovascular Risk in Young Finns Study 
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Table 2: Item-by-item results using the AMSTAR assessment instrument for previous SRs and MA  
 
Authors Year 1 2 3 4 5* 6 7 8 9 10 11 12 Total score Row 
(%) 
Park et al. 38 2012 SR Yes Yes Yes No Yes Yes Yes No NA Yes Yes 8/10=80% 
Lloyd et al.18 2012 SR Yes Yes Yes No No Yes Yes Yes NA No Yes 7/10=70% 
Lloyd et al.37 2010 SR Yes Yes Yes No No Yes Yes Yes NA No No 6/10=60% 
Reilly et al. 39 2011 SR Yes No Yes No No Yes No No NA No Yes 4/10=40% 
Juonala et al. 40 2011 MA Yes No NA NA NA Yes No Yes Yes NA Yes 5/7=71% 
Total score column (%)   5/5= 
100% 
3/5= 
60% 
4/4= 
100% 
0/4= 
0% 
1/4= 
25% 
5/5= 
100% 
3/5= 
60% 
3/5= 
60% 
1/1= 
100% 
1/4= 
25% 
4/5= 
80% 
 
Note: NA is “Not Applicable” is chosen when item is not relevant. Scores are adjusted for NA responses.  
A Measurement Tool to Assess Systematic Reviews (AMSTAR) instrument: 
1-Type of study design   
2-Was a priori design provided?   
3-Was there duplicate study selection and data extraction?  
4-Was a comprehensive literature search performed?   
5-Was the status of publication (i.e. grey literature) used as an inclusion criterion? * 
6-Was a list of studies (included and excluded) provided?   
7-Were the characteristics of the included studies provided?   
8-Was the scientific quality of the included studies assessed and documented?   
9-Was the scientific quality of the included studies used appropriately in formulating conclusions?   
10-Were the methods used to combine the findings of studies appropriate?   
11-Was the likelihood of publication bias assessed?   
12-Was the conflict of interest included?  
*This question was modified and is asking if the authors included grey literature as their inclusion criteria. ‘Yes’ means they did and ‘No’ means 
they did not.  
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Table 3: Study and participants characteristics:  
Study-cohort 
name 
Study 
start 
year 
Country  Study 
design*  
N 
(Baseline) 
Age 
exposure 
assessed  
Age 
outcome 
assessed 
Exposure Outcome Adj. 
adult 
BMI  
Sex 
Abraham et al., 
1971 (HMS)95 
1923 USA Prospective 
Cohort 
1087 9-12 48 Relative over 
weight 
SBP, 
DBP, TC 
No Male 
Barker et al., 
2005 (HBCS)96 
1934 Finland Retrospective 
longitudinal 
study  
2003 2 – 11 (age 
used in our 
study 2) 
62 BMI SBP, TC, 
TG 
Yes 
(only) 
Overall 
Berkey et al., 
1998 
(LSCHD)97 
1929 USA Prospective 
longitudinal 
study 
67 17 30 BMI SBP No Male 
(this 
study) 
Female  
Eisenmann et 
al., 2005 
(ACLS)98 
1970 USA Longitudinal, 
prospective 
epidemiologi
cal study 
48 16 27 BMI, WC, 
%BF 
SBP, 
DBP, TC, 
HDL, TG 
No Overall 
Freedman et al., 
2001 (BHS)4 
1973 USA Cross panel 
design later 
longitudinal 
component 
2617 
 
10 27 BMI, Triceps 
ST 
SBP, 
DBP, TC, 
LDL, 
HDL, TG 
Yes Overall 
Graversen et 
al., 2014 
(NFBC 1966)99 
1966 Finland Population 
based cohort 
 
4111 
 
2-5 (age used 
in our study 
5) 
31 BMI SBP, 
DBP, 
HDL, TG 
No Overall 
Gustafsson et 
al., 2011 
(NSC)100 
1981 Sweden  Prospective 
cohort study 
1083;  
F=506 
M=577  
16 21 (this 
study), 
30, 43  
BMI SBP, DBP No Male  
Female 
Holland et al., 
1993 
(NSHD)101 
1946 England, 
Wales, 
Scotland  
Prospective 
longitudinal 
study 
3332 at 
birth  
4-7, 11-14 36 BMI 
 
SBP, DBP No Male 
Female 
Kanade et al., 
2011 (CBCI)102 
1979 India Community 
base 
387 3, 15 24 BMI SBP, 
DBP, TG# 
No Male 
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prospective 
cohort study 
Klumbiene et 
al., 2000 
(JHL)103 
 
1977 Lithuania 
 
Longitudinal 
cohort 
 
505 
M=217 
F=288 
12-13 32-33 BMI, Triceps 
ST, Sub-
scapular ST 
SBP, DBP No Male  
Female 
Kneisley et al., 
1990 (BPS-
TM)104 
1959 USA Retrospective 
Cohort Study 
 
576  
M=271 
F= 305 
7 32 Sub-scapular 
ST 
SBP No Male  
Female 
Koziel et al., 
2011 (WGS)105 
1961 
 
Poland Longitudinal 
Study 
M=124 
F= 139 
8, 9, 10, 11, 
12, 13, 14, 
15, 16, 17, 18 
50 BMI SBP Yes 
(only) 
Male  
Female 
Lauer et al., 
1993 (MS)106 
1971 USA Longitudinal 
Cohort 
M=677 
F= 748 
 
M=492 
F= 528 
7-8, 9-10, 11-
12, 13-14, 
15-16, 17-18:  
13-14, 15-16, 
17-18 
20 – 25,  
26 – 30 
 
BMI SBP, DBP No Male  
Female 
Li et al., 2007 
(BBC- 1958)107 
1958 England, 
Wales 
and 
Scotland 
Longitudinal, 
Birth Cohort 
 
9297 7, 11, 16 33, 45 
(this 
study) 
BMI SBP, DBP Yes Overall 
Liddle et al., 
2012 
(MUSP)108 
1981 Australia 
 
Longitudinal 
Birth Cohort 
study 
1755 5 21 BMI, Triceps 
ST 
SBP, DBP No Overall 
Lyngdoh et al., 
2013 
(SCDC)109 
1989 Seychelle
s  
Longitudinal 
cohort 
 
390 
M=175 
F=215 
12-15 19-20 BMI SBP, 
DBP, 
LDL, 
HDL, TG 
Yes Overall 
Male 
Female 
Miura et al., 
2001 (YAJS)110 
1965 Japan 20-year FU 
data using 
record 
linkage of a 
Birth cohort 
M=2198 
F= 2428 
3 20 BMI SBP, 
DBP, TC 
No Male 
Female 
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Pereira et al., 
2013 (BBC- 
1958)111 
1958 England, 
Wales 
and 
Scotland 
Large 
Population 
based Birth 
Cohort 
M=3927 
F=3897 
7, 11, 16 23, 33, 
42, 45 
BMI TC, LDL, 
HDL, TG, 
non-HDL 
No Male 
Female 
Porkka et al., 
1994 (YFS)112 
1980 Finland Longitudinal 
Cohort 
3596 3-9, 12-18 
(this study) 
24-30 BMI, Sub-
scapular ST 
TC, LDL, 
HDL, TG 
No Male 
Female 
Schmidt et al., 
2011 (ASHFS-
CDAHS)113 
1985 Australia Prospective 
cohort study 
 
2188 7-15 26-32 BMI, WC, 
WHR, weight 
to height 
ratio, sum ST 
SBP, 
DBP, 
HDL, TG 
No Overall 
Skidmore et al., 
2007 
(NSHD)114 
1946 England, 
Wales 
and 
Scotland 
Prospective 
longitudinal 
birth cohort 
study 
5362 
births 
(2311 for 
the 
analysis) 
2, 4, 7, 11, 15 53 BMI TC, LDL, 
HDL 
No Overall 
Weitz et al., 
2014 (LS-Mid-
TC)115 
1966 Six 
Solomon 
Island  
Longitudinal 
 
540 
M=169 
F=219 
0-5, 6-11, 12-
19 (6-11, 12-
19 for this 
study) 
25 BMI, Sub-
scapular ST 
TC, TG No Male 
Female 
Wright et al., 
2001 
(NTFCS)116 
1947 UK Prospective 
birth cohort  
1142 at 
birth, 2/3rd 
followed 
till age 15 
9, 13 50  SBP, 
DBP, TC, 
LDL, 
HDL, TG 
Yes Male 
Female 
CVD-Cardiovascular Disease; SBP-systolic blood pressure; DBP-diastolic blood pressure; TC-total cholesterol; LDL-low-density lipoprotein 
cholesterol; HDL-high-density lipoprotein; non-HDL-non-high-density lipoprotein cholesterol; cholesterol; TG-triglycerides; BMI-body mass 
index; WC-waist circumference; WHR-waist to hip ratio; ST-skinfold thickness; BF-body fat; M-male; F-female; USA-United States of America; 
UK-United Kingdom; FU- follow up; HMS-Hagerstown Morbidity Study; LSCHD-Longitudinal Study of Child Health and Development; HBCS-
Helsinki Birth Cohort Study; ACLS-Aerobics Center Longitudinal Study; BHS-Bogalusa Heart Study; NSC-Northern Swedish Cohort; NFBC 
1966- Northern Finland Birth Cohort 1966 Study; NSHD-Medical Research Council National Survey of Health and Development; CBCI-
Community Based Cohort study India; JHL-Study of Juvenile Hypertension in Lithuania; BPS-TM-Blood Pressure Study in Tecumseh, Michigan; 
WGS-Wroclaw Growth Study; MS- The Muscatine Study; BBC 1958-British Birth Cohort 1958; MUSP-The Mater-University of Queensland 
Study of Pregnancy (MUSP); SCDC-Seychelles Child Development Study; YAJS- Young Adult Japanese Study; YFS-Cardiovascular Risk in 
Young Finns; ASHFS-CDAHS-Australian Schools Health and Fitness Survey-Childhood Determinants of Adult Health Study; NSHD-Medical 
Research Council National Survey of Health and Development; LS-Mid-TC-Longitudinal Study of the Mid-20th Century; NTFCS-Thousand 
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Families Cohort Study 
Holland et al., 1993 and Pereira et al., 2013 were not included in the meta-analysis.  
#Kanade et al., 2011-TG could not be used for meta-analysis because the study’s main outcome was blood pressure and there was not enough 
information provided for TG to calculate an effects size. 
*Terminologies used by the authors  
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Table 4: Changes in primary outcomes using any definition for adiposity  
 
Variable  Studies (#) Participants (#) Zr (95% CI) Q (P) I2 (%) 95% PI 
SBP  16 27487 0.11 (0.07, 0.14) 162.44  (<0.001) 90.77 -0.03, 0.23 
SBP (adjusted) 6 15156 -0.13 (-0.18, -0.07) 43.05 (<0.001) 88.39 -0.31, 0.01 
DBP  14 27153 0.11 (0.07, 0.14) 135.95 (<0.001) 90.44 -0.01, 0.23 
DBP (adjusted) 5 13356 -0.11 (-0.17, -0.04) 51.75 (<0.001) 92.27 -0.37, 0.06 
TC  8 10420 0.01 (-0.05, 0.06) 79.69 (<0.001) 91.22 -0.16, 0.18 
TC (adjusted) 4 7272 -0.06 (-0.12, 0.01) 21.72 (<0.001) 86.19 -0.32, 0.19 
LDL  5 5462 0.02 (-0.06, 0.10) 63.07 (<0.001) 93.66 -0.25, 0.27 
LDL (adjusted) 3 3365 -0.08 (-0.12, -0.05) 0.25 (0.879) 0 -0.08, -0.08 
HDL  8 7915 -0.06 (-0.10, -0.02) 57.22 (<0.001) 87.77 -0.18, 0.06 
HDL (adjusted) 4 5854 0.04 (-0.08, 0.15) 51.65  (<0.001) 86.44 -0.47, 0.47 
TG  8 5919 0.08 (0.03, 0.13) 42.0 (<0.001) 83.33 -0.05, 0.25 
TG (adjusted) 5 5854 -0.08 (-0.19, 0.02) 76.20 (<0.001) 94.75 -0.39, 0.31 
SBP-systolic blood pressure; DBP-diastolic blood pressure; TC-total cholesterol; LDL-low-density lipoprotein cholesterol; HDL-high-density 
lipoprotein; non-HDL-non-high-density lipoprotein cholesterol; cholesterol; TG-triglycerides; 
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Table 5: Changes in primary outcomes using BMI measures only for the childhood exposure 
 
Variable  
Studies   
(#) Zr (95% CI) Q (P) I2 (%) 95% PI 
SBP  14 0.10 (0.06, 0.13) 97.56  (<0.001) 86.68 0, 0.23 
DBP  13 0.11 (0.07, 0.14) 100.19 (<0.001) 88.02 0, 0.24 
TC  7 0.01 (-0.05, 0.07) 54.28 (<0.001) 88.95 -0.17, 0.16 
LDL  5 0.02 (-0.06, 0.10) 63.07 (<0.001) 93.66 -0.28, 0.28 
HDL  8 -0.06 (-0.11, -0.01) 39.61 (<0.001) 82.33 -0.19, 0.09 
TG  7 0.10 (0.02, 0.17) 42.0 (<0.001) 83.33 -0.13, 0.34 
SBP-systolic blood pressure; DBP-diastolic blood pressure; TC-total cholesterol; LDL-low-
density lipoprotein cholesterol; HDL-high-density lipoprotein; non-HDL-non-high-density 
lipoprotein cholesterol; cholesterol; TG-triglycerides. 
All the studies that used that adjusted for adult BMI used BMI as the exposure during childhood. 
The results of the adjusted analysis are same as in table 4. 
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Figures 
Chapter 4 
 
 
Figure 1: Flow diagram for the selection of studies 
 
SBP-systolic blood pressure; DBP-diastolic blood pressure; TC-total cholesterol; LDL-low-
density lipoprotein cholesterol; HDL-high-density lipoprotein; non-HDL-non-high-density 
lipoprotein cholesterol; cholesterol; TG-triglycerides. 
Non-HDL was not analyzed because there were less than 3 studies to pool. 
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Figure 2: Risk of bias assessment using STROBE instrument for each study  
 
 
STROBE-Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) 
consists of a checklist of 22 items related to the title, abstract, introduction, methods, results and 
discussion sections of the articles. Each study was assessed for the items. NA is “Not Applicable” 
is chosen when item is not relevant. Scores are adjusted for NA responses. The STROBE 
checklist is available at: http://strobe-statement.org/index.php?id=available-checklists 
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Figure 3. Forest plot for the association between childhood obesity and adult SBP  
 
 
The common metric for the effect size for each study is the Fisher’s r to z transformation of the 
correlation statistics. The vertical lines represent the represent the Fishers Zr while the left and 
right extremes of the vertical lines represent the corresponding 95% CI. The middle of the black 
diamond represents the overall Fishers Zr while the left and right extremes of the diamond 
represent the corresponding 95%CI. Combined measures represent those studies in which male 
and female were combined, or different age cohorts from each study were combines, or multiple 
readings from the same cohort were combined or one study using more than one exposure 
definition.  
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Figure 4. Forest plot for the association between childhood obesity and adult SBP (adjusted 
for adult BMI) 
 
The common metric for the effect size for each study is the Fisher’s r to z transformation of the 
correlation statistics. The vertical lines represent the represent the Fishers Zr while the left and 
right extremes of the vertical lines represent the corresponding 95% CI. The middle of the black 
diamond represents the overall Fishers Zr while the left and right extremes of the diamond 
represent the corresponding 95%CI. Combined measures represent those studies in which male 
and female were combined, or different age cohorts from each study were combines, or multiple 
readings from the same cohort were combined or one study using more than one exposure 
definition.  
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Figure 5. Forest plot for the association between childhood obesity and adult DBP  
 
The common metric for the effect size for each study is the Fisher’s r to z transformation of the 
correlation statistics. The vertical lines represent the represent the Fishers Zr while the left and 
right extremes of the vertical lines represent the corresponding 95% CI. The middle of the black 
diamond represents the overall Fishers Zr while the left and right extremes of the diamond 
represent the corresponding 95%CI. Combined measures represent those studies in which male 
and female were combined, or different age cohorts from each study were combines, or multiple 
readings from the same cohort were combined or one study using more than one exposure 
definition.  
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Figure 6. Forest plot for the association between childhood obesity and adult DBP (adjusted 
for adult BMI) 
 
 
 
The common metric for the effect size for each study is the Fisher’s r to z transformation of the 
correlation statistics. The vertical lines represent the represent the Fishers Zr while the left and 
right extremes of the vertical lines represent the corresponding 95% CI. The middle of the black 
diamond represents the overall Fishers Zr while the left and right extremes of the diamond 
represent the corresponding 95%CI. Combined measures represent those studies in which male 
and female were combined, or different age cohorts from each study were combines, or multiple 
readings from the same cohort were combined or one study using more than one exposure 
definition.  
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Figure 7. Forest plot for the association between childhood obesity and adult TC 
 
  
The common metric for the effect size for each study is the Fisher’s r to z transformation of the 
correlation statistics. The vertical lines represent the represent the Fishers Zr while the left and 
right extremes of the vertical lines represent the corresponding 95% CI. The middle of the black 
diamond represents the overall Fishers Zr while the left and right extremes of the diamond 
represent the corresponding 95%CI. Combined measures represent those studies in which male 
and female were combined, or different age cohorts from each study were combines, or multiple 
readings from the same cohort were combined or one study using more than one exposure 
definition.  
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Figure 8. Forest plot for the association between childhood obesity and adult TC (adjusted 
for adult BMI) 
 
 
The common metric for the effect size for each study is the Fisher’s r to z transformation of the 
correlation statistics. The vertical lines represent the represent the Fishers Zr while the left and 
right extremes of the vertical lines represent the corresponding 95% CI. The middle of the black 
diamond represents the overall Fishers Zr while the left and right extremes of the diamond 
represent the corresponding 95%CI. Combined measures represent those studies in which male 
and female were combined, or different age cohorts from each study were combines, or multiple 
readings from the same cohort were combined or one study using more than one exposure 
definition.  
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Figure 9. Forest plot for the association between childhood obesity and adult LDL 
 
 
 
The common metric for the effect size for each study is the Fisher’s r to z transformation of the 
correlation statistics. The vertical lines represent the represent the Fishers Zr while the left and 
right extremes of the vertical lines represent the corresponding 95% CI. The middle of the black 
diamond represents the overall Fishers Zr while the left and right extremes of the diamond 
represent the corresponding 95%CI. Combined measures represent those studies in which male 
and female were combined, or different age cohorts from each study were combines, or multiple 
readings from the same cohort were combined or one study using more than one exposure 
definition.  
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Figure 10. Forest plot for the association between childhood obesity and adult LDL 
(adjusted for adult BMI) 
 
 
 
The common metric for the effect size for each study is the Fisher’s r to z transformation of the 
correlation statistics. The vertical lines represent the represent the Fishers Zr while the left and 
right extremes of the vertical lines represent the corresponding 95% CI. The middle of the black 
diamond represents the overall Fishers Zr while the left and right extremes of the diamond 
represent the corresponding 95%CI. Combined measures represent those studies in which male 
and female were combined, or different age cohorts from each study were combines, or multiple 
readings from the same cohort were combined or one study using more than one exposure 
definition.  
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Figure 11. Forest plot for the association between childhood obesity and adult HDL 
 
 
 
The common metric for the effect size for each study is the Fisher’s r to z transformation of the 
correlation statistics. The vertical lines represent the represent the Fishers Zr while the left and 
right extremes of the vertical lines represent the corresponding 95% CI. The middle of the black 
diamond represents the overall Fishers Zr while the left and right extremes of the diamond 
represent the corresponding 95%CI. Combined measures represent those studies in which male 
and female were combined, or different age cohorts from each study were combines, or multiple 
readings from the same cohort were combined or one study using more than one exposure 
definition.  
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Figure 12. Forest plot for the association between childhood obesity and adult HDL 
(adjusted for adult BMI) 
 
 
The common metric for the effect size for each study is the Fisher’s r to z transformation of the 
correlation statistics. The vertical lines represent the represent the Fishers Zr while the left and 
right extremes of the vertical lines represent the corresponding 95% CI. The middle of the black 
diamond represents the overall Fishers Zr while the left and right extremes of the diamond 
represent the corresponding 95%CI. Combined measures represent those studies in which male 
and female were combined, or different age cohorts from each study were combines, or multiple 
readings from the same cohort were combined or one study using more than one exposure 
definition.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 175
Figure 13. Forest plot for the association between childhood obesity and adult TG  
 
 
 
The common metric for the effect size for each study is the Fisher’s r to z transformation of the 
correlation statistics. The vertical lines represent the represent the Fishers Zr while the left and 
right extremes of the vertical lines represent the corresponding 95% CI. The middle of the black 
diamond represents the overall Fishers Zr while the left and right extremes of the diamond 
represent the corresponding 95%CI. Combined measures represent those studies in which male 
and female were combined, or different age cohorts from each study were combines, or multiple 
readings from the same cohort were combined or one study using more than one exposure 
definition.  
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Figure 14. Forest plot for the association between childhood obesity and adult TG (adjusted 
for adult BMI) 
 
The common metric for the effect size for each study is the Fisher’s r to z transformation of the 
correlation statistics. The vertical lines represent the represent the Fishers Zr while the left and 
right extremes of the vertical lines represent the corresponding 95% CI. The middle of the black 
diamond represents the overall Fishers Zr while the left and right extremes of the diamond 
represent the corresponding 95%CI. Combined measures represent those studies in which male 
and female were combined, or different age cohorts from each study were combines, or multiple 
readings from the same cohort were combined or one study using more than one exposure 
definition.  
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Additional Files 
Chapter 4 
 
Additional File 1- Search Strategy for Databases (June 5, 2015) 
PubMed Database Search:  
 
Web of Science Database Search  
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Scopus Database Search  
 
 
Search Strategy for Databases (February 2, 2015) to find existing systematic reviews and meta-
analysis on the topic: 
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Additional file 2: List of excluded studies with reasons.  
Approximately 5000 citations 
Available upon request: Contact amnaumer@gmail.com 
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Additional file 3: Strobe Checklist 
 
STROBE items 
1 
(a) 
1 
(b) 
2 3 4 5 6 (a) 
6 
(b) 
7 8 9 10 11 
12 
(a) 
12 
(b) 
12 
('c) 
12 
(d) 
Abraham et al., 1971 
H H L L L L L NA L L L L L H L H L 
Berkey et al., 1998 
L L L L L L H NA L L H H H L H H H 
Barker et al., 2005 
L L L L L L L NA L L H L H L L H H 
Eisenmann JC et al., 
2005 L L L L L L L NA L L H L L L L H H 
Freedman DS et al., 
2001 L L L L L L L NA L L H L L L L H H 
Gustafsson et al., 
2011 L L L L L L L NA L L L L L L L L L 
Graversen et al, 2014 
L L L L L L L NA L L H L L L L H H 
Holland et al., 1993 
L L L L L L L NA L L L L L H H L H 
Kanade et al., 2011 
L L L L L L L NA L L H L L H H H H 
Klumbiene et al., 
2000 L L L L L L L NA L L H L L L L H H 
Kneisley et al., 1990 
H L H L H H L NA UN H H L L H H H H 
Koziel et al., 2011 
L L L L L L H NA L L H UN L L H H H 
Lauer et al., 1993 
H H L L L L L NA L L L L L L L H H 
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Li et al., 2007 
L L L L L L L NA L L H L L L L H H 
Liddle et al., 2012 
L L L L L L L NA L L L L L UN H H L 
Lyngdoh et al., 2013 
L L L L L L L NA L L H L L L L L H 
Miura et al., 2001 
L L L L L L L NA L L H L UN L L H UN 
Pereira et al., 2013 
L L L L L L L NA L L L L L L L L H 
Porkka et al., 1994 
L L L L L L L NA L H H L H L L H H 
Schmidt et al., 2011 
L L L L L L L NA L L H L L L L H L 
Skidmore et al., 2007 
L L L L L L L NA L L H UN L L L H H 
Weitz et al., 2014 
L L L L L L L NA L L H L L L L H H 
Wright et al., 2001 
L L L L L L L NA H H H L L L L H H 
 STROBE items 
12 
(e) 
13 
(a) 
13 
(b) 
13 
('c) 
14 
(a) 
14 
(b) 
14 
('c) 
15 
16 
(a) 
16 
(b) 
16 
('c) 
17 18 19 20 21 22 
Abraham et al., 1971 
H L H H H L L L L L H H L H L UN H 
Berkey et al. , 1998 
H L H H L L L L L L NA L L L L H L 
Barker et al. , 2005 
H H H H L H L L L L NA L L UN L L L 
Eisenmann JC et al., 
2005 H L H H L H L L H L NA H L L L L L 
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Freedman DS et al., 
2001 H L UN H L H L L L L NA L L L L L L 
Gustafsson et al., 
2011 H L L H L L L L L L NA L L L L L H 
Graversen et al, 2014 
L L L L L L L L L L H L L L L L L 
Holland et al., 1993 
H H H H H H H H L L L L L L L L H 
Kanade et al., 2011 
H H H H L L H H H L H L L H L L L 
Klumbiene et al., 
2000 H H H H H L L L L L NA L L H L UN H 
Kneisley et al., 1990 
H H H H H H H H H L NA L L H L L L 
Koziel et al., 2011 
H H H H H H H L H NA NA H L H L L L 
Lauer et al., 1993 
L H H H H H H L L L H L L H L L L 
Li et al., 2007 L L H H L L H L L L NA L L L L L L 
Liddle et al., 2012 
H H H H L H H L L L H H L L L L L 
Lyngdoh et al., 2013 
L L H H L H H L L L H L L L L L L 
Miura et al., 2001 
H L H H H H L L L NA NA L L L L L L 
Pereira et al., 2013 
L L H H H L H L L L NA L L L L L L 
Porkka et al., 1994 
H L H H H L L H UN NA NA L L H L L L 
 183
Schmidt et al., 2011 
H L H H H L L L L L H L L L L L L 
Skidmore et al., 2007 
L H L H H L L L L NA NA L L L L L L 
Weitz et al., 2014 
H L L H H L L L L NA NA L L L L L H 
Wright et al., 2001 
H H L H H H H H L NA NA L L L L L L 
NA-Not Applicable 
L- Low Risk  
H- High Risk  
UN- Unclear 
 
STROBE Statement—checklist of items that should be included in reports of observational studies 
 
1 a. Indicate the study’s design with a commonly used term in the title or the abstract 
1 b. Provide in the abstract an informative and balanced summary of what was done and what was found 
2. Explain the scientific background and rationale for the investigation being reported 
3. State specific objectives, including any pre-specified hypotheses 
4. Present key elements of study design early in the paper 
5. Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data collection 
6 a. Give the eligibility criteria, and the sources and methods of selection of participants. Describe methods of follow-up 
6 b. For matched studies, give matching criteria and number of exposed and unexposed-Not Applicable for any study therefore this item is not 
shown in the figure below 
7. Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicable 
8. For each variable of interest, give sources of data and details of methods of assessment. Describe comparability of assessment methods if there 
is more than one group 
9. Describe any efforts to address potential sources of bias 
10. Explain how the study size was arrived at.  
11. Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and why 
12 a. Describe all statistical methods, including those used to control for confounding 
12 b. Describe any methods used to examine subgroups and interactions 
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12 c. Explain how missing data were addressed 
12 d. Cohort study—If applicable, explain how loss to follow-up was addressed 
12 e. Describe any sensitivity analyses 
13 a. Report numbers of individuals at each stage of study 
13 b. Give reasons for non-participation at each stage 
13 c. Consider use of a flow diagram 
14 a. Give characteristics of study participants 
14 b. Indicate numbers of participants with missing data for each variable of interest 
14 c. Summaries follow-up time 
15. Report numbers of outcome events or summary measures over time 
16 a. Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision. Make clear which confounders were adjusted 
for and why they were included 
16 b. Report category boundaries when continuous variables were categorized 
16 c. If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time period 
17. Report other analyses done—eg analyses of subgroups and interactions, and sensitivity analyses 
18. Summaries key results with reference to study objectives 
19. Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any 
potential bias 
20. Give a cautious overall interpretation of results considering objectives, limitations, and multiplicity of analyses, results from similar studies, 
and other relevant evidence 
21. Discuss the generalizability (external validity) of the study results 
22. Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article 
is based 
 
 
 
 
 
Risk of Bias Assessment: 
Figure: Risk of bias assessment for each item of the STROBE instrument 
 185
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
1 (a)
1 (b)
2
3
4
5
6
7
8
9
10
11
12 (a)
12 (b)
12 ('c)
12 (d)
12 (e)
13 (a)
13 (b)
13 ('c)
14 (a)
14 (b)
14 ('c)
15
16 (a)
16 (b)
16 ('c)
17
18
19
20
21
22
LOW RISK HIGH RISK UNCLEAR
 186
 
Additional File 4: 
 
Influence meta-analysis, Cumulative meta-analysis and Funnel plots 
 
 
Influence Analysis 
 
Figure 1a. Influence analysis for the association between childhood obesity and adult SBP  
 
 
 
Influence analysis for point estimate changes in SBP with each corresponding study deleted from 
the model once. The vertical lines represent the represent the Fishers Zr while the left and right 
extremes of the squares represent the corresponding 95% confidence intervals. The middle of the 
black diamond represents the overall mean difference while the left and right extremes of the 
diamond represent the corresponding 95% confidence intervals. Results are ordered from smallest 
to largest reductions. Combined measures represent those studies in which male and female were 
combined, or different age cohorts from each study were combines, or multiple readings from the 
same cohort were combined or one study using more than one exposure definition. 
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Figure 1b. Influence analysis for the association between childhood obesity and adult SBP 
adjusted for adult BMI 
 
 
Influence analysis for point estimate changes in SBP with each corresponding study deleted from 
the model once. The vertical lines represent the represent the Fishers Zr while the left and right 
extremes of the squares represent the corresponding 95% confidence intervals. The middle of the 
black diamond represents the overall mean difference while the left and right extremes of the 
diamond represent the corresponding 95% confidence intervals. Results are ordered from smallest 
to largest reductions. Combined measures represent those studies in which male and female were 
combined, or different age cohorts from each study were combines, or multiple readings from the 
same cohort were combined or one study using more than one exposure definition. 
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Figure 2a. Influence analysis for the association between childhood obesity and adult DBP  
 
 
Influence analysis for point estimate changes in DBP with each corresponding study deleted from 
the model once. The vertical lines represent the represent the Fishers Zr while the left and right 
extremes of the squares represent the corresponding 95% confidence intervals. The middle of the 
black diamond represents the overall mean difference while the left and right extremes of the 
diamond represent the corresponding 95% confidence intervals. Results are ordered from smallest 
to largest reductions. Combined measures represent those studies in which male and female were 
combined, or different age cohorts from each study were combines, or multiple readings from the 
same cohort were combined or one study using more than one exposure definition. 
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Figure 2b. Influence analysis for the association between childhood obesity and adult DBP 
adjusted for adult BMI 
 
 
Influence analysis for point estimate changes in DBP with each corresponding study deleted from 
the model once. The vertical lines represent the represent the Fishers Zr while the left and right 
extremes of the squares represent the corresponding 95% confidence intervals. The middle of the 
black diamond represents the overall mean difference while the left and right extremes of the 
diamond represent the corresponding 95% confidence intervals. Results are ordered from smallest 
to largest reductions. Combined measures represent those studies in which male and female were 
combined, or different age cohorts from each study were combines, or multiple readings from the 
same cohort were combined or one study using more than one exposure definition. 
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Figure 3a. Influence analysis for the association between childhood obesity and adult TC  
 
Influence analysis for point estimate changes in TC with each corresponding study deleted from 
the model once. The vertical lines represent the represent the Fishers Zr while the left and right 
extremes of the squares represent the corresponding 95% confidence intervals. The middle of the 
black diamond represents the overall mean difference while the left and right extremes of the 
diamond represent the corresponding 95% confidence intervals. Results are ordered from smallest 
to largest reductions. Combined measures represent those studies in which male and female were 
combined, or different age cohorts from each study were combines, or multiple readings from the 
same cohort were combined or one study using more than one exposure definition. 
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Figure 3b. Influence analysis for the association between childhood obesity and adult TC 
adjusted for adult BMI 
 
 
Influence analysis for point estimate changes in TC with each corresponding study deleted from 
the model once. The vertical lines represent the represent the Fishers Zr while the left and right 
extremes of the squares represent the corresponding 95% confidence intervals. The middle of the 
black diamond represents the overall mean difference while the left and right extremes of the 
diamond represent the corresponding 95% confidence intervals. Results are ordered from smallest 
to largest reductions. Combined measures represent those studies in which male and female were 
combined, or different age cohorts from each study were combines, or multiple readings from the 
same cohort were combined or one study using more than one exposure definition. 
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Figure 4a. Influence analysis for the association between childhood obesity and adult LDL  
 
 
Influence analysis for point estimate changes in LDL with each corresponding study deleted from 
the model once. The vertical lines represent the represent the Fishers Zr while the left and right 
extremes of the squares represent the corresponding 95% confidence intervals. The middle of the 
black diamond represents the overall mean difference while the left and right extremes of the 
diamond represent the corresponding 95% confidence intervals. Results are ordered from smallest 
to largest reductions. Combined measures represent those studies in which male and female were 
combined, or different age cohorts from each study were combines, or multiple readings from the 
same cohort were combined or one study using more than one exposure definition. 
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Figure 4b. Influence analysis for the association between childhood obesity and adult LDL 
adjusted for adult BMI 
 
 
Influence analysis for point estimate changes in LDL with each corresponding study deleted from 
the model once. The vertical lines represent the represent the Fishers Zr while the left and right 
extremes of the squares represent the corresponding 95% confidence intervals. The middle of the 
black diamond represents the overall mean difference while the left and right extremes of the 
diamond represent the corresponding 95% confidence intervals. Results are ordered from smallest 
to largest reductions. Combined measures represent those studies in which male and female were 
combined, or different age cohorts from each study were combines, or multiple readings from the 
same cohort were combined or one study using more than one exposure definition. 
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Figure 5a. Influence analysis for the association between childhood obesity and adult HDL  
 
 
Influence analysis for point estimate changes in HDL with each corresponding study deleted from 
the model once. The vertical lines represent the represent the Fishers Zr while the left and right 
extremes of the squares represent the corresponding 95% confidence intervals. The middle of the 
black diamond represents the overall mean difference while the left and right extremes of the 
diamond represent the corresponding 95% confidence intervals. Results are ordered from smallest 
to largest reductions. Combined measures represent those studies in which male and female were 
combined, or different age cohorts from each study were combines, or multiple readings from the 
same cohort were combined or one study using more than one exposure definition. 
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Figure 5b. Influence analysis for the association between childhood obesity and adult HDL 
adjusted for adult BMI 
 
 
Influence analysis for point estimate changes in HDL with each corresponding study deleted from 
the model once. The vertical lines represent the represent the Fishers Zr while the left and right 
extremes of the squares represent the corresponding 95% confidence intervals. The middle of the 
black diamond represents the overall mean difference while the left and right extremes of the 
diamond represent the corresponding 95% confidence intervals. Results are ordered from smallest 
to largest reductions. Combined measures represent those studies in which male and female were 
combined, or different age cohorts from each study were combines, or multiple readings from the 
same cohort were combined or one study using more than one exposure definition. 
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Figure 6a. Influence analysis for the association between childhood obesity and adult TG  
 
 
Influence analysis for point estimate changes in TG with each corresponding study deleted from 
the model once. The vertical lines represent the represent the Fishers Zr while the left and right 
extremes of the squares represent the corresponding 95% confidence intervals. The middle of the 
black diamond represents the overall mean difference while the left and right extremes of the 
diamond represent the corresponding 95% confidence intervals. Results are ordered from smallest 
to largest reductions. Combined measures represent those studies in which male and female were 
combined, or different age cohorts from each study were combines, or multiple readings from the 
same cohort were combined or one study using more than one exposure definition. 
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Figure 6b. Influence analysis for the association between childhood obesity and adult TG 
adjusted for adult BMI 
 
 
Influence analysis for point estimate changes in TG with each corresponding study deleted from 
the model once. The vertical lines represent the represent the Fishers Zr while the left and right 
extremes of the squares represent the corresponding 95% confidence intervals. The middle of the 
black diamond represents the overall mean difference while the left and right extremes of the 
diamond represent the corresponding 95% confidence intervals. Results are ordered from smallest 
to largest reductions. Combined measures represent those studies in which male and female were 
combined, or different age cohorts from each study were combines, or multiple readings from the 
same cohort were combined or one study using more than one exposure definition. 
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Cumulative Meta-Analysis:  
 
 
Figure 1a. Cumulative meta-analysis for the association between childhood obesity and 
adult SBP  
 
 
Cumulative meta-analysis, ordered by the year the study started. The vertical lines represent the 
represent the Fishers Zr while the left and right extremes of the vertical lines represent the 
corresponding 95% confidence intervals. The results of each corresponding study are pooled with 
all studies preceding it. The middle of the black diamond represents the overall Fishers Zr while 
the left and right extremes of the diamond represent the corresponding 95% confidence intervals. 
Combined measures represent those studies in which male and female were combined, or 
different age cohorts from each study were combines, or multiple readings from the same cohort 
were combined or one study using more than one exposure definition. 
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Figure 1b. Cumulative meta-analysis for the association between childhood obesity and 
adult SBP adjusted for adult BMI 
 
Cumulative meta-analysis, ordered by the year the study started. The vertical lines represent the 
represent the Fishers Zr while the left and right extremes of the vertical lines represent the 
corresponding 95% confidence intervals. The results of each corresponding study are pooled with 
all studies preceding it. The middle of the black diamond represents the overall Fishers Zr while 
the left and right extremes of the diamond represent the corresponding 95% confidence intervals. 
Combined measures represent those studies in which male and female were combined, or 
different age cohorts from each study were combines, or multiple readings from the same cohort 
were combined or one study using more than one exposure definition. 
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Figure 2a. Cumulative meta-analysis for the association between childhood obesity and 
adult DBP 
 
Cumulative meta-analysis, ordered by the year the study started. The vertical lines represent the 
represent the Fishers Zr while the left and right extremes of the vertical lines represent the 
corresponding 95% confidence intervals. The results of each corresponding study are pooled with 
all studies preceding it. The middle of the black diamond represents the overall Fishers Zr while 
the left and right extremes of the diamond represent the corresponding 95% confidence intervals. 
Combined measures represent those studies in which male and female were combined, or 
different age cohorts from each study were combines, or multiple readings from the same cohort 
were combined or one study using more than one exposure definition. 
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Figure 2b. Cumulative meta-analysis for the association between childhood obesity and 
adult DBP adjusted for adult BMI 
 
 
Cumulative meta-analysis, ordered by the year the study started. The vertical lines represent the 
represent the Fishers Zr while the left and right extremes of the vertical lines represent the 
corresponding 95% confidence intervals. The results of each corresponding study are pooled with 
all studies preceding it. The middle of the black diamond represents the overall Fishers Zr while 
the left and right extremes of the diamond represent the corresponding 95% confidence intervals. 
Combined measures represent those studies in which male and female were combined, or 
different age cohorts from each study were combines, or multiple readings from the same cohort 
were combined or one study using more than one exposure definition. 
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Figure 3a. Cumulative meta-analysis for the association between childhood obesity and 
adult TC  
 
Cumulative meta-analysis, ordered by the year the study started. The vertical lines represent the 
represent the Fishers Zr while the left and right extremes of the vertical lines represent the 
corresponding 95% confidence intervals. The results of each corresponding study are pooled with 
all studies preceding it. The middle of the black diamond represents the overall Fishers Zr while 
the left and right extremes of the diamond represent the corresponding 95% confidence intervals. 
Combined measures represent those studies in which male and female were combined, or 
different age cohorts from each study were combines, or multiple readings from the same cohort 
were combined or one study using more than one exposure definition. 
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Figure 3b. Cumulative meta-analysis for the association between childhood obesity and 
adult TC adjusted for adult BMI 
 
Cumulative meta-analysis, ordered by the year the study started. The vertical lines represent the 
represent the Fishers Zr while the left and right extremes of the vertical lines represent the 
corresponding 95% confidence intervals. The results of each corresponding study are pooled with 
all studies preceding it. The middle of the black diamond represents the overall Fishers Zr while 
the left and right extremes of the diamond represent the corresponding 95% confidence intervals. 
Combined measures represent those studies in which male and female were combined, or 
different age cohorts from each study were combines, or multiple readings from the same cohort 
were combined or one study using more than one exposure definition. 
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Figure 4a. Cumulative meta-analysis for the association between childhood obesity and 
adult LDL  
 
 
Cumulative meta-analysis, ordered by the year the study started. The vertical lines represent the 
represent the Fishers Zr while the left and right extremes of the vertical lines represent the 
corresponding 95% confidence intervals. The results of each corresponding study are pooled with 
all studies preceding it. The middle of the black diamond represents the overall Fishers Zr while 
the left and right extremes of the diamond represent the corresponding 95% confidence intervals. 
Combined measures represent those studies in which male and female were combined, or 
different age cohorts from each study were combines, or multiple readings from the same cohort 
were combined or one study using more than one exposure definition. 
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Figure 4b. Cumulative meta-analysis for the association between childhood obesity and 
adult LDL adjusted for adult BMI 
 
Cumulative meta-analysis, ordered by the year the study started. The vertical lines represent the 
represent the Fishers Zr while the left and right extremes of the vertical lines represent the 
corresponding 95% confidence intervals. The results of each corresponding study are pooled with 
all studies preceding it. The middle of the black diamond represents the overall Fishers Zr while 
the left and right extremes of the diamond represent the corresponding 95% confidence intervals. 
Combined measures represent those studies in which male and female were combined, or 
different age cohorts from each study were combines, or multiple readings from the same cohort 
were combined or one study using more than one exposure definition. 
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Figure 5a. Cumulative meta-analysis for the association between childhood obesity and 
adult HDL  
 
Cumulative meta-analysis, ordered by the year the study started. The vertical lines represent the 
represent the Fishers Zr while the left and right extremes of the vertical lines represent the 
corresponding 95% confidence intervals. The results of each corresponding study are pooled with 
all studies preceding it. The middle of the black diamond represents the overall Fishers Zr while 
the left and right extremes of the diamond represent the corresponding 95% confidence intervals. 
Combined measures represent those studies in which male and female were combined, or 
different age cohorts from each study were combines, or multiple readings from the same cohort 
were combined or one study using more than one exposure definition. 
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Figure 5b. Cumulative meta-analysis for the association between childhood obesity and 
adult HDL adjusted for adult BMI 
 
Cumulative meta-analysis, ordered by the year the study started. The vertical lines represent the 
represent the Fishers Zr while the left and right extremes of the vertical lines represent the 
corresponding 95% confidence intervals. The results of each corresponding study are pooled with 
all studies preceding it. The middle of the black diamond represents the overall Fishers Zr while 
the left and right extremes of the diamond represent the corresponding 95% confidence intervals. 
Combined measures represent those studies in which male and female were combined, or 
different age cohorts from each study were combines, or multiple readings from the same cohort 
were combined or one study using more than one exposure definition. 
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Figure 6a. Cumulative meta-analysis for the association between childhood obesity and 
adult TG  
 
Cumulative meta-analysis, ordered by the year the study started. The vertical lines represent the 
represent the Fishers Zr while the left and right extremes of the vertical lines represent the 
corresponding 95% confidence intervals. The results of each corresponding study are pooled with 
all studies preceding it. The middle of the black diamond represents the overall Fishers Zr while 
the left and right extremes of the diamond represent the corresponding 95% confidence intervals. 
Combined measures represent those studies in which male and female were combined, or 
different age cohorts from each study were combines, or multiple readings from the same cohort 
were combined or one study using more than one exposure definition. 
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Figure 6b. Cumulative meta-analysis for the association between childhood obesity and 
adult TG  
 
 
Cumulative meta-analysis, ordered by the year the study started. The vertical lines represent the 
represent the Fishers Zr while the left and right extremes of the vertical lines represent the 
corresponding 95% confidence intervals. The results of each corresponding study are pooled with 
all studies preceding it. The middle of the black diamond represents the overall Fishers Zr while 
the left and right extremes of the diamond represent the corresponding 95% confidence intervals. 
Combined measures represent those studies in which male and female were combined, or 
different age cohorts from each study were combines, or multiple readings from the same cohort 
were combined or one study using more than one exposure definition. 
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Funnel plots: 
 
 
Figure 1: Funnel plot for the association between childhood obesity and adult SBP 
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Figure 1: Funnel plot for the association between childhood obesity and adult DBP 
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Additional File 5 
 
Meta-Regression results for the association between childhood adiposity and adult cardiovascular disease (CVD) risk factors  
 
 
Table 1: Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) 
 
CVD risk factors 
  SBP DBP 
Covariate # of 
Studies 
Beta ± SE CI (95%) P-value # of 
Studies 
Beta ± SE CI (95%) P-
value 
          
Baseline Age 16 0.0104 ± 0.004 0.0025, 0.0183 0.0096 14 0.0096 ± 0.0039 0.0019, 0.0173 0.0145 
Follow-up Age 16 -0.0006 ± 0.002 -0.0045, 0.0033 0.7559 14 -0.0011 ± 0.0016 -0.0042, 0.0021 0.5116 
Length of FU 16 -0.0024 ± 0.002 -0.0063, 0.0014 0.216 14 -0.0028 ± 0.0017 -0.0062, 0.0006 0.1076 
Type of Analysis  16 0.0218 ± 0.0421 -0.0607, 0.1043 0.6046 14 0.0176 ± 0.0393 -0.0594, 0.0946 0.6535 
Country  16 0.0741 ± 0.0386 -0.0015, 0.1497 0.0548 14 0.014 ± 0.0412 -0.0668, 0.0948 0.7342 
*Sex   0.0303 ± 0.029 -0.0265, 0.0871 0.2964  -0.0304 ± 0.0294 -0.0879, 0.0272 0.3008 
*Exposure  0.0476 ± 0.0245 -0.0005, 0.0956 0.0524  0.0156 ± 0.0258 -0.0351, 0.0662 0.5465 
CVD risk factors adjusted for adult BMI 
  SBP DBP 
Baseline Age 6 0.0055 ± 0.0084 -0.011, 0.0221 0.5118 5 0.0072 ± 0.0249 -0.0416, 0.0559 0.7723 
Follow-up Age 6 -0.0046 ± 0.0015 -0.0075, -0.0017 0.0017 5 -0.006 ± 0.0014 -0.0087, -0.0032 0.0001 
Follow-up Time 6 -0.0038 ± 0.0014 -0.0066, -0.001 0.0078 5 -0.0061 ± 0.0014 -0.0089, -0.0034 0.0001 
*Sex  0.0409 ± 0.0432 -0.0438, 0.1256 0.3435  0.0165 ± 0.045 -0.0717, 0.1047 0.7141 
Type of Analysis: Correlation/Beta coefficient vs. Mean Difference/OR/RR 
Country: USA vs. Others  
Sex: Male vs. Female 
Exposure: BMI vs. Other Measures of Adiposity 
*Factors assessed using sub-group as the study of analysis instead of study as the unit of analysis 
For categorical variables, less than three results for any one category were used as the cut-off for analysis 
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Table 2: Total cholesterol (TC) and Low-density lipoprotein cholesterol (LDL): 
 
CVD risk factors 
  TC LDL 
Covariate # of 
Studies 
Beta ± SE CI (95%) P-value # of 
Studies 
Beta ± SE CI (95%) P-
value 
          
Baseline Age 8 -0.0017 ± 0.0086 -0.0186, 0.0153 0.8477 5 0.0108 ± 0.0159 -0.0204, 0.042 0.4965 
Follow-up Age 8 -0.0035 ± 0.0017 -0.0068, -0.0002 0.0379 5 -0.0049 ± 0.0013 -0.0073, -0.0024 0.0001 
Length of FU 8 -0.0036 ± 0.0014 -0.0064, -0.0008 0.0124 5 -0.0041 ± 0.0015 -0.007, -0.0013 0.0047 
Type of Analysis  
Country  8 0.0599 ± 0.0465 -0.0313, 0.1511 0.1978 
*Sex    0.0055 ± 0.0464 -0.0853, 0.0964 0.905   0.0163 ± 0.0833 -0.147, 0.1795 0.8453 
*Exposure   -0.0584 ± 0.0408 -0.1383, 0.0216 0.1526 
CVD risk factors adjusted for adult BMI 
  TC LDL 
Baseline Age 4 -0.0125 ± 0.0027 -0.0179, -0.0071 0.0001 
Follow-up Age 4 0.0023 ± 0.0028 -0.0031, 0.0077 0.4002 
Length of FU 4 0.0025 ± 0.0019 -0.0012, 0.0062 0.1903 
*Sex   -0.3151 ± 0.0444 -0.4022, -0.228 0.0001   0.0797 ± 0.0651 -0.0479, 0.2072 0.2208 
Type of Analysis: Correlation/Beta coefficient vs. Mean Difference/OR/RR 
Country: USA vs. Others  
Sex: Male vs. Female 
Exposure: BMI vs. Other Measures of Adiposity 
*Factors assessed using sub-group as the study of analysis instead of study as the unit of analysis 
For categorical variables, less than three results for any one category were used as the cut-off for analysis 
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Table 3: High-density lipoprotein cholesterol (HDL) and triglycerides (TG) 
 
 
CVD risk factors 
 
  HDL TG 
Covariate # of 
Studies 
Beta ± SE CI (95%) P-value # of 
Studies 
Beta ± SE CI (95%) P-
value 
          
Baseline Age 8 -0.0072 ± 0.0079 -0.0227, 0.0083 0.3622 8 -0.0041 ± 0.0095 -0.0227, 0.0146 0.6699 
Follow-up Age 8 0.0014 ± 0.0016 -0.0017, 0.0045 0.3754 8 -0.0091 ± 0.0016 -0.0122, -0.006 0.0001 
Length of FU 8 0.0013 ± 0.0014 -0.0015, 0.0041 0.3507 8 -0.0073 ± 0.0019 -0.011, -0.0037 0.0001 
Type of Analysis    
Country    
*Sex    0.0144 ± 0.0517 -0.0868, 0.1157 0.7798   0.0141 ± 0.0964 -0.1749, 0.2031 0.884 
*Exposure   0.0231 ± 0.0232 -0.0224, 0.0685 0.3197   -0.0237 ± 0.0329 -0.0882, 0.0408 0.4715 
 
CVD risk factors adjusted for adult BMI 
 
  HDL TG 
Baseline Age 4 0.0104 ± 0.0438 -0.0755, 0.0963 0.8123 5 -0.0208 ± 0.0112 -0.0427, 0.0011 0.0622 
Follow-up Age 4 -0.0069 ± 0.0024 -0.0115, -0.0022 0.0036 5 0.0055 ± 0.0028 0, 0.0109 0.0493 
Length of FU 4 -0.0068 ± 0.0024 -0.0115, -0.0022 0.0041 5 0.0049 ± 0.0021 0.0008, 0.0091 0.0205 
*Sex   -0.1345 ± 0.0528 -0.2381, -0.031 0.0109   0.144 ± 0.0456 0.0546, 0.2334 0.0016 
Type of Analysis: Correlation/Beta coefficient vs. Mean Difference/OR/RR 
Country: USA vs. Others  
Sex: Male vs. Female 
Exposure: BMI vs. Other Measures of Adiposity 
*Factors assessed using sub-group as the study of analysis instead of study as the unit of analysis 
For categorical variables, less than three results for any one category were used as the cut-off for analysis 
